Processing 00000000.tx.1: Elevated amyloid  protein (A42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene Nilfer Ertekin-Taner1, James Ronald1, Lars Feuk3, Jonathan Prince3, Michael Tucker4,5, Linda Younkin1, Maria Hella1, Shushant Jain1, Alyssa Hackett1, Leah Scanlin1, Jason Kelly1, Muthoni Kihiko-Ehman4,5, Matthew Neltner4,5, Louis Hersh5, Mark Kindy5, William Markesbery5, Michael Hutton1, Mariza de Andrade6, Ronald C. 

Phrase: "Elevated amyloid  protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0748024:elevated protein [Finding]
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A42"

Phrase: ")"

Phrase: "and"

Phrase: "late onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "associated with single nucleotide polymorphisms"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032529:polymorphisms [Genetic Function]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the urokinase-type plasminogen activator gene Nilfer Ertekin-Taner1,"

Phrase: "James Ronald1,"

Phrase: "Lars Feuk3,"

Phrase: "Jonathan Prince3,"

Phrase: "Michael Tucker4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "Linda Younkin1,"

Phrase: "Maria Hella1,"

Phrase: "Shushant Jain1,"

Phrase: "Alyssa Hackett1,"

Phrase: "Leah Scanlin1,"

Phrase: "Jason Kelly1,"

Phrase: "Muthoni Kihiko-Ehman4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "Matthew Neltner4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "Louis Hersh5,"

Phrase: "Mark Kindy5,"

Phrase: "William Markesbery5,"

Phrase: "Michael Hutton1,"

Phrase: "Mariza de Andrade6,"

Phrase: "Ronald C."
Processing 00000000.tx.2: Petersen7, Neill Graff-Radford2, Steve Estus4,5, Anthony J. 

Phrase: "Petersen7,"

Phrase: "Neill Graff-Radford2,"

Phrase: "Steve Estus4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "Anthony J."
Processing 00000000.tx.3: Brookes3 and Steven G. 

Phrase: "Brookes3"

Phrase: "and"

Phrase: "Steven G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.4: Younkin1,* 1Department of Neuroscience and 2Department of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA, 3Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, Sweden, 4Department of Physiology and 5Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA and 6Department of Health Sciences Research and 7Department of Neurology, Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA * To whom correspondence should be addressed. 

Phrase: "Younkin1,"

Phrase: "* 1Department of Neuroscience"

Phrase: "and"

Phrase: "2Department of Neurology,"

Phrase: "Mayo Clinic Jacksonville,"

Phrase: "4500 San Pablo Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "Jacksonville,"

Phrase: "FL 32224,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "3Center for Genomics"

Phrase: "and"

Phrase: "Bioinformatics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "4Department of Physiology"

Phrase: "and"

Phrase: "5Sanders-Brown Center on Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "University of Kentucky,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Lexington,"

Phrase: "KY,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "6Department of Health Sciences"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "and"

Phrase: "7Department of Neurology,"

Phrase: "Mayo Clinic Rochester,"

Phrase: "200 First Street SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1420193:SW [Gene or Genome]
   812   C1832169:SW [Body System]
   812   C3538902:SW [Gene or Genome]

Phrase: "Rochester,"

Phrase: "MN 55905,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.5: Email: younkin.steven{at}mayo.edu Received June 11, 2004; 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "younkin.steven{at}mayo.edu Received June 11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   793   C0454788:Mayo [Geographic Area]
   793   C1077578:mayo [Plant]
   793   C1514756:Received [Qualitative Concept]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.6: Revised October 8, 2004; 

Phrase: "Revised October 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.7: Accepted December 10, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Plasma amyloid  protein (A42) levels and late onset Alzheimer's disease (LOAD) have been linked to the same region on chromosome 10q. 

Phrase: "Accepted December 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Plasma amyloid  protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A42"

Phrase: ")"

Phrase: "levels and late onset Alzheimer's disease (LOAD)"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "linked to the same region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0445247:Same [Qualitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "on chromosome 10q."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520266:10q [Nucleotide Sequence]
Processing 00000000.tx.8: The PLAU gene within this region encodes urokinase-type plasminogen activator, which converts plasminogen to plasmin. 

Phrase: "The PLAU gene within this region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1335224:PLAU gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "urokinase-type plasminogen activator,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0042071:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Plasminogen Activator, Urokinase
           Urokinase
  1000   C1522670:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Urokinase Plasminogen Activator
           Urokinase
   923   C1335224:plasminogen activator, urokinase [Gene or Genome]
           UROKINASE
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "which"

Phrase: "converts"

Phrase: "plasminogen to plasmin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1367553:PLASMINOGEN [Gene or Genome]
Processing 00000000.tx.9: A aggregates induce PLAU expression thereby increasing plasmin, which degrades both aggregated and non-aggregated forms of A. 

Phrase: "A"

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "PLAU expression thereby"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "plasmin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "which"

Phrase: "degrades"

Phrase: "both aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "non-aggregated forms of A."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0332621:Aggregated [Functional Concept]
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   760   C1518422:Non [Functional Concept]
   726 E C0205418:Aggregate [Qualitative Concept]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.10: We evaluated single nucleotide polymorphisms (SNPs) in PLAU for association with A42 and LOAD. 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "single nucleotide polymorphisms (SNPs) in PLAU"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032529:polymorphisms [Genetic Function]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "for association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with A42"

Phrase: "and"

Phrase: "LOAD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.11: PLAU SNP compound genotypes composed of haplotype pairs showed significant association with AD in three independent casecontrol series. 

Phrase: "PLAU SNP compound genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "composed of haplotype pairs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018591:Haplotype [Organism Attribute]
   770   C1709450:Pair [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association with AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "in three independent casecontrol series."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]
Processing 00000000.tx.12: PLAU SNP haplotypes associated significantly with plasma A42 in 10 extended LOAD families. 

Phrase: "PLAU SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "significantly with plasma A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032105:Plasma [Body Substance]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "in 10 extended LOAD families."
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   868   C0015341:Extended Family [Family Group]
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C0344339:disease family [Finding]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0015576:Families [Family Group]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0231448:Extended [Functional Concept]
   790   C0231449:Extended [Spatial Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0439792:extended [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C1704727:Family [Conceptual Entity]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
   706 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.13: One of the SNPs analyzed was a missense C/T polymorphism in exon 6 of PLAU (PLAU_1=rs2227564), which causes a proline to leucine change (P141L). 

Phrase: "One of the SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "was"

Phrase: "a missense C/T polymorphism in exon 6 of PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(PLAU_1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1335224:PLAU [Gene or Genome]

Phrase: "=rs2227564"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a proline to leucine change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(P141L"

Phrase: ")."
Processing 00000000.tx.14: We analyzed PLAU_1 for association with AD in six casecontrol series and 24 extended LOAD families. 

Phrase: "We"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "PLAU_1 for association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004083:Association [Mental Process]
   770   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   770   C1335224:PLAU [Gene or Genome]

Phrase: "with AD"

Phrase: "in six casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "and"

Phrase: "24 extended LOAD families."
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
   879   C0015341:Extended Family [Family Group]
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Families [Family Group]
   791   C0205087:Late [Temporal Concept]
   791   C0231448:Extended [Functional Concept]
   791   C0231449:Extended [Spatial Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0439792:extended [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C1704727:Family [Conceptual Entity]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   708 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.15: The CT and TT PLAU_1 genotypes showed association (P=0.05) with an overall estimated odds ratio of 1.2 (1.01.5). 

Phrase: "The CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT PLAU_1 genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "(P=0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "with an overall estimated odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "of 1.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(1.01.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0450316:1/5 [Quantitative Concept]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: The CT and TT genotypes of PLAU_1 were also associated with significant age-dependent elevation of plasma A42 in 24 extended LOAD families (P=0.0006). 

Phrase: "The CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT genotypes of PLAU_1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "also"

Phrase: "associated with significant age-dependent elevation of plasma A42"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0001779:Age [Organism Attribute]
   742   C0032105:Plasma [Body Substance]
   742   C0237881:significant [Quantitative Concept]
   742   C0439775:Elevation [Therapeutic or Preventive Procedure]
   742   C0702240:Elevation [Spatial Concept]
   742   C0750502:Significant [Idea or Concept]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1546944:Significant [Qualitative Concept]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in 24 extended LOAD families"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   868   C0015341:Extended Family [Family Group]
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C0344339:disease family [Finding]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0015576:Families [Family Group]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0231448:Extended [Functional Concept]
   790   C0231449:Extended [Spatial Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0439792:extended [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C1704727:Family [Conceptual Entity]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
   706 E C0241888:Familial [Functional Concept]

Phrase: "(P=0.0006"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.17: In knockout mice lacking the PLAU gene, plasmabut not brainA42 as well as A40 was significantly elevated, also in an age-dependent manner. 

Phrase: "In knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206745:Knock-out Mice [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the PLAU gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335224:PLAU gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "plasmabut"

Phrase: "not brainA42"

Phrase: "as well as"

Phrase: "A40"

Phrase: "was"

Phrase: "significantly"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: ","

Phrase: "also in an age-dependent manner."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.18: The PLAU_1 associations were independent of the associations we found among plasma A42, LOAD and variants in the IDE or VR22 region. 

Phrase: "The PLAU_1 associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0004083:Associations [Mental Process]
   793 E C0439849:Association [Qualitative Concept]
   793 E C0596306:Association [Phenomenon or Process]
   793 E C0699792:association [Social Behavior]

Phrase: "were independent of the associations"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0332291:Independent of [Functional Concept]
   760   C0004083:Associations [Mental Process]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "we"

Phrase: "found among plasma A42,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0032105:Plasma [Body Substance]
   770   C0150312:Found [Quantitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0243095:Find [Finding]

Phrase: "LOAD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "variants in the IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:variants [Qualitative Concept]

Phrase: "or"

Phrase: "VR22 region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.19: These results provide strong evidence that PLAU or a nearby gene is involved in the development of LOAD. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "or"

Phrase: "a nearby gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "involved in the development of LOAD."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   797   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   770   C0814122:late disease onset [Finding]
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   754   C0277793:disease onset [Temporal Concept]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0205087:Late [Temporal Concept]
   738   C0243107:development [Physiologic Function]
   738   C0332162:Onset [Qualitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0678723:Development [Organism Function]
   738   C1314939:Involved [Functional Concept]
   738   C1527148:Development [Functional Concept]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.20: PLAU_1 is a plausible pathogenic mutation that could act by increasing A42, but additional biological experiments are required to show this definitively.  

Phrase: "PLAU_1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1335224:PLAU [Gene or Genome]

Phrase: "is"

Phrase: "a plausible pathogenic mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "could"

Phrase: "act by increasing A42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0442808:Increasing [Functional Concept]

Phrase: "but"

Phrase: "additional biological experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "this definitively."
Processing 00000000.tx.21: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  In previous studies, we and others showed that plasma amyloid  protein (A42) (1) and late onset Alzheimer's disease (LOAD) (2) are linked to a locus at 81cM on chromosome 10. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES  In previous studies,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   802   C2985663:Study Reference [Intellectual Product]
   770   C0205156:Previous [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1514811:Reference [Idea or Concept]
   770   C1552607:previous [Temporal Concept]
   770   C1706462:Reference [Conceptual Entity]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that plasma amyloid  protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A42"

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "late onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(LOAD"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   901   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   799   C0205087:Late [Temporal Concept]
   799   C0332162:Onset [Qualitative Concept]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "are"

Phrase: "linked to a locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1708726:Locus [Gene or Genome]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "at 81cM"

Phrase: "on chromosome 10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.22: Together these two independent studies provide strong evidence for a novel Alzheimer's disease (AD) risk gene at this locus that acts on A42. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these two independent studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C0681367:independent study [Educational Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence for a novel Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "(AD)"

Phrase: "risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "gene at this locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1708726:Gene Locus [Gene or Genome]
   770   C0017337:Gene [Gene or Genome]

Phrase: "that acts on A42."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0079613:ACT [Therapeutic or Preventive Procedure]
Processing 00000000.tx.23: The urokinase-type plasminogen activator gene (PLAU) is located on chromosome 10q2122 at 95cM within the 1LOD support interval of the linkage peak at 81cM. 

Phrase: "The urokinase-type plasminogen activator gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C1367553:Plasminogen Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0042071:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Plasminogen Activator, Urokinase
   771   C1522670:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Urokinase Plasminogen Activator
   722   C1335224:plasminogen activator, urokinase [Gene or Genome]

Phrase: "(PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "located on chromosome 10q2122"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0008633:Chromosome [Cell Component]

Phrase: "at 95cM"

Phrase: "within the 1LOD support interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]

Phrase: "of the linkage peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "at 81cM."
Processing 00000000.tx.24: Urokinase-type plasminogen activator is a serine protease that converts plasminogen to plasmin (3). 

Phrase: "Urokinase-type plasminogen activator"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0042071:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Plasminogen Activator, Urokinase
           Urokinase
  1000   C1522670:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Urokinase Plasminogen Activator
           Urokinase
   923   C1335224:plasminogen activator, urokinase [Gene or Genome]
           UROKINASE
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "a serine protease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "that"

Phrase: "converts"

Phrase: "plasminogen to plasmin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.25: PLAU expression is induced by A aggregates, and plasmin degrades both aggregated and non-aggregated A in vitro in a possible negative feedback loop. 

Phrase: "PLAU expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "induced by A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "degrades"

Phrase: "both aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "non-aggregated A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregated [Functional Concept]
   827   C1518422:Non [Functional Concept]
   793 E C0205418:Aggregate [Qualitative Concept]

Phrase: "in vitro in a possible negative feedback loop."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.26: Thus, PLAU could have an important role in controlling A aggregation, which is widely believed to play an important role in AD pathogenesis. 

Phrase: "Thus,"

Phrase: "PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "could"

Phrase: "have"

Phrase: "an important role in controlling A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0035820:Role [Social Behavior]
   753   C0332298:controlling [Functional Concept]
   753   C1705810:Role [Conceptual Entity]
   753   C2587213:Controlling [Functional Concept]

Phrase: "aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "widely"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in AD pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.27: A is the major proteinaceous component of senile plaques, one of the main pathologic hallmarks of AD (4). 

Phrase: "A"

Phrase: "is"

Phrase: "the major proteinaceous component of senile plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "one of the main pathologic hallmarks of AD (4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205447:One [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.28: A composed of 42(43) amino acids (A42) is present in all senile plaques, and A40 is also found in most cases (5). 

Phrase: "A"

Phrase: "composed of 42"

Phrase: "(43"

Phrase: ")"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(A42"

Phrase: ")"

Phrase: "is"

Phrase: "present in all senile plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "A40"

Phrase: "is"

Phrase: "also"

Phrase: "found in most cases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C0243095:Find [Finding]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.29: A42 was shown to be elevated in serum, brain and cell culture studies performed in patients and animal models of familial AD due to known autosomal dominant mutations (612). 

Phrase: "A42"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elevated in serum,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205250:Elevated [Qualitative Concept]
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cell culture studies"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   966   C0681854:cell culture study [Research Activity]
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0947630:studies [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "performed in patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "animal models of familial AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599779:Models, Animal [Animal]
   760   C0003062:Animal [Animal]
   760   C3161035:Models [Intellectual Product]
   745   C3640174:Model Family [Intellectual Product]

Phrase: "due to known autosomal dominant mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(612"

Phrase: ")."
Processing 00000000.tx.30: Some of these studies have also shown elevations in A40, though not as consistently and to the same degree as A42. 

Phrase: "Some of these studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C3540770:Some [Intellectual Product]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "elevations in A40,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0702240:elevations [Spatial Concept]
   756 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "though"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "as"

Phrase: "consistently"

Phrase: "and to the same degree"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441889:Degree [Qualitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1515981:And [Idea or Concept]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "as A42."
Processing 00000000.tx.31: Thus, it is postulated that although both A42 and A40 associate with one of the pathogenic hallmarks of AD, owing to its consistent and more prominent presence along with the biochemical properties of greater fibrillogenicity and aggregation potential, A42 is a more pathogenic biomarker of AD. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "postulated"

Phrase: "that"

Phrase: "although"

Phrase: "both A42"

Phrase: "and"

Phrase: "A40"

Phrase: "associate with one of the pathogenic hallmarks of AD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205447:One [Quantitative Concept]
   742   C0450254:Pathogenic [Organism]
   742   C0750490:Associate [Idea or Concept]
   742   C1706221:Associate [Professional or Occupational Group]

Phrase: "owing to its consistent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332290:Consistent [Idea or Concept]
   928 E C0332529:Consistencies [Qualitative Concept]
   928 E C1547017:Consistency [Quantitative Concept]

Phrase: "and"

Phrase: "more prominent presence along with the biochemical properties of greater fibrillogenicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "aggregation potential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "A42"

Phrase: "is"

Phrase: "a more pathogenic biomarker of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005516:Biomarker [Clinical Attribute]
Processing 00000000.tx.32: Given its genomic location and potential functional relevance to AD, we tested PLAU as a candidate gene for LOAD. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "its genomic location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "and"

Phrase: "potential functional relevance to AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevance [Qualitative Concept]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "PLAU as a candidate gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1335224:PLAU gene [Gene or Genome]
           PLAU
   760   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "for LOAD."
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   877   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   818   C0002395:Alzheimer's Disease [Disease or Syndrome]
   818   C1521724:Alzheimer's Disease [Pathologic Function]
   795   C0012634:Disease [Disease or Syndrome]
   795   C0205087:Late [Temporal Concept]
   795   C0332162:Onset [Qualitative Concept]
   795   C0441889:Levels [Qualitative Concept]
   795   C0521125:For [Qualitative Concept]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   740 E C1836721:MALS [Finding]
   740 E C3538764:MALS [Gene or Genome]
   740 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.33: PLAU is a relatively small, 5970bp gene found on the NT_008583 chromosome 10 contig and also defined by the AF377330 sequence (www.ncbi.nlm.nih.gov). 

Phrase: "PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "is"

Phrase: "a relatively small, 5970bp gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "found on the NT_008583 chromosome 10 contig"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0008652:Chromosome 10 [Cell Component]
   744   C0008633:Chromosome [Cell Component]
   744   C0150312:Found [Quantitative Concept]
   744   C0332126:NT [Qualitative Concept]
   744   C1449832:NT [Diagnostic Procedure]
   744   C1511491:Contig [Spatial Concept]
   711 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "also"

Phrase: "defined by the AF377330 sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "(www.ncbi.nlm.nih.gov"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1419208:GOV [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.34: We genotyped a total of seven single nucleotide polymorphisms (SNPs) spanning the whole length of this gene from the 72nd to the 5885th bp. 

Phrase: "We"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "a total of seven single nucleotide polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]

Phrase: "(SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ")"

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the whole length of this gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "from the 72nd"

Phrase: "to the 5885th bp."
Processing 00000000.tx.35: We found evidence for significant linkage disequilibrium (LD) among these variants, allowing for complex genotype analysis. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "evidence for significant linkage disequilibrium (LD)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "among these variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "allowing for complex genotype analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0017431:Genotype [Organism Attribute]
   760   C0439855:Complex [Qualitative Concept]
   760   C0683607:allowing [Social Behavior]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.36: In this article, we initially depict the results of the association analyses between plasma A42 and PLAU haplotypes in 10 LOAD families and between AD and PLAU compound genotypes forming the haplotype pairs in three casecontrol series. 

Phrase: "In this article,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "we initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "depict"

Phrase: "the results of the association analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "between plasma A42"

Phrase: "and"

Phrase: "PLAU haplotypes in 10 LOAD families"
Meta Candidates (Total=23; Excluded=4; Pruned=0; Remaining=19)
   797   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   785   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   772   C1864828:ALZHEIMER DISEASE 10 [Disease or Syndrome]
           Alzheimer Disease, Familial, 10
   770   C0814122:late disease onset [Finding]
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C0344339:disease family [Finding]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   754   C0277793:disease onset [Temporal Concept]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0015576:Families [Family Group]
   738   C0018591:Haplotypes [Organism Attribute]
   738   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   738   C0205087:Late [Temporal Concept]
   738   C0332162:Onset [Qualitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C1335224:PLAU [Gene or Genome]
   738   C1704727:Family [Conceptual Entity]
   730   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   712 E C0277558:Familial disease [Disease or Syndrome]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "and between AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "PLAU compound genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "the haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "pairs in three casecontrol series."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205449:Three [Quantitative Concept]
   760   C0205549:Series [Quantitative Concept]
   760   C1709450:Pair [Qualitative Concept]
   760   C2348044:Series [Intellectual Product]
Processing 00000000.tx.37: After establishing significant association between PLAU variants and two AD phenotypes, plasma A42 levels and AD-affected status, we focus on a single missense mutation in a larger data set of 24 LOAD families and six casecontrol series. 

Phrase: "After"

Phrase: "establishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establishing [Qualitative Concept]

Phrase: "significant association between PLAU variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "two AD phenotypes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "plasma A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "AD-affected status,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449438:Status [Qualitative Concept]

Phrase: "we focus on a single missense mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205234:Focus [Spatial Concept]
   748   C1285542:focus [Functional Concept]

Phrase: "in a larger data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0150098:Data Set [Intellectual Product]
   901   C1706233:Dataset [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "of 24 LOAD families"
Meta Candidates (Total=18; Excluded=7; Pruned=0; Remaining=11)
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Families [Family Group]
   791   C0205087:Late [Temporal Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332285:Of [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C1704727:Family [Conceptual Entity]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   708 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "six casecontrol series."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]
Processing 00000000.tx.38: The missense mutation is a variant in exon 6 (rs2227564=PLAU_1) that causes a proline to leucine change (P141L) within the kringle domain of PLAU at the junction between two -pleated sheets (13,14). 

Phrase: "The missense mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599155:Missense Mutation [Genetic Function]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "a variant in exon 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "(rs2227564"

Phrase: "=PLAU_1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1335224:PLAU [Gene or Genome]

Phrase: ")"

Phrase: "that"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a proline to leucine change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(P141L"

Phrase: ")"

Phrase: "within the kringle domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0064417:Kringle Domain [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "at the junction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205144:Junction [Spatial Concept]
  1000   C1706311:Junction [Medical Device]

Phrase: "between two -pleated sheets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439643:Sheets [Spatial Concept]
   793 E C2349187:Sheet [Quantitative Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.39: The minor T variant of PLAU_1 does not appear to affect PLAU activity, but Yoshimoto etal. 

Phrase: "The minor T variant of PLAU_1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variant [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "PLAU activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "Yoshimoto etal."
Processing 00000000.tx.40: (14) have reported that the P141-PLAU zymogen binds fibrin aggregates less efficiently than the L141-PLAU zymogen, suggesting the possibility of altered extracellular PLAU localization or stability. 

Phrase: "(14"

Phrase: ")"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the P141-PLAU zymogen"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014436:zymogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734 E C0015852:Fermentation [Molecular Function]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "fibrin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0015982:Fibrin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   928 E C0443215:Fibrinous [Qualitative Concept]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "less efficiently than the L141-PLAU zymogen,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0439092:Less Than [Intellectual Product]
           less
   748   C0014436:zymogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0547044:Less [Qualitative Concept]
   748   C1335224:PLAU [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility of altered extracellular PLAU localization"

Phrase: "or"

Phrase: "stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.41: Previously, Finckh etal. 

Phrase: "Previously,"

Phrase: "Finckh etal."
Processing 00000000.tx.42: (15) have shown significant association between the major C/C genotype of rs2227564 and LOAD in their series from Germany, Switzerland and Italy. 

Phrase: "(15"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association between the major C/C genotype of rs2227564"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "LOAD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]

Phrase: "in their series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "from Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: "and"

Phrase: "Italy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]
Processing 00000000.tx.43: In this article, we show evidence of significant association between LOAD and the minor allele of this variant and discuss potential reasons for the discrepancy. 

Phrase: "In this article,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "evidence of significant association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between LOAD"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   877   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   818   C0002395:Alzheimer's Disease [Disease or Syndrome]
   818   C1521724:Alzheimer's Disease [Pathologic Function]
   795   C0012634:Disease [Disease or Syndrome]
   795   C0205087:Late [Temporal Concept]
   795   C0205103:Between [Spatial Concept]
   795   C0332162:Onset [Qualitative Concept]
   795   C0441889:Levels [Qualitative Concept]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   740 E C1836721:MALS [Finding]
   740 E C3538764:MALS [Gene or Genome]
   740 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "the minor allele of this variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "discuss"

Phrase: "potential reasons for the discrepancy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.44: We find evidence of significant association with PLAU variants in both extended LOAD families and independent casecontrol series using both plasma A42 and LOAD-affected status as the phenotypes. 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "evidence of significant association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with PLAU variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "in both extended LOAD families"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   868   C0015341:Extended Family [Family Group]
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C0344339:disease family [Finding]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0015576:Families [Family Group]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0231448:Extended [Functional Concept]
   790   C0231449:Extended [Spatial Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0439792:extended [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C1704727:Family [Conceptual Entity]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
   706 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "independent casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both plasma A42"

Phrase: "and"

Phrase: "LOAD-affected status"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   793   C0441889:Levels [Qualitative Concept]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]

Phrase: "as the phenotypes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031437:Phenotypes [Organism Attribute]
   966 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.45: In addition, we provide functional data from PLAU knock out (KO) mice, supporting the role of this gene in A metabolism. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "functional data from PLAU knock out (KO) mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the role of this gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: "metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.46: Our results are depicted subsequently.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "depicted"

Phrase: "subsequently."
Processing 00000000.tx.47: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Identification of SNPs, haplotypes and compound genotypes in PLAU We identified six SNPs by sequencing PLAU exons in LOAD family members. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Identification of SNPs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "compound genotypes in PLAU"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "six SNPs by sequencing PLAU exons"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   800   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   767   C0004793:nucleotide sequencing [Nucleotide Sequence]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032529:polymorphisms [Genetic Function]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in LOAD family members."
Meta Candidates (Total=23; Excluded=9; Pruned=0; Remaining=14)
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0086282:Family Members [Family Group]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Family [Family Group]
   791   C0150312:In [Quantitative Concept]
   791   C0205087:Late [Temporal Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C0680022:members [Population Group]
   791   C1704727:Family [Conceptual Entity]
   774 E C1611821:Family Member [Intellectual Product]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2698041:Member [Professional or Occupational Group]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   720 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.48: An additional SNP in exon 2 was identified using the public SNP databases. 

Phrase: "An additional SNP in exon 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0752046:SNP [Nucleotide Sequence]
   753   C1527094:SNP [Conceptual Entity]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the public SNP databases."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0242356:Databases [Intellectual Product]
   793 E C0993637:Database [Intellectual Product]
Processing 00000000.tx.49: The seven PLAU SNPs, their locations and NCBI SNP names are summarized in Table 1. 

Phrase: "The seven PLAU SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:polymorphisms [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "their locations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0450429:locations [Spatial Concept]
   966 E C1515974:Location [Body Location or Region]

Phrase: "and"

Phrase: "NCBI SNP names"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027365:Name [Intellectual Product]
   827   C1547383:Name [Intellectual Product]

Phrase: "are"

Phrase: "summarized in Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.50: These SNPs, which spanned 5.8kb in the PLAU gene, were analyzed in the 10 LOAD families used to link plasma A42 to chromosome 10 (1). 

Phrase: "These SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "which"

Phrase: "spanned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "5.8kb in the PLAU gene,"

Phrase: "were"

Phrase: "analyzed in the 10 LOAD families"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   797   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   785   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   772   C1864828:ALZHEIMER DISEASE 10 [Disease or Syndrome]
           Alzheimer Disease, Familial, 10
   770   C0814122:late disease onset [Finding]
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C0344339:disease family [Finding]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   754   C0277793:disease onset [Temporal Concept]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0015576:Families [Family Group]
   738   C0205087:Late [Temporal Concept]
   738   C0332162:Onset [Qualitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0936012:Analyzed [Research Activity]
   738   C1704727:Family [Conceptual Entity]
   730   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   712 E C0277558:Familial disease [Disease or Syndrome]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "plasma A42 to chromosome 10"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.51: In addition, they were genotyped in three independent casecontrol series collected at Mayo Clinic Rochester (MCR), Mayo Clinic Jacksonville (MCJ) and University of Kentucky (UKy). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "they"

Phrase: "were"

Phrase: "genotyped in three independent casecontrol series"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0085862:Independent [Idea or Concept]
   753   C0205449:Three [Quantitative Concept]
   753   C0205549:Series [Quantitative Concept]
   753   C1299583:Independent [Finding]
   753   C2348044:Series [Intellectual Product]
   719   C0017431:Genotype [Organism Attribute]

Phrase: "collected at Mayo Clinic Rochester (MCR),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0454788:Mayo [Geographic Area]
   760   C1077578:mayo [Plant]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "Mayo Clinic Jacksonville (MCJ)"

Phrase: "and"

Phrase: "University of Kentucky (UKy)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
Processing 00000000.tx.52: The SNP allele frequencies, deviations from HardyWeinberg equilibrium (HWE) and allelic association results are summarized in Table 2. 

Phrase: "The SNP allele frequencies,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   901   C0017270:Frequencies, Allele [Quantitative Concept]
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "deviations from HardyWeinberg equilibrium (HWE)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012727:Deviation [Spatial Concept]
   737   C0205419:Deviation [Qualitative Concept]
   737   C1705236:Deviation [Finding]

Phrase: "and"

Phrase: "allelic association results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "are"

Phrase: "summarized in Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.53: Given that the two exon 11 SNPs are in complete LD, the results for only one of these exon 11 SNPs are summarized in Table 2. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "the two exon 11 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   799   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0032529:polymorphisms [Genetic Function]
   799   C0037179:Single [Population Group]
   799   C0087136:single [Finding]
   799   C0205171:Single [Quantitative Concept]
   766 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are in complete LD,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   806   C1880153:Complete Linkage [Research Activity]
   760   C0023745:linkage [Molecular Function]
   760   C0205197:Complete [Qualitative Concept]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0725685:COMPLEAT [Food]
   760   C1551058:Are [Quantitative Concept]

Phrase: "the results for only one of these exon 11 SNPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   703   C1274040:Result [Functional Concept]
   703   C1546471:Result [Idea or Concept]
   703   C2825142:Result [Finding]

Phrase: "are"

Phrase: "summarized in Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.54: In summary, the rare exon 2 SNP showed HardyWeinberg disequilibrium in the MCJ and MCR series in both the case and the control groups. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the rare exon 2 SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0752046:SNP [Nucleotide Sequence]
   812   C1527094:SNP [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "HardyWeinberg disequilibrium in the MCJ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0281825:Disequilibrium [Finding]
   748   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "MCR series in both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]
   748   C2985404:Clinical Series [Research Activity]

Phrase: "the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "the control groups."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.55: Apart from this, there was only one instance where an SNP deviated significantly from the HWE in the control group (exon 6 SNP=PLAU_1 in MCJ controls). 

Phrase: "Apart from this,"

Phrase: "there"

Phrase: "was"

Phrase: "only one instance where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1550608:Instance [Idea or Concept]

Phrase: "an SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "deviated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012727:Deviated [Spatial Concept]

Phrase: "significantly from the HWE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]

Phrase: "in the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(exon 6 SNP=PLAU_1 in MCJ controls"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   739   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   739   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   739   C0454788:Mayo [Geographic Area]
   739   C0752046:SNP [Nucleotide Sequence]
   739   C1077578:mayo [Plant]
   739   C1335224:PLAU [Gene or Genome]
   739   C1527094:SNP [Conceptual Entity]
   706   C0243148:control [Qualitative Concept]
   706   C1550141:Control [Substance]
   706   C1882979:Control [Conceptual Entity]
   706   C2587213:Control [Functional Concept]
   706   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.56: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.57: PLAU SNPs and haplotypes  View this table: [in this window] [in a new window]  Table 2. 

Phrase: "PLAU SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.58: PLAU SNP frequencies  From the PLAU SNP genotypes of the family members, PLAU SNP haplotypes were identified using the haplotyping algorithm within the computer program Simwalk2 (17,18). 

Phrase: "PLAU SNP frequencies  From the PLAU SNP genotypes of the family members,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   736   C0439603:Frequencies [Temporal Concept]
   703 E C0376249:frequency [Quantitative Concept]
   703 E C0871396:Frequency [Quantitative Concept]
   703 E C1561548:Frequency [Qualitative Concept]
   703 E C1705502:Frequency [Quantitative Concept]

Phrase: "PLAU SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the haplotyping algorithm within the computer program Simwalk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0002045:algorithm [Intellectual Product]
   744   C1553907:algorithm [Laboratory Procedure]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.59: Three major PLAU SNP haplotypes were identified, as were three minor haplotypes. 

Phrase: "Three major PLAU SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "were"

Phrase: "three minor haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.60: Collectively, the six PLAU SNP haplotypes accounted for >95% of all of the haplotypes in these families. 

Phrase: "Collectively,"

Phrase: "the six PLAU SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: ">95% of all of the haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018591:Haplotypes [Organism Attribute]

Phrase: "in these families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.61: The frequency of each PLAU SNP haplotype in the 10 AD families is summarized in Table 1. 

Phrase: "The frequency of each PLAU SNP haplotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "in the 10 AD families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "is"

Phrase: "summarized in Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.62: Because there was profound LD (D'>0.95 for all SNPs and d2>0.4 for all SNPs except exon 8 SNP), only five of the seven SNPs were required to construct all six haplotypes. 

Phrase: "Because"

Phrase: "there"

Phrase: "was"

Phrase: "profound LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "("

Phrase: "D'>"

Phrase: "0.95 for all SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "d2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414052:D2 [Gene or Genome]
  1000   C1415944:D2 [Gene or Genome]

Phrase: ">0.4 for all SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "except exon 8 SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0752046:SNP [Nucleotide Sequence]
   827   C1527094:SNP [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "only five of the seven SNPs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   800   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032529:polymorphisms [Genetic Function]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Only [Quantitative Concept]
           Single
   744   C0205451:Five [Quantitative Concept]
   744   C0205453:Seven [Quantitative Concept]
   744   C1720467:Only [Intellectual Product]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "all six haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.63: Table 3 summarizes the LD parameters, Lewontin's standardized disequilibrium coefficient (19) D' and d2, estimated from the founders in the 10 extended LOAD families. 

Phrase: "Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "summarizes"

Phrase: "the LD parameters,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0449381:Parameters [Finding]
   793 E C0549193:Parameter [Spatial Concept]
   793 E C1704769:Parameter [Conceptual Entity]
   793 E C2350001:Parameter [Quantitative Concept]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "Lewontin's standardized disequilibrium coefficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707429:*Coefficient [Quantitative Concept]

Phrase: "(19"

Phrase: ")"

Phrase: "D'"

Phrase: "and"

Phrase: "d2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414052:D2 [Gene or Genome]
  1000   C1415944:D2 [Gene or Genome]

Phrase: "estimated from the founders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0263541:founders [Disease or Syndrome]
   770   C0750572:Estimated [Quantitative Concept]

Phrase: "in the 10 extended LOAD families."
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   860   C0015341:Extended Family [Family Group]
   832   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   801   C0002395:Alzheimer's Disease [Disease or Syndrome]
   801   C0344339:disease family [Finding]
   801   C1521724:Alzheimer's Disease [Pathologic Function]
   788   C0012634:Disease [Disease or Syndrome]
   788   C0015576:Families [Family Group]
   788   C0150312:In [Quantitative Concept]
   788   C0205087:Late [Temporal Concept]
   788   C0231448:Extended [Functional Concept]
   788   C0231449:Extended [Spatial Concept]
   788   C0332162:Onset [Qualitative Concept]
   788   C0332285:In [Spatial Concept]
   788   C0439792:extended [Spatial Concept]
   788   C0441889:Levels [Qualitative Concept]
   788   C1704727:Family [Conceptual Entity]
   755 E C0456079:Level [Classification]
   755 E C1547707:Level [Geographic Area]
   755 E C2946261:Level [Pharmacologic Substance]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]
   705 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.64: The profound LD between the SNPs can easily be appreciated in this table. 

Phrase: "The profound LD between the SNPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0023746:Linkage Disequilibrium [Quantitative Concept]
   762   C1883037:Single Linkage [Research Activity]
   742   C0023745:linkage [Molecular Function]
   742   C0281825:Disequilibrium [Finding]
   742   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "can"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "be"

Phrase: "appreciated in this table."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.65: Exon 11 deletion mutant was in complete LD with the other exon 11 SNP. 

Phrase: "Exon 11 deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was in complete LD"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   806   C1880153:Complete Linkage [Research Activity]
   760   C0023745:linkage [Molecular Function]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0205197:Complete [Qualitative Concept]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0725685:COMPLEAT [Food]
   760   C1421478:WAS [Gene or Genome]

Phrase: "with the"

Phrase: "other exon 11 SNP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0752046:SNP [Nucleotide Sequence]
   827   C1527094:SNP [Conceptual Entity]
Processing 00000000.tx.66: Exon 2 SNP was too rare to yield meaningful results. 

Phrase: "Exon 2 SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0752046:SNP [Nucleotide Sequence]
   827   C1527094:SNP [Conceptual Entity]

Phrase: "was"

Phrase: "too rare to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0521114:Rare [Temporal Concept]
   827   C0522498:Rare [Qualitative Concept]
   827   C1514917:RARE [Gene or Genome]

Phrase: "yield"

Phrase: "meaningful results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.67: Thus, these two SNPs were omitted from the LD analysis. 

Phrase: "Thus,"

Phrase: "these two SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "omitted from the LD analysis."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   783   C0796345:analysis linkage [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0023745:linkage [Molecular Function]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C0750563:omitted [Idea or Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.68: LD was also estimated in the MCR, MCJ and UKy series within the cases and controls and yielded similar results. 

Phrase: "LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "also"

Phrase: "estimated in the MCR,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   753   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   753   C0454788:Mayo [Geographic Area]
   753   C0750572:Estimated [Quantitative Concept]
   753   C1077578:mayo [Plant]
   748   C1441517:Clinical.estimated [Laboratory Procedure]

Phrase: "MCJ"

Phrase: "and"

Phrase: "UKy series within the cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0150093:Case Series [Research Activity]
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "yielded similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
Processing 00000000.tx.69: As each individual carries two haplotypes, we termed the genotype formed by these two haplotypes as compound genotypes. 

Phrase: "As each individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "two haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "we"

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "the genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "formed by these two haplotypes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0018591:Haplotypes [Organism Attribute]
   760   C0205431:Formed [Functional Concept]
   760   C0205448:Two [Quantitative Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "as compound genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.70: As described subsequently, each compound genotype essentially unambiguously defines a haplotype pair due to profound LD between PLAU SNPs and limited haplotype diversity. 

Phrase: "As"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "subsequently,"

Phrase: "each compound genotype essentially unambiguously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0017431:Genotype [Organism Attribute]
   812   C0205198:Compound [Qualitative Concept]
   812   C1706082:Compound [Chemical]

Phrase: "defines"

Phrase: "a haplotype pair due to profound LD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709450:Pair [Qualitative Concept]

Phrase: "between PLAU SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "limited haplotype diversity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.71: We next tested for association between plasma A42 levels and PLAU haplotypes. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested for association"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0392366:tested [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "between plasma A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "PLAU haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.72: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.73: PLAU SNPs LD  Association of PLAU variants with plasma A42 levels in 10 LOAD families To test for association between plasma A42 and PLAU variants in family members, we used the variance components methodology implemented in the computer program SOLAR (20). 

Phrase: "PLAU SNPs LD  Association of PLAU variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "with plasma A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "in 10 LOAD families To"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C0344339:disease family [Finding]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0015576:Families [Family Group]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C1704727:Family [Conceptual Entity]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
   706 E C0241888:Familial [Functional Concept]

Phrase: "test for association"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0004083:Association [Mental Process]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:test [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "between plasma A42"

Phrase: "and"

Phrase: "PLAU variants in family members,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the variance components methodology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0969625:methodology [Intellectual Product]
   827   C3266812:Methodology [Idea or Concept]

Phrase: "implemented in the computer program"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0037585:Computer Program [Intellectual Product,Manufactured Object]
   760   C0009622:Computer [Manufactured Object]
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]

Phrase: "SOLAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0038817:Sun [Natural Phenomenon or Process]
   944   C0376223:Sun [Geographic Area]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.74: Using the within-pedigree identity-by-state model of Hopper and Mathews (21), PLAU SNP haplotypes were initially analyzed in family members between the ages of 20 and 65 years because this was the age group in which plasma A42 was linked to the chromosome 10 locus (1). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the within-pedigree identity-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030761:Pedigree [Intellectual Product]
   770   C0424215:Identity [Mental Process]
   770   C2003939:Identity [Finding]

Phrase: "by-state model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of Hopper"

Phrase: "and"

Phrase: "Mathews"

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "PLAU SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "analyzed in family members"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0086282:Family Members [Family Group]
   799 E C1611821:Family Member [Intellectual Product]
   770   C0015576:Family [Family Group]
   770   C0680022:members [Population Group]
   770   C0936012:Analyzed [Research Activity]
   770   C1704727:Family [Conceptual Entity]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "between the ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 20"

Phrase: "and"

Phrase: "65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "because"

Phrase: "this"

Phrase: "was"

Phrase: "the age group in which plasma A42"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0027362:Age Group [Age Group]
   778   C2348001:Age Group [Population Group]
   748   C0001779:Age [Organism Attribute]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "linked to the chromosome 10 locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0008652:Chromosome 10 [Cell Component]
   753   C0008633:Chromosome [Cell Component]
   753   C1708726:Locus [Gene or Genome]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.75: In this age group, there was no significant association between PLAU variants and plasma A42 levels (Table 4). 

Phrase: "In this age group,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0027362:Age Group [Age Group]
  1000   C2348001:Age Group [Population Group]
   861   C0001779:Age [Organism Attribute]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "there"

Phrase: "was"

Phrase: "no significant association between PLAU variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "plasma A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.76: Inspection of our data suggested that there might be an association between PLAU SNP haplotypes and plasma A42 in older family members, so we performed a second analysis using family members of all ages. 

Phrase: "Inspection of our data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0199219:Inspection [Functional Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "might"

Phrase: "be"

Phrase: "an association between PLAU SNP haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "plasma A42 in older family members,"

Phrase: "so"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a second analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "family members of all ages."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0086282:Family Members [Family Group]
   773 E C1611821:Family Member [Intellectual Product]
   760   C0015576:Family [Family Group]
   760   C0680022:members [Population Group]
   760   C1704727:Family [Conceptual Entity]
   726 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.77: Remarkably, this group showed significant association between PLAU SNP haplotypes and plasma A42 (P=0.02), with PLAU association accounting for an estimated 12% of the total variance in A42. 

Phrase: "Remarkably,"

Phrase: "this group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association between PLAU SNP haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "plasma A42"

Phrase: "(P=0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "with PLAU association accounting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0000938:Accounting [Occupational Activity]

Phrase: "for an estimated 12%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750572:Estimated [Quantitative Concept]

Phrase: "of the total variance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C1711260:Variance [Qualitative Concept]
   861   C2348152:Variance [Quantitative Concept]
   789 E C0205419:Variant [Qualitative Concept]

Phrase: "in A42."
Processing 00000000.tx.78: View this table: [in this window] [in a new window]  Table 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.79: Association of PLAU SNP haplotypes with plasma A42 in 10 LOAD families  Association of PLAU variants with AD in three casecontrol series Our working hypothesis is that any gene with variants influencing A42 is likely to have variants influencing risk for AD. 

Phrase: "Association of PLAU SNP haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with plasma A42"

Phrase: "in 10 LOAD families  Association"
Meta Candidates (Total=25; Excluded=7; Pruned=0; Remaining=18)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   813   C1511978:Disease Association [Temporal Concept]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C0344339:disease family [Finding]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0004083:Association [Mental Process]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0015576:Families [Family Group]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0439849:Association [Qualitative Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   790   C1704727:Family [Conceptual Entity]
   762   C0544093:Association, familial [Finding]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
   706 E C0241888:Familial [Functional Concept]

Phrase: "of PLAU variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "with AD"

Phrase: "in three casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "Our working hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043227:Working [Occupational Activity]
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "that"

Phrase: "any gene with variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "influencing"

Phrase: "A42"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "influencing"

Phrase: "risk for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.80: To determine whether PLAU has variants that are associated with AD in casecontrol series, we analyzed the PLAU SNPs in three independent series obtained at MCR, MCJ and UKy. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "has"

Phrase: "variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "associated with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in casecontrol series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the PLAU SNPs in three independent series"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   742   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0032529:polymorphisms [Genetic Function]
   742   C0037179:Single [Population Group]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "obtained at MCR,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0454788:Mayo [Geographic Area]
   760   C1077578:mayo [Plant]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "MCJ"

Phrase: "and"

Phrase: "UKy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
Processing 00000000.tx.81: All three series were entirely composed of Caucasian subjects, and in every AD patient the age of onset was 59 years. 

Phrase: "All three series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "entirely"

Phrase: "composed of Caucasian subjects,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0007457:Caucasian [Population Group]
   770   C0043157:Caucasian [Population Group]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and in every AD patient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030705:*^patient [Patient or Disabled Group]
   760   C1515981:And [Idea or Concept]

Phrase: "the age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "59 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.82: Using the computer program GOLD (22) to analyze the PLAU SNPs, we determined that there is profound LD among the five PLAU SNPs in the casecontrol series similar to the LOAD family founders (data not shown). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the computer program GOLD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1304897:Gold [Functional Concept]
   734   C0037585:Computer Program [Intellectual Product,Manufactured Object]

Phrase: "(22"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the PLAU SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "we"

Phrase: "determined"

Phrase: "that there"

Phrase: "is"

Phrase: "profound LD among the five PLAU SNPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023746:Linkage Disequilibrium [Quantitative Concept]
   757   C1883037:Single Linkage [Research Activity]
   739   C0023745:linkage [Molecular Function]
   739   C0281825:Disequilibrium [Finding]
   739   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "in the casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "similar to the LOAD family founders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2348205:Similar [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.83: An important consequence of the profound LD among the five PLAU SNPs that we analyzed was that there were relatively few common genotypes such that 96100% of the subjects were accounted for by only 12 compound genotypes (Table 5). 

Phrase: "An important consequence of the profound LD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "among the five PLAU SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:polymorphisms [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "was"

Phrase: "that there"

Phrase: "were"

Phrase: "relatively few common genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "such"

Phrase: "that 96100% of the subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by only 12 compound genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: In Table 5, the two haplotypes producing six of the 12 compound genotypes (A, D, F, I, J and K) were unambiguous, because no more than one SNP was heterozygous. 

Phrase: "In Table 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "the two haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "producing"

Phrase: "six of the 12 compound genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017431:Genotypes [Organism Attribute]
   753   C0205198:Compound [Qualitative Concept]
   753   C0205452:Six [Quantitative Concept]
   753   C1706082:Compound [Chemical]

Phrase: "(A"

Phrase: ","

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J"

Phrase: "and"

Phrase: "K)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "were"

Phrase: "unambiguous,"

Phrase: "because"

Phrase: "no more than one SNP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205447:One [Quantitative Concept]
   760   C0752046:SNP [Nucleotide Sequence]
   760   C1298908:no [Idea or Concept]
   760   C1527094:SNP [Conceptual Entity]
   760   C1549444:No [Idea or Concept]

Phrase: "was"

Phrase: "heterozygous."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]
Processing 00000000.tx.85: Each of the remaining six genotypes is produced by one and only one pair of the six haplotypes identified in the LOAD families (Table 1). 

Phrase: "Each of the remaining six genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017431:Genotypes [Organism Attribute]
   753   C0205452:Six [Quantitative Concept]
   753   C1457900:Each [Quantitative Concept]
   753   C1527428:Remaining [Qualitative Concept]

Phrase: "is"

Phrase: "produced by one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "and"

Phrase: "only one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "pair of the six haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018591:Haplotypes [Organism Attribute]
   760   C0205452:Six [Quantitative Concept]
   760   C1709450:Pair [Qualitative Concept]

Phrase: "identified in the LOAD families"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   806   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   794   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   775   C0814122:late disease onset [Finding]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0344339:disease family [Finding]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0277793:disease onset [Temporal Concept]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0015576:Families [Family Group]
   739   C0205087:Late [Temporal Concept]
   739   C0205396:Identified [Qualitative Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C1550043:Identified [Finding]
   739   C1551388:Identified [Functional Concept]
   739   C1704727:Family [Conceptual Entity]
   736   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   716 E C0277558:Familial disease [Disease or Syndrome]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: The only other pairs that could produce these categories would include at least one haplotype that is so rare it was never identified unambiguously in the casecontrol series or by Simwalk2 haplotype analysis of the LOAD families. 

Phrase: "The only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "other pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "produce"

Phrase: "these categories"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0683312:Categories [Intellectual Product]
   966 E C1555713:category [Idea or Concept]

Phrase: "would"

Phrase: "include at least one haplotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018591:Haplotype [Organism Attribute]
   760   C0205447:One [Quantitative Concept]
   760   C0332257:include [Functional Concept]
   760   C1552866:include [Idea or Concept]
   760   C2700399:Include [Activity]

Phrase: "that"

Phrase: "is"

Phrase: "so rare"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521114:Rare [Temporal Concept]
   861   C0522498:Rare [Qualitative Concept]
   861   C1514917:RARE [Gene or Genome]

Phrase: "it"

Phrase: "was"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "unambiguously in the casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "or by Simwalk2 haplotype analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0018591:Haplotype [Organism Attribute]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "of the LOAD families."
Meta Candidates (Total=18; Excluded=7; Pruned=0; Remaining=11)
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Families [Family Group]
   791   C0205087:Late [Temporal Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332285:Of [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C1704727:Family [Conceptual Entity]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   708 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.87: As these combinations will be rare, the PLAU SNP haplotypes in 96100% of the subjects in our LOAD casecontrol series were easily identified and essentially unambiguous (Table 5). 

Phrase: "As these combinations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0453882:Combinations [Manufactured Object]
   966 E C0205195:Combination [Qualitative Concept]
   966 E C1947911:Combination [Physical Object]

Phrase: "will"

Phrase: "be"

Phrase: "rare,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "the PLAU SNP haplotypes in 96100% of the subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0018591:Haplotypes [Organism Attribute]

Phrase: "in our LOAD casecontrol series"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0205549:Series [Quantitative Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C2348044:Series [Intellectual Product]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "essentially unambiguous"

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.88: View this table: [in this window] [in a new window]  Table 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.89: Association of PLAU compound genotypes with AD in three casecontrol series  To evaluate association between AD and the compound genotypes summarized in Table 5, we performed 2-tests on each series using the Monte Carlo approach (T1) implemented in CLUMP to determine significance. 

Phrase: "Association of PLAU compound genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with AD"

Phrase: "in three casecontrol series  To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "association between AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the compound genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "summarized in Table 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "2-tests on each series"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0022885:Tests [Laboratory Procedure]
   760   C0392366:Tests [Intellectual Product]
   726 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Monte Carlo approach"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approach [Spatial Concept]
   734   C0026507:Monte Carlo [Quantitative Concept]

Phrase: "(T1)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413227:T1 [Gene or Genome]

Phrase: "implemented in CLUMP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205387:clump [Qualitative Concept]

Phrase: "determine"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.90: In each of the three series examined, these genotypes showed significant association with AD (MCR, P=0.001; MCJ, P=0.03 and UKy, P=0.03). 

Phrase: "In each"

Phrase: "of the three series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "these genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association with AD (MCR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "P=0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; MCJ,"

Phrase: "P=0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "UKy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "P=0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.91: Some compound genotypes tended to have the same trends in two or more series analyzed (e.g. 2/2, 1/4 and 3/5), suggesting the presence of functional variants on the backbones of these genotypes. 

Phrase: "Some compound genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "the same trends in two"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040833:trends [Temporal Concept]
   760   C1521798:Trends [Temporal Concept]

Phrase: "or"

Phrase: "more series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "("

Phrase: "e.g. 2/2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "1/4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "3/5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442758:3 5 [Quantitative Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of functional variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "on the backbones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037949:backbones [Body Part, Organ, or Organ Component]
   966 E C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "of these genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.92: After we found the association between PLAU compound genotypes and three casecontrol series, MCR, MCJ and UKy, we tested for association between the missense PLAU_1 SNP and the larger data set of six casecontrol series, the results of which are depicted subsequently. 

Phrase: "After"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "the association between PLAU compound genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "three casecontrol series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "MCR,"

Phrase: "MCJ"

Phrase: "and"

Phrase: "UKy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "we"

Phrase: "tested for association"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0392366:tested [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "between the missense PLAU_1 SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0752046:SNP [Nucleotide Sequence]
   812   C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "the larger data set of six casecontrol series,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0150098:Data Set [Intellectual Product]
   770   C1706233:Dataset [Intellectual Product]
   744   C0036849:Set [Mental Process]
   744   C1442518:Set [Functional Concept]
   744   C1511726:Data [Idea or Concept]
   744   C1705195:Set [Conceptual Entity]
   744   C3245479:data [Medical Device]

Phrase: "the results of which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "are"

Phrase: "depicted"

Phrase: "subsequently."
Processing 00000000.tx.93: Finally, we went back to test for association between PLAU compound genotypes and the three additional casecontrol series (Gothenburg, Gothenburg-Postmortem, Scottish) and did not find significant association in these series (data not shown). 

Phrase: "Finally,"

Phrase: "we"

Phrase: "went"

Phrase: "back to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004600:Back [Body Location or Region]
   861   C0205095:Back [Spatial Concept]
   861   C0460009:Back [Body Location or Region]
   861   C1995000:Back [Body Location or Region]

Phrase: "test for association"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0004083:Association [Mental Process]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:test [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "between PLAU compound genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "the three additional casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "(Gothenburg,"

Phrase: "Gothenburg-Postmortem,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]

Phrase: "Scottish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0240966:Scottish [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "significant association in these series"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: Association of PLAU_1 SNP (rs2227564) with plasma A42 levels in 24 LOAD families Of the PLAU variants analyzed, rs2227564, which we internally termed PLAU_1, is a relatively common missense SNP, which leads to a proline to leucine change in the kringle domain of PLAU at the junction between two -pleated sheets (13,14) and has been shown to have a functional effect on the fibrin binding of PLAU zymogen (14). 

Phrase: "Association of PLAU_1 SNP (rs2227564"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: ")"

Phrase: "with plasma A42 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "in 24 LOAD families"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Families [Family Group]
   791   C0150312:In [Quantitative Concept]
   791   C0205087:Late [Temporal Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C1704727:Family [Conceptual Entity]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   708 E C0241888:Familial [Functional Concept]

Phrase: "Of the PLAU variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ","

Phrase: "rs2227564,"

Phrase: "which"

Phrase: "we internally termed PLAU_1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0205102:Internally [Spatial Concept]
   812   C1335224:PLAU [Gene or Genome]
   779   C1515273:Term [Temporal Concept]
   779   C1705313:Term [Idea or Concept]
   779   C2826302:TERM [Intellectual Product]

Phrase: "is"

Phrase: "a relatively common missense SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0752046:SNP [Nucleotide Sequence]
   812   C1527094:SNP [Conceptual Entity]

Phrase: "which"

Phrase: "leads to a proline"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to leucine change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "in the kringle domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0064417:Kringle Domain [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "at the junction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205144:Junction [Spatial Concept]
  1000   C1706311:Junction [Medical Device]

Phrase: "between two -pleated sheets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439643:Sheets [Spatial Concept]
   793 E C2349187:Sheet [Quantitative Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a functional effect on the fibrin binding of PLAU zymogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.95: To determine whether PLAU_1 genotypes are associated with plasma A42, we analyzed a larger set of 24 extended LOAD families, which includes the original group of 10 families. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "PLAU_1 genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "are"

Phrase: "associated with plasma A42,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0032105:Plasma [Body Substance]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "a larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443228:larger [Quantitative Concept]
  1000   C0549177:Larger [Quantitative Concept]
  1000   C1704243:Larger [Quantitative Concept]

Phrase: "set of 24 extended LOAD families,"
Meta Candidates (Total=26; Excluded=4; Pruned=0; Remaining=22)
   805   C0338448:Familial Alzheimer's disease of late onset [Disease or Syndrome]
           Late onset familial Alzheimer disease
   797   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   770   C0814122:late disease onset [Finding]
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C0344339:disease family [Finding]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   754   C0015341:Extended Family [Family Group]
   754   C0277793:disease onset [Temporal Concept]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0015576:Families [Family Group]
   738   C0036849:Set [Mental Process]
   738   C0205087:Late [Temporal Concept]
   738   C0231448:Extended [Functional Concept]
   738   C0231449:Extended [Spatial Concept]
   738   C0332162:Onset [Qualitative Concept]
   738   C0439792:extended [Spatial Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C1442518:Set [Functional Concept]
   738   C1704727:Family [Conceptual Entity]
   738   C1705195:Set [Conceptual Entity]
   730   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   712 E C0277558:Familial disease [Disease or Syndrome]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the original group of 10 families."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0015576:Family Group [Family Group]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
Processing 00000000.tx.96: To take family relationships into account, these analyses were performed using variance components methodology implemented in the program SOLAR (20). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "family relationships into account,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0015608:Family Relationships [Social Behavior]
   833   C0548112:family relationships [Health Care Activity]
   770   C0439849:Relationships [Qualitative Concept]
   737 E C1705630:Relationship [Idea or Concept]
   737 E C1706279:Relationship [Idea or Concept]
   737 E C3540605:Relationship [Intellectual Product]

Phrase: "these analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "variance components methodology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0969625:methodology [Intellectual Product]
   827   C3266812:Methodology [Idea or Concept]

Phrase: "implemented in the program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1709697:Program [Conceptual Entity]
   770   C2728259:Program [Pharmacologic Substance]
   770   C3484370:Program [Functional Concept]

Phrase: "SOLAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0038817:Sun [Natural Phenomenon or Process]
   944   C0376223:Sun [Geographic Area]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.97: In the members of these 24 families, the change that occurs in plasma A42 with aging is complex. 

Phrase: "In the members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "of these 24 families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "the change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "occurs in plasma A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032105:Plasma [Body Substance]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "is"

Phrase: "complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.98: Plasma A42, which is elevated in young subjects, first decreases and then increases again with age >50. 

Phrase: "Plasma A42,"

Phrase: "which"

Phrase: "is"

Phrase: "elevated in young subjects,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205250:Elevated [Qualitative Concept]
   770   C0332239:Young [Temporal Concept]
   770   C3163633:Elevated [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "again with age >50."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001779:Age [Organism Attribute]
Processing 00000000.tx.99: This is shown in Figure 1, where plasma A42 stratified by PLAU_1 genotype is plotted as a function of age. 

Phrase: "This"

Phrase: "is"

Phrase: "shown in Figure 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "where plasma A42"

Phrase: "stratified by PLAU_1 genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017431:Genotype [Organism Attribute]
   760   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205363:Stratified [Qualitative Concept]
   760   C1335224:PLAU [Gene or Genome]

Phrase: "is"

Phrase: "plotted as a function of age."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0001779:Age [Organism Attribute]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.100: Non-linear analysis, in which we analyzed age, age(2) and PLAU_1 genotype (CC, CT, TT or CT+TT) and the interactions among age, age(2) and PLAU_1 genotype in the variance components framework, showed a significant age-dependent association between plasma A42 and PLAU_1 CT and TT genotypes (CTxage, TTxage(2), CT+TTxage(2) and age(2) were all significant at P<0.05) (Table 6). 

Phrase: "Non-linear analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "in which"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "age(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "PLAU_1 genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "(CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538933:CC [Cell Component]

Phrase: "CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "TT"

Phrase: "or"

Phrase: "CT+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "TT)"

Phrase: "and"

Phrase: "the interactions among age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "age(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "PLAU_1 genotype in the variance components framework,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0017431:Genotype [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant age-dependent association between plasma A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "PLAU_1 CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "(CTxage,"

Phrase: "TTxage"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "CT+TTxage"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "age(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "all significant at P<0.05"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237881:significant [Quantitative Concept]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]

Phrase: ")"

Phrase: "(Table 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.101: As our main concern was to determine whether there is a significant age-dependent elevation of plasma A42 in elderly subjects associated with the CT, TT or pooled CT+TT genotypes, we performed a second analysis in which family members >50 years (Fig.2) were analyzed using linear regression in the variance components framework. 

Phrase: "As our main concern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699424:Concern [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "a significant age-dependent elevation of plasma A42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439775:Elevation [Therapeutic or Preventive Procedure]
   744   C0702240:Elevation [Spatial Concept]

Phrase: "in elderly subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "associated with the CT,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C3540513:CT [Gene or Genome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "TT"

Phrase: "or"

Phrase: "pooled CT+TT genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a second analysis in which family members"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: ">50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "linear regression in the variance components framework."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0023733:Linear Regression [Quantitative Concept]
   778   C2346679:Linear Regression [Intellectual Product]
   748   C0205132:Linear [Spatial Concept]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
Processing 00000000.tx.102: This analysis showed that the CTxage and TTxage covariates had significant effects (P=0.003 and P=0.007, respectively) in the 24 LOAD families (Table 7). 

Phrase: "This analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the CTxage"

Phrase: "and"

Phrase: "TTxage covariates"

Phrase: "had"

Phrase: "significant effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "(P=0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P=0.007,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")"

Phrase: "in the 24 LOAD families"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C0344339:disease family [Finding]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0015576:Families [Family Group]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C1704727:Family [Conceptual Entity]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
   706 E C0241888:Familial [Functional Concept]

Phrase: "(Table 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: When the CT and TT variables were tested as a single CT+TT variable, the CT+TTxage covariate was even more significant (P=0.0006). 

Phrase: "When"

Phrase: "the CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "were"

Phrase: "tested as a single CT+TT variable,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0392366:tested [Intellectual Product]
   748   C0439828:Variable [Qualitative Concept]
   748   C3540513:CT [Gene or Genome]
   714 E C0022885:Test [Laboratory Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "the CT+TTxage covariate"

Phrase: "was"

Phrase: "even more significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0237881:significant [Quantitative Concept]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "(P=0.0006"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.104: It is noteworthy that even when we correct for the fact that three age groups were tested prior to the analysis of the 50 age group summarized in Table 7, using the most conservative approach of Bonferroni correction, there is still highly significant age-related PLAU genotype effect in these families (overall corrected P-values are 0.000024 for Model 1 and 0.00006 for Model 2). 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that even"

Phrase: "when"

Phrase: "we correct for the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2349182:Correct [Qualitative Concept]

Phrase: "that three age groups"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0027362:Age Groups [Age Group]
   867 E C2348001:Age Group [Population Group]
   827   C0001779:Age [Organism Attribute]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "tested prior to the analysis of the 50 age group"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   760   C0027362:Age Group [Age Group]
   760   C0332152:Prior to [Temporal Concept]
           Prior
   760   C2348001:Age Group [Population Group]
   739   C0001779:Age [Organism Attribute]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0392366:tested [Intellectual Product]
   739   C0441833:Group [Idea or Concept]
   739   C0687744:group [Population Group]
   739   C0936012:Analysis [Research Activity]
   739   C1257890:Group [Population Group]
   739   C1524024:analysis [Functional Concept]
   739   C1552516:Group [Health Care Related Organization]
   739   C1705428:Group [Conceptual Entity]
   739   C1705429:Group [Population Group]
   739   C2826257:PRIOR [Event]
   706 E C0022885:Test [Laboratory Procedure]
   706 E C0039593:Test [Functional Concept]

Phrase: "summarized in Table 7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the most conservative approach of Bonferroni correction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449445:Approach [Spatial Concept]

Phrase: "there"

Phrase: "is"

Phrase: "still highly significant age-related PLAU genotype effect in these families"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "(overall corrected P-values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709380:P-Value [Quantitative Concept]
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "0.000024 for Model 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "0.00006 for Model 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: View larger version (21K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.106: Plasma A42 in members of all ages from 24 LOAD families. 

Phrase: "Plasma A42 in members of all"

Phrase: "ages from 24 LOAD families."
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   806   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   794   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   775   C0814122:late disease onset [Finding]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0344339:disease family [Finding]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0206132:Onset Age [Quantitative Concept]
   757   C0277793:disease onset [Temporal Concept]
   739   C0001779:Age [Organism Attribute]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0015576:Families [Family Group]
   739   C0205087:Late [Temporal Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C1704727:Family [Conceptual Entity]
   736   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   716 E C0277558:Familial disease [Disease or Syndrome]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.107: Curves shown for each PLAU_1 (rs2227564) genotype are a polynomial function of age and age2: (A) CC genotype (n=285); 

Phrase: "Curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "shown for each PLAU_1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1335224:PLAU [Gene or Genome]
   726   C1547282:Show [Intellectual Product]

Phrase: "(rs2227564"

Phrase: ")"

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "are"

Phrase: "a polynomial function of age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "age2: (A)"

Phrase: "CC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "(n=285"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.108: (B) CT genotype (n=137); 

Phrase: "(B) CT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "(n=137"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0068482:N-137 [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.109: (C) TT genotype (n=34); 

Phrase: "(C) TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "(n=34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.110: (D) combined CT+TT genotypes (n=171).  

Phrase: "("

Phrase: "D)"

Phrase: "combined CT+TT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "(n=171"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.111: View this table: [in this window] [in a new window]  Table 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.112: Association of PLAU exon 6 SNP with plasma A42 in members of all ages from 24 LOAD families  View larger version (17K): [in this window] [in a new window]  Figure 2. 

Phrase: "Association of PLAU exon 6 SNP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with plasma A42"

Phrase: "in members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "of all"

Phrase: "ages from 24 LOAD families"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   806   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   794   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   775   C0814122:late disease onset [Finding]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0344339:disease family [Finding]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0206132:Onset Age [Quantitative Concept]
   757   C0277793:disease onset [Temporal Concept]
   739   C0001779:Age [Organism Attribute]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0015576:Families [Family Group]
   739   C0205087:Late [Temporal Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C1704727:Family [Conceptual Entity]
   736   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   716 E C0277558:Familial disease [Disease or Syndrome]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.113: Plasma A42 in members 50 years of age in 24 LOAD families. 

Phrase: "Plasma A42 in members 50 years of age"

Phrase: "in 24 LOAD families."
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Families [Family Group]
   791   C0150312:In [Quantitative Concept]
   791   C0205087:Late [Temporal Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C1704727:Family [Conceptual Entity]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   708 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.114: Curves shown for each PLAU_1 (rs2227564) genotype are a linear function of age: (A) CC genotype (n=136); 

Phrase: "Curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "shown for each PLAU_1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1335224:PLAU [Gene or Genome]
   726   C1547282:Show [Intellectual Product]

Phrase: "(rs2227564"

Phrase: ")"

Phrase: "genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "are"

Phrase: "a linear function of age"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031843:function [Physiologic Function]
   760   C0205132:Linear [Spatial Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: ":"

Phrase: "(A"

Phrase: ")"

Phrase: "CC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "(n=136"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.115: (B) CT genotype (n=59); 

Phrase: "(B) CT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "(n=59"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.116: (C) TT genotype (n=17); 

Phrase: "(C) TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "(n=17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.117: (D) combined CT+TT genotypes (n=76).  

Phrase: "("

Phrase: "D)"

Phrase: "combined CT+TT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotypes [Organism Attribute]

Phrase: "(n=76"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.118: View this table: [in this window] [in a new window]  Table 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 7."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.119: Multivariate regression analysis in members 50 years of age in 24 LOAD families  On the basis of these findings, when we re-analyzed the haplotypic associations in the 10 LOAD families for subjects 50 years of age, the association was even more significant at P=0.005 (Table 4). 

Phrase: "Multivariate regression analysis in members 50 years of age"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0034980:Regression Analysis [Intellectual Product]
   762   C0026777:Multivariate Analysis [Quantitative Concept]
   762   C0237461:age regression [Therapeutic or Preventive Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0684320:Regression [Pathologic Function]
   742   C0684321:Regression [Mental Process]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "in 24 LOAD families"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Families [Family Group]
   791   C0150312:In [Quantitative Concept]
   791   C0205087:Late [Temporal Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C1704727:Family [Conceptual Entity]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   708 E C0241888:Familial [Functional Concept]

Phrase: "On the basis of these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "when"

Phrase: "we"

Phrase: "re-analyzed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0936012:Analyzed [Research Activity]
   861   C2986904:RE [Idea or Concept]

Phrase: "the haplotypic associations in the 10 LOAD families"
Meta Candidates (Total=25; Excluded=7; Pruned=0; Remaining=18)
   784   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   771   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   763   C1864828:ALZHEIMER DISEASE 10 [Disease or Syndrome]
           Alzheimer Disease, Familial, 10
   762   C0814122:late disease onset [Finding]
   750   C0002395:Alzheimer's Disease [Disease or Syndrome]
   750   C0344339:disease family [Finding]
   750   C1521724:Alzheimer's Disease [Pathologic Function]
   749   C0277793:disease onset [Temporal Concept]
   735   C0004083:Associations [Mental Process]
   735   C0012634:Disease [Disease or Syndrome]
   735   C0015576:Families [Family Group]
   735   C0205087:Late [Temporal Concept]
   735   C0332162:Onset [Qualitative Concept]
   735   C0441889:Levels [Qualitative Concept]
   735   C1704727:Family [Conceptual Entity]
   732   C1511978:Disease Association [Temporal Concept]
   722   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   707 E C0277558:Familial disease [Disease or Syndrome]
   702 E C0439849:Association [Qualitative Concept]
   702 E C0456079:Level [Classification]
   702 E C0596306:Association [Phenomenon or Process]
   702 E C0699792:association [Social Behavior]
   702 E C1547707:Level [Geographic Area]
   702 E C2946261:Level [Pharmacologic Substance]

Phrase: "for subjects 50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "even more significant at P=0.005"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237881:significant [Quantitative Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: We subsequently went back to analyze the haplotypes in the 24 families in this age group, which accounted for 22% of the total variance in the plasma A42 phenotype and was also significant (P=0.009, data not shown). 

Phrase: "We subsequently"

Phrase: "went"

Phrase: "back to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004600:Back [Body Location or Region]
   861   C0205095:Back [Spatial Concept]
   861   C0460009:Back [Body Location or Region]
   861   C1995000:Back [Body Location or Region]

Phrase: "analyze"

Phrase: "the haplotypes in the 24 families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018591:Haplotypes [Organism Attribute]

Phrase: "in this age group,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0027362:Age Group [Age Group]
  1000   C2348001:Age Group [Population Group]
   861   C0001779:Age [Organism Attribute]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "which"

Phrase: "accounted for 22% of the total variance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]
   714   C1551359:account [Idea or Concept]
   714   C2741673:Account # [Clinical Attribute]
   714   C2981730:Account [Classification]

Phrase: "in the plasma A42 phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "was"

Phrase: "also significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P=0.009,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.121: Association of PLAU_1 SNP (rs2227564) with AD in six casecontrol series We initially analyzed three series from two groups, MCR and MCJ series from Mayo Clinic and UKy series from the University of Kentucky. 

Phrase: "Association of PLAU_1 SNP (rs2227564"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: ")"

Phrase: "with AD"

Phrase: "in six casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "three series from two groups,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "MCR"

Phrase: "and"

Phrase: "MCJ series from Mayo Clinic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]
   738   C2985404:Clinical Series [Research Activity]

Phrase: "and"

Phrase: "UKy series from the University of Kentucky."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205549:Series [Quantitative Concept]
   742   C2348044:Series [Intellectual Product]
Processing 00000000.tx.122: To analyze the missense PLAU_1 SNP, we obtained three more series from our collaborators at Karolinska Institute: the Gothenburg LOAD-control series, an autopsy-confirmed LOAD series from Gothenburg and a Scottish early onset AD (LOAD) series. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the missense PLAU_1 SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0752046:SNP [Nucleotide Sequence]
   812   C1527094:SNP [Conceptual Entity]

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "three more series from our collaborators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "at Karolinska Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: ":"

Phrase: "the Gothenburg LOAD-control series,"
Meta Candidates (Total=21; Excluded=6; Pruned=0; Remaining=15)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C0920467:disease control [Therapeutic or Preventive Procedure]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0205087:Late [Temporal Concept]
   790   C0205549:Series [Quantitative Concept]
   790   C0243148:control [Qualitative Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2348044:Series [Intellectual Product]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "an autopsy-confirmed LOAD series"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0004398:Autopsy [Diagnostic Procedure]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0205087:Late [Temporal Concept]
   790   C0205549:Series [Quantitative Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   790   C2348044:Series [Intellectual Product]
   756 E C0456079:Level [Classification]
   756 E C1456348:Confirm [Qualitative Concept]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "from Gothenburg"

Phrase: "and"

Phrase: "a Scottish early onset AD (LOAD"
Meta Candidates (Total=18; Excluded=6; Pruned=0; Remaining=12)
   876   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   870   C0679245:early disease [Temporal Concept]
   853   C0002395:AD - Alzheimer's disease [Disease or Syndrome]
           Alzheimer's Disease
   801   C1521724:Alzheimer's Disease [Pathologic Function]
   801   C1833334:Early-onset [Finding]
   788   C0012634:Disease [Disease or Syndrome]
   788   C0205087:Late [Temporal Concept]
   788   C0240966:Scottish [Population Group]
   788   C0332162:Onset [Qualitative Concept]
   788   C0441889:Levels [Qualitative Concept]
   788   C1279919:Early [Temporal Concept]
   755 E C0456079:Level [Classification]
   755 E C1547707:Level [Geographic Area]
   755 E C2946261:Level [Pharmacologic Substance]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "series."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]
Processing 00000000.tx.123: In the MCR series, significant association was observed for the CT (P=0.006) and CT+TT (P=0.008) genotypes with odds ratio (OR) of 1.7 (1.22.6) and 1.7 (1.12.4), respectively. 

Phrase: "In the MCR series,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C2985404:Clinical Series [Research Activity]
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "significant association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "was"

Phrase: "observed for the CT (P=0.006"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1441672:Observed [Functional Concept]
   748   C3540513:CT [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "CT+TT (P=0.008"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3540513:CT [Gene or Genome]

Phrase: ")"

Phrase: "genotypes with odds ratio (OR) of 1.7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017431:Genotypes [Organism Attribute]

Phrase: "(1.22.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "1.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(1.12.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.124: The TT genotype was enriched in the LOAD patients of the MCR series, but this enrichment did not achieve significance. 

Phrase: "The TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "enriched in the LOAD patients"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   775   C0814122:late disease onset [Finding]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0277793:disease onset [Temporal Concept]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0030705:Patients [Patient or Disabled Group]
   739   C0205087:Late [Temporal Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C0359583:enriched [Food]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "of the MCR series,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C2985404:Clinical Series [Research Activity]
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "but"

Phrase: "this enrichment"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieve"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.125: In the UKy series, the first series where PLAU_1 was analyzed, the TT genotype showed significant (P=0.029) association with LOAD and had an OR of 3.5 (1.110.7). 

Phrase: "In the UKy series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "the first series where PLAU_1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0205435:First [Quantitative Concept]
   804   C0205549:Series [Quantitative Concept]
   804   C1279901:First [Qualitative Concept]
   804   C1335224:PLAU [Gene or Genome]
   804   C2348044:Series [Intellectual Product]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ","

Phrase: "the TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "(P=0.029"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "association with LOAD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1511978:Disease Association [Temporal Concept]
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "had"

Phrase: "an OR of 3.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "(1.110.7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C3541329:1-7 [Gene or Genome]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.126: Three of the four remaining series (MCJ, Gothenburg and Scottish) showed some non-significant enrichment of the CT and/or TT genotypes (Table 8), but this did not occur in the autopsy-confirmed Gothenburg series. 

Phrase: "Three of the four remaining series"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205449:Three [Quantitative Concept]
   753   C0205450:Four [Quantitative Concept]
   753   C0205549:Series [Quantitative Concept]
   753   C1527428:Remaining [Qualitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "(MCJ,"

Phrase: "Gothenburg"

Phrase: "and"

Phrase: "Scottish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0240966:Scottish [Population Group]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "some non-significant enrichment of the CT"

Phrase: "and/or"

Phrase: "TT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "(Table 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "this"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur in the autopsy-confirmed Gothenburg series."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0004398:Autopsy [Diagnostic Procedure]
   748   C0205549:Series [Quantitative Concept]
   748   C0521093:confirmed [Qualitative Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1709305:Occur [Activity]
   748   C2348044:Series [Intellectual Product]
   748   C2745955:OCCUR [Temporal Concept]
   714 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.127: Testing for homogeneity (BreslowDay) showed no evidence for heterogeneity among the six series (P=0.45), and meta analysis gave a pooled estimate of the OR for the CT+TT genotype of 1.21 (1.01.47) with a fixed effects P=0.056 and a random effects P=0.051 (Fig.3). 

Phrase: "Testing for homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0039593:Testing [Functional Concept]
   790   C0392366:testing [Intellectual Product]

Phrase: "(BreslowDay"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no evidence for heterogeneity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "among the six series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "(P=0.45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "meta analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a pooled estimate of the OR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750572:Estimate [Quantitative Concept]

Phrase: "for the CT+TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "of 1.21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(1.01.47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "with a fixed effects P=0.056"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0231441:Fixed [Finding]
   804   C0443218:Fixed [Qualitative Concept]
   804   C1280500:effects [Qualitative Concept]
   804   C2827483:Fixed [Body Substance]
   771 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "a random effects P=0.051"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0034656:RANDOM [Research Activity]
   804   C0439605:Random [Qualitative Concept]
   804   C1280500:effects [Qualitative Concept]
   771 E C2348382:Effect [Qualitative Concept]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.128: View this table: [in this window] [in a new window]  Table 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 8."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.129: PLAU_1 (rs2227564) genotypes and Odds ratios in six AD casecontrol series  View larger version (11K): [in this window] [in a new window]  Figure 3. 

Phrase: "PLAU_1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1335224:PLAU [Gene or Genome]

Phrase: "(rs2227564"

Phrase: ")"

Phrase: "genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "Odds ratios in six AD casecontrol series"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0028873:Odds Ratios [Quantitative Concept]
   757   C1709842:Ratio Series [Quantitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.130: ORs for PLAU_1 (rs2227564) CT+TT versus CC genotypes in casecontrol series. 

Phrase: "ORs for PLAU_1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(rs2227564"

Phrase: ")"

Phrase: "CT+TT"

Phrase: "versus"

Phrase: "CC genotypes in casecontrol series."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.131: ORs are shown with 95% confidence intervals. 

Phrase: "ORs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "shown with 95% confidence intervals."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0009667:Confidence Intervals [Quantitative Concept]
   760   C0237529:Confidence [Mental Process]
   760   C1272706:intervals [Temporal Concept]
   760   C1704725:Confidence [Qualitative Concept]
   760   C1704726:Confidence [Mental Process]
   726   C1547282:Show [Intellectual Product]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.132: The AD cases in the Scottish series had an early age of onset. 

Phrase: "The AD cases in the Scottish series"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   757   C0150093:Case Series [Research Activity]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "an early age of onset."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   926   C1835401:Early age of onset [Finding]
   862   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
Processing 00000000.tx.133: All others are LOAD versus control series.  

Phrase: "All others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "are"

Phrase: "LOAD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]

Phrase: "versus"

Phrase: "control series."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]
Processing 00000000.tx.134: Analysis of A in PLAU knockout mice Our finding that PLAU variants are associated with elevated plasma A42 predicts that plasma A42 should be elevated in KO mice lacking a functional PLAU gene. 

Phrase: "Analysis of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "in PLAU knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that PLAU variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "are"

Phrase: "associated with elevated plasma A42"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0032105:Plasma [Body Substance]
   760   C0205250:Elevated [Qualitative Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C3163633:Elevated [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "predicts"

Phrase: "that plasma A42"

Phrase: "should"

Phrase: "be"

Phrase: "elevated in KO mice"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0206745:Knock-out Mice [Mammal]
   806   C0560617:knock out [Injury or Poisoning]
   806   C1522225:Knock-out [Experimental Model of Disease]
   797   C1517676:Knock-in [Research Activity]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "a functional PLAU gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1335224:PLAU gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.135: To test this, we analyzed plasma A42 in 11 PLAU KO mice (16) and 14 control mice with the same genetic background. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "plasma A42 in 11 PLAU KO mice"

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "14 control mice with the same genetic background."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   767   C0017263:genetic control [Genetic Function]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0243148:control [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   739 E C0700589:Birth Control [Therapeutic or Preventive Procedure]
Processing 00000000.tx.136: For comparison, KO mice lacking a functional neprilysin gene, which is known to be involved in A degradation (24), were analyzed in parallel. 

Phrase: "For comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "KO mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0560617:knock out [Injury or Poisoning]
   734   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "a functional neprilysin gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "in parallel."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]
Processing 00000000.tx.137: When compared with controls, 3 to 6-month-old PLAU KO mice showed a highly significant increase in plasma A42 (P=0.006 by MannWhitney test) (Fig.4A). 

Phrase: "When"

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "3 to 6-month-old PLAU KO mice"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   790   C0206745:Knock-out Mice [Mammal]
   764   C0560617:knock out [Injury or Poisoning]
   764   C1522225:Knock-out [Experimental Model of Disease]
   762   C0442759:3 6 [Finding]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0439086:<3 [Quantitative Concept]
   742   C0439231:month [Temporal Concept]
   742   C0439507:/month [Temporal Concept]
   742   C0439787:Out [Spatial Concept]
   742   C0580836:Old [Temporal Concept]
   742   C0849355:Out [Qualitative Concept]
   742   C1335224:PLAU [Gene or Genome]
   742   C2827736:3+ [Quantitative Concept]
   742   C2981702:3+ [Classification]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a highly significant increase in plasma A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(P=0.006 by MannWhitney test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0392366:test [Intellectual Product]
   753   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.138: Plasma A40 also increased (P=0.003) in the PLAU KO mice (Fig.4B). 

Phrase: "Plasma A40 also"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(P=0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in the PLAU KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.139: By 11 months, plasma A42 and A40 increased and the difference between KO and control mice appeared to increase in the small number of mice analyzed (two PLAU KO versus six controls). 

Phrase: "By 11 months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "plasma A42"

Phrase: "and"

Phrase: "A40"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "the difference between KO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase in the small number of mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0237753:*Number [Quantitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C0700321:Small [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "(two PLAU KO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]
   812   C0439787:Out [Spatial Concept]
   812   C0849355:Out [Qualitative Concept]

Phrase: "versus"

Phrase: "six controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.140: Thus, the PLAU gene influences plasma A42 and our data suggest that this effect may become more pronounced with aging, consistent with our genetic analyses in LOAD families. 

Phrase: "Thus,"

Phrase: "the PLAU gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335224:PLAU gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "influences"

Phrase: "plasma A42"

Phrase: "and"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "become"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced with aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001811:Ageing [Organism Function]

Phrase: "consistent with our genetic analyses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in LOAD families."
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   861   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C0344339:disease family [Finding]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0015576:Families [Family Group]
   793   C0150312:In [Quantitative Concept]
   793   C0205087:Late [Temporal Concept]
   793   C0332162:Onset [Qualitative Concept]
   793   C0332285:In [Spatial Concept]
   793   C0441889:Levels [Qualitative Concept]
   793   C1704727:Family [Conceptual Entity]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
   710 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.141: Remarkably, brain A42 (Fig.5A) and A40 (Fig.5B) showed no detectable increase in PLAU KO mice when compared with control mice. 

Phrase: "Remarkably,"

Phrase: "brain A42"

Phrase: "(Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "A40"

Phrase: "(Fig.5B"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no detectable increase in PLAU KO mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "when"

Phrase: "compared with control mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.142: The implications of this result are presented in the Discussion. 

Phrase: "The implications of this result"

Phrase: "are"

Phrase: "presented in the Discussion."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449450:Presented [Idea or Concept]
   770   C0557061:Discussion [Therapeutic or Preventive Procedure]
   770   C2584313:Discussion [Social Behavior]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.143: View larger version (21K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.144: Plasma A in PLAU KO. 

Phrase: "Plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "in PLAU KO."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0560617:knock out [Injury or Poisoning]
   901   C1522225:Knock-out [Experimental Model of Disease]
   827   C0439787:Out [Spatial Concept]
   827   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.145: (A) Plasma A42 and (B) plasma A40 were analyzed by sandwich ELISA as previously described (19). 

Phrase: "(A"

Phrase: ")"

Phrase: "Plasma A42"

Phrase: "and ("

Phrase: "B) plasma A40"

Phrase: "were"

Phrase: "analyzed by sandwich ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014441:ELISA [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.146: All KO mice were homozygous for the null allele. 

Phrase: "All KO mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0560617:knock out [Injury or Poisoning]
   734   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "were"

Phrase: "homozygous for the null allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]
Processing 00000000.tx.147: All results were normalized to the A present in 3- to 6-month-old control (wild-type) mice. 

Phrase: "All results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "normalized to the A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882115:Normalized [Research Activity]

Phrase: "present in 3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "to 6-month-old control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "(wild-type) mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.148: Values shown are meanSE. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "meanSE."
Processing 00000000.tx.149: Numbers analyzed were 3- to 6-month-old PLAU KO (14) (n=9), control mice (n=6); 

Phrase: "Numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "were"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 6-month-old PLAU KO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0560617:knock out [Injury or Poisoning]
   827   C1522225:Knock-out [Experimental Model of Disease]
   799   C0439787:Out [Spatial Concept]
   799   C0849355:Out [Qualitative Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "(n=9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.150: 11-month-old PLAU KO mice (n=2), control mice (n=7) mice; 

Phrase: "11-month-old PLAU KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0206745:Knock-out Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(n=2),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.151: 3- to 6-month-old neprilysin KO (15) (n=3), control mice (n=3). 

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 6-month-old neprilysin KO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0560617:knock out [Injury or Poisoning]
   827   C1522225:Knock-out [Experimental Model of Disease]
   799   C0439787:Out [Spatial Concept]
   799   C0849355:Out [Qualitative Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.152: The neprilysin KO mice were used for additional positive control (15). 

Phrase: "The neprilysin KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used for additional positive control"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1524062:Additional [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.153: In these mice, plasma A42 (A) and A40 (B) increased.  

Phrase: "In these mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "plasma A42"

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "A40"

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.154: View larger version (24K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.155: Brain A in PLAU KO mice. 

Phrase: "Brain A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in PLAU KO mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.156: (A) Brain A42 and (B) brain A40 extracted directly into 70% formic acid. 

Phrase: "(A"

Phrase: ")"

Phrase: "Brain A42"

Phrase: "and ("

Phrase: "B) brain A40"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "directly into 70% formic acid."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.157: Brain A42 and A40 were analyzed by ELISA following direct extraction into formic acid and neutralization as previously described (26). 

Phrase: "Brain A42"

Phrase: "and"

Phrase: "A40"

Phrase: "were"

Phrase: "analyzed by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "direct extraction into formic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "neutralization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1578828:Neutralization [Laboratory Procedure]
  1000   C2987668:Neutralization [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.158: Values shown are meanSE. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "meanSE."
Processing 00000000.tx.159: Numbers analyzed were 3- to 6-month-old PLAU KO mice (n=9), control mice (n=6); 

Phrase: "Numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "were"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 6-month-old PLAU KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0206745:Knock-out Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(n=9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.160: 11-month-old PLAU KO mice (n=2), control mice (n=7); 

Phrase: "11-month-old PLAU KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0206745:Knock-out Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(n=2),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.161: 3- to 6-month-old neprilysin KO mice (n=3), control mice (n=3). 

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 6-month-old neprilysin KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0206745:Knock-out Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.162: For additional positive control, we investigated neprilysin KO mice (15). 

Phrase: "For additional positive control,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C1883676:Positive Control [Conceptual Entity]
   827   C0243148:control [Qualitative Concept]
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2825490:Positive [Qualitative Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "neprilysin KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.163: In these mice, brain A42 and A40 increased as previously reported (15). 

Phrase: "In these mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "brain A42"

Phrase: "and"

Phrase: "A40"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "as"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.164: Plasma A42 (Fig.4A) and A40 (Fig.4B) also increased in the neprilysin KO mice.   

Phrase: "Plasma A42"

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "A40"

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: "also"

Phrase: "increased in the neprilysin KO mice."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0206745:Knock-out Mice [Mammal]
   778   C0560617:knock out [Injury or Poisoning]
   778   C1522225:Knock-out [Experimental Model of Disease]
   774   C1517676:Knock-in [Research Activity]
   748   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205217:Increased [Quantitative Concept]
   748   C0439787:Out [Spatial Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.165: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Identification of an LOAD risk locus on chromosome 10 (2), which also affects plasma A (1) levels in extended LOAD families, has led to the search for genes that are good functional candidates in this region. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Identification of an LOAD risk locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0150323:Risk identification [Health Care Activity]
   738   C0020792:Identification [Mental Process]
   738   C0205396:Identification [Qualitative Concept]

Phrase: "on chromosome 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "which also"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "levels in extended LOAD families,"

Phrase: "has"

Phrase: "led to the search"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C1552603:search [Intellectual Product]
   770   C1706202:Search [Activity]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "for genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "are"

Phrase: "good functional candidates in this region."
Processing 00000000.tx.166: PLAU is both a good functional and a good positional candidate gene that converts plasminogen to plasmin, which in turn degrades A. 

Phrase: "PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "is"

Phrase: "both a good functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205245:Functional [Functional Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "a good positional candidate gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332838:Candidate Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "converts"

Phrase: "plasminogen to plasmin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1367553:PLASMINOGEN [Gene or Genome]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "degrades"

Phrase: "A."
Processing 00000000.tx.167: We genotyped seven SNPs within this relatively small gene spanning almost its entire length. 

Phrase: "We"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "seven SNPs within this relatively small gene spanning almost"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   775   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   754   C0678951:gene polymorphisms [Genetic Function]
   738   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0032529:polymorphisms [Genetic Function]
   738   C0037179:Single [Population Group]
   738   C0087136:single [Finding]
   738   C0205171:Single [Quantitative Concept]
   704 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "its entire length."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]
Processing 00000000.tx.168: We found that these SNPs were in profound LD with each other leading to limited haplotype diversity in the region analyzed, a finding consistent with previous work (2527). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "these SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were in profound LD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C0439808:Profound [Qualitative Concept]

Phrase: "with each other"

Phrase: "leading to limited haplotype diversity"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0018591:Haplotype [Organism Attribute]
   760   C0332152:Leading [Temporal Concept]
   760   C0439801:Limited [Functional Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1880371:Diversity [Qualitative Concept]
   760   C3542948:Limited [Intellectual Product]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ","

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "consistent with previous work"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(2527"

Phrase: ")."
Processing 00000000.tx.169: The limited haplotype diversity allowed us to perform association analysis using the compound genotypes that make up the haplotype pair for each subject. 

Phrase: "The limited haplotype diversity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880371:Diversity [Qualitative Concept]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "association analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the compound genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "that make up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881534:Make [Functional Concept]

Phrase: "the haplotype pair for each subject."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.170: The advantage of this approach is that it does not require phase information as each compound genotype forms a group per se. 

Phrase: "The advantage of this approach"

Phrase: "is"

Phrase: "that"

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "phase information as each compound genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "per se."
Processing 00000000.tx.171: Nonetheless, given the small number of compound genotypes observed in all series, one can identify the underlying haplotype pair for >95% of all subjects essentially unambiguously. 

Phrase: "Nonetheless,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the small number of compound genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "observed in all series,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205549:Series [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "can"

Phrase: "identify"

Phrase: "the underlying haplotype pair for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709450:Pair [Qualitative Concept]

Phrase: ">95% of all"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "essentially unambiguously."
Processing 00000000.tx.172: The other advantage of the compound genotype approach is that it allows for the analysis of the haplotype pair rather than individual haplotypes. 

Phrase: "The"

Phrase: "other advantage of the compound genotype approach"

Phrase: "is"

Phrase: "that"

Phrase: "it"

Phrase: "allows for the analysis of the haplotype pair"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0018591:Haplotype [Organism Attribute]
   744   C0683607:allow [Social Behavior]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1709450:Pair [Qualitative Concept]
   731   C2825412:Paired Analysis [Idea or Concept]

Phrase: "rather than"

Phrase: "individual haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.173: Thus, variants that are effective in an additive fashion, but not when encountered alone, will be easier to identify using this approach. 

Phrase: "Thus,"

Phrase: "variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "effective in an additive fashion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "when"

Phrase: "encountered alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "will"

Phrase: "be"

Phrase: "easier to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332219:Easy [Qualitative Concept]
   777 E C1331418:Ease [Mental Process]

Phrase: "identify"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this approach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.174: We determined significant association between the PLAU compound genotypes with AD in three independent casecontrol series. 

Phrase: "We"

Phrase: "determined"

Phrase: "significant association between the PLAU compound genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with AD"

Phrase: "in three independent casecontrol series."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]
Processing 00000000.tx.175: We then analyzed a common missense SNP, PLAU_1 (rs2227564) in a larger set of 24 families and six casecontrol series that include the initial series analyzed. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "a common missense SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0752046:SNP [Nucleotide Sequence]
   827   C1527094:SNP [Conceptual Entity]

Phrase: "PLAU_1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1335224:PLAU [Gene or Genome]

Phrase: "(rs2227564"

Phrase: ")"

Phrase: "in a larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443228:larger [Quantitative Concept]
  1000   C0549177:Larger [Quantitative Concept]
  1000   C1704243:Larger [Quantitative Concept]

Phrase: "set of 24 families"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0015576:Families [Family Group]
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1704727:Family [Conceptual Entity]
   770   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "six casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "that"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the initial series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.176: In the extended families, this SNP was associated with an age-related elevation in plasma A levels in individuals >50 years of age. 

Phrase: "In the extended families,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0015341:Families, Extended [Family Group]
   861   C0015576:Families [Family Group]
   861   C0231448:Extended [Functional Concept]
   861   C0231449:Extended [Spatial Concept]
   861   C0439792:extended [Spatial Concept]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "this SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "was"

Phrase: "associated with an age-related elevation"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0001779:Age [Organism Attribute]
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0702240:Elevation [Spatial Concept]
   719 E C0163712:Relate [Organic Chemical]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in plasma A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032105:Plasma [Body Substance]
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "levels in individuals"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: ">50 years of age."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510829:Age-Years [Temporal Concept]
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.177: Plasma A displays a complex characteristic in that it appears to decline in an age-related fashion until 50 years of age and increase thereafter. 

Phrase: "Plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a complex characteristic in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decline in an age-related fashion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "until 50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "thereafter."
Processing 00000000.tx.178: This characteristic is much more pronounced in subjects who have the CT or TT genotype for PLAU_1. 

Phrase: "This characteristic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristic [Qualitative Concept]

Phrase: "is"

Phrase: "much more"

Phrase: "pronounced in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "have"

Phrase: "the CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "or"

Phrase: "TT genotype for PLAU_1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.179: It is also noteworthy that the significance of association with PLAU haplotypes is enhanced when the >50 age group is analyzed separately in the 10 families, as expected (Table 4). 

Phrase: "It"

Phrase: "is"

Phrase: "also noteworthy"

Phrase: "that"

Phrase: "the significance of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "with PLAU haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "is"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "when"

Phrase: "the >50 age group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0027362:Age Group [Age Group]
   901   C2348001:Age Group [Population Group]
   827   C0001779:Age [Organism Attribute]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "separately in the 10 families,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Families [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.180: The finding of age-related increase in A is also evident in the plasma A of PLAU KO mice, consistent with the finding in humans. 

Phrase: "The finding of age-related increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0037088:Finding [Sign or Symptom]
   753   C0243095:Finding [Finding]
   753   C2825141:Finding [Finding]

Phrase: "in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: "is"

Phrase: "also evident in the plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032105:Plasma [Body Substance]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "of PLAU KO mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "consistent with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   783   C0332529:Consistency finding [Qualitative Concept]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.181: These mice have significantly higher plasma A levels when compared with wild-type littermates; 

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "significantly higher plasma A"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0032105:Plasma [Body Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   779   C0205250:High [Qualitative Concept]
   779   C1299351:High [Qualitative Concept]
   779   C2700149:HIGH [Intellectual Product]
   729 E C0489786:Height [Organism Attribute]

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "when"

Phrase: "compared with wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: ";"
Processing 00000000.tx.182: however, their brain A levels did not show significant difference. 

Phrase: "however,"

Phrase: "their brain A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "significant difference."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.183: This finding could have several explanations. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "could"

Phrase: "have"

Phrase: "several explanations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanations [Intellectual Product]
Processing 00000000.tx.184: This may suggest that PLAU variants influence AD through an effect on plasma but not brain A42. 

Phrase: "This"

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PLAU variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "influence"

Phrase: "AD through an effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C1883473:Ad Effect [Qualitative Concept]

Phrase: "on plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "but"

Phrase: "not brain A42."
Processing 00000000.tx.185: While this is conceivable, it is more likely that PLAU influences both plasma and brain A in a way that is not evident in KO mice. 

Phrase: "While"

Phrase: "this"

Phrase: "is"

Phrase: "conceivable,"

Phrase: "it"

Phrase: "is"

Phrase: "more likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that PLAU influences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C0021399:influential [Idea or Concept]

Phrase: "both plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "brain A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in a way"

Phrase: "that"

Phrase: "is"

Phrase: "not evident in KO mice."
Processing 00000000.tx.186: Thus, PLAU may have a greater influence on secreted than on cell-associated A. 

Phrase: "Thus,"

Phrase: "PLAU"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "may"

Phrase: "have"

Phrase: "a greater influence on secreted"

Phrase: "than"

Phrase: "on cell-associated A."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C0699040:cell associated [Cell Component]
   812   C0007634:Cell [Cell]
   812   C0332281:Associated [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1720176:On [Functional Concept]
   812   C1720294:On [Intellectual Product]
   812   C1948049:Cell [Spatial Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.187: As most brain A is cell-associated (28), effects on secreted A that are easily detected in plasma could be hard to detect in brain. 

Phrase: "As most brain A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "cell-associated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0699040:cell associated [Cell Component]
   861   C0332281:Associated [Qualitative Concept]
   827 E C0750490:Associate [Idea or Concept]
   827 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "effects on secreted A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "detected in plasma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0032105:Plasma [Body Substance]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "could"

Phrase: "be"

Phrase: "hard to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018599:Hard [Qualitative Concept]

Phrase: "detect in brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C0442726:detect [Finding]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.188: Alternatively, compensatory changes triggered by PLAU KO may maintain brain A more effectively than plasma A. 

Phrase: "Alternatively,"

Phrase: "compensatory changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "triggered by PLAU KO"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0560617:knock out [Injury or Poisoning]
   806   C1444748:Triggered by [Qualitative Concept]
           Trigger
   806   C1522225:Knock-out [Experimental Model of Disease]
   760   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1335224:PLAU [Gene or Genome]
   726   C0032930:Trigger [Clinical Attribute]

Phrase: "may"

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "brain A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "more effectively than plasma A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0032105:Plasma [Body Substance]
   760   C0205172:More [Functional Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.189: We analyzed PLAU_1 in six casecontrol series using meta-analysis. 

Phrase: "We"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "PLAU_1 in six casecontrol series"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0205452:Six [Quantitative Concept]
   753   C0205549:Series [Quantitative Concept]
   753   C1335224:PLAU [Gene or Genome]
   753   C2348044:Series [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.190: Lohmueller et al. 

Phrase: "Lohmueller et al."
Processing 00000000.tx.191: (29) reported their meta-analyses of published genetic associations with various disease phenotypes. 

Phrase: "(29"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "their meta-analyses of published genetic associations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0920317:meta-analyses [Research Activity]
   757   C0679560:genetic analysis [Laboratory Procedure]
   757   C0796344:Genetic Analysis [Laboratory Procedure]
   748   C1042496:Meta [Eukaryote]
   745 E C0282458:Meta-Analysis [Intellectual Product]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "with various disease phenotypes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.192: Of the 25 reported associations that they investigated by meta-analysis, eight showed significant association that replicated the original study, with most ORs in the 1.12.0 range. 

Phrase: "Of the 25 reported associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0004083:Associations [Mental Process]
   793 E C0439849:Association [Qualitative Concept]
   793 E C0596306:Association [Phenomenon or Process]
   793 E C0699792:association [Social Behavior]

Phrase: "that"

Phrase: "they"

Phrase: "investigated by meta-analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0282458:Meta-Analysis [Intellectual Product]
   833   C0920317:Meta-Analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1042496:Meta [Eukaryote]
   770   C1292732:investigated [Functional Concept]
   770   C1524024:analysis [Functional Concept]

Phrase: "eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205454:Eight [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "that"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "the original study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "with most ORs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "in the 1.12.0 range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]
Processing 00000000.tx.193: On the basis of these findings, the authors recommended that large, collaborative genetic association studies should be encouraged, that all sound studies, positive or negative, should be published and that reports of association should include a meta-analysis of all available data. 

Phrase: "On the basis of these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "recommended"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034866:Recommended [Idea or Concept]

Phrase: "that large, collaborative genetic association studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C2717878:Genetic Association Studies [Molecular Biology Research Technique]
   858   C0681804:collaborative study [Research Activity]
   836   C2827447:Genetic Study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "should"

Phrase: "be"

Phrase: "encouraged"

Phrase: ","

Phrase: "that"

Phrase: "all sound studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "or"

Phrase: "negative,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: "should"

Phrase: "be"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "and"

Phrase: "that reports of association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   737 E C3273238:Report [Intellectual Product]

Phrase: "should"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a meta-analysis of all available data."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0282458:Meta-Analysis [Intellectual Product]
   778   C0920317:Meta-Analysis [Research Activity]
   774   C0010992:Data Analysis [Occupational Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1042496:Meta [Eukaryote]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.194: Our meta-analyses of the PLAU_1 SNP in six casecontrol series indicate that the PLAU_1 CT+TT is associated with a modest (OR=1.21), but marginally significant (P=0.0510.056) increase in risk for AD. 

Phrase: "Our meta-analyses of the PLAU_1 SNP"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0920317:meta-analyses [Research Activity]
   744   C1042496:Meta [Eukaryote]
   737 E C0282458:Meta-Analysis [Intellectual Product]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "in six casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "indicate"

Phrase: "that"

Phrase: "the PLAU_1 CT+TT"

Phrase: "is"

Phrase: "associated with a modest"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "=1.21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "marginally significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P=0.0510.056"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increase in risk"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   790   C0035647:Risk [Qualitative Concept]
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "for AD."
Processing 00000000.tx.195: This result is similar to that of Lohmueller etal. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "similar to that of Lohmueller etal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.196: (29), whose meta-analyses identified many other common genetic variants with modest, but significant effects on other disease phenotypes. 

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "whose meta-analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0920317:meta-analyses [Research Activity]
   966 E C0282458:Meta-Analysis [Intellectual Product]
   861   C1042496:Meta [Eukaryote]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "many other common genetic variants with modest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "but"

Phrase: "significant effects on other disease phenotypes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.197: Two other groups had previously published their findings on this SNP (15,30). 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "had"

Phrase: "previously"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "their findings on this SNP (15,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.198: Finckh etal. 

Phrase: "Finckh etal."
Processing 00000000.tx.199: (15) found significant association in three casecontrol series from Germany, Switzerland and Italy, whereas Myers etal. 

Phrase: "(15"

Phrase: ")"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "significant association in three casecontrol series"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "from Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: "and"

Phrase: "Italy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "whereas"

Phrase: "Myers etal."
Processing 00000000.tx.200: (30) did not find evidence of association with any of the PLAU SNPs they analyzed including PLAU_1. 

Phrase: "(30"

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with any"

Phrase: "of the PLAU SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "they"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PLAU_1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1335224:PLAU [Gene or Genome]
Processing 00000000.tx.201: Interestingly, the former found that in their series, it is the CC genotype that is associated with increased risk for LOAD, whereas in our series, it is the CT and TT genotypes. 

Phrase: "Interestingly,"

Phrase: "the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in their series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "it"

Phrase: "is"

Phrase: "the CC genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "that"

Phrase: "is"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for LOAD,"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   877   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   818   C0002395:Alzheimer's Disease [Disease or Syndrome]
   818   C1521724:Alzheimer's Disease [Pathologic Function]
   795   C0012634:Disease [Disease or Syndrome]
   795   C0205087:Late [Temporal Concept]
   795   C0332162:Onset [Qualitative Concept]
   795   C0441889:Levels [Qualitative Concept]
   795   C0521125:For [Qualitative Concept]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   740 E C1836721:MALS [Finding]
   740 E C3538764:MALS [Gene or Genome]
   740 E C3540595:MAL [Gene or Genome]

Phrase: "whereas in our series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "it"

Phrase: "is"

Phrase: "the CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.202: Furthermore, another group from Germany also found significant association with the CT and TT genotypes (M. Riemenschneider, personal communication). 

Phrase: "Furthermore,"

Phrase: "another group from Germany also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "significant association with the CT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "TT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "(M. Riemenschneider,"

Phrase: "personal communication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]

Phrase: ")."
Processing 00000000.tx.203: Thus, there clearly is heterogeneity among all these findings, with one group having significant results in the same direction as our series (M. Riemenschneider), another finding significance with the common genotype (15) and a third group not finding any significance. 

Phrase: "Thus,"

Phrase: "there clearly"

Phrase: "is"

Phrase: "heterogeneity among all"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0019409:Heterogeneity [Qualitative Concept]
   706 E C1512426:Heterogenous [Idea or Concept]

Phrase: "these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "with one group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "having"

Phrase: "significant results in the same direction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "as our series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "(M. Riemenschneider"

Phrase: ")"

Phrase: ","

Phrase: "another"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "significance with the common genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "a third group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "any significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.204: Clearly, all results need to be analyzed in one meta-analysis subsequent to their publication. 

Phrase: "Clearly,"

Phrase: "all results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "analyzed in one meta-analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0205447:One [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
           Analyzed
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]

Phrase: "subsequent to their publication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]
Processing 00000000.tx.205: Nonetheless, as demonstrated by Lohmueller etal. 

Phrase: "Nonetheless,"

Phrase: "as"

Phrase: "demonstrated by Lohmueller etal."
Processing 00000000.tx.206: (29), such discrepancies are frequent among studies of common genetic variants in complex diseases, particularly when the effect size is modest. 

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "such discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:discrepancies [Finding]

Phrase: "are"

Phrase: "frequent among studies of common genetic variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332183:Frequent [Temporal Concept]

Phrase: "in complex diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "particularly"

Phrase: "when"

Phrase: "the effect size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814843:effect size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "modest."
Processing 00000000.tx.207: There are many reasons for such discrepancies including small sample size, genegene and geneenvironment interactions not modelled in studies, intra-sample heterogeneity/population substructure and analysis of the marker variant instead of the disease variant with varying degrees of LD. 

Phrase: "There"

Phrase: "are"

Phrase: "many reasons for such discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:reasons [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "small sample size,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0748864:small size [Finding]
   901   C0242618:Sample Size [Quantitative Concept]
   827   C0456389:size [Spatial Concept]

Phrase: "genegene"

Phrase: "and"

Phrase: "geneenvironment interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modelled in studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]
   756   C3161035:Model [Intellectual Product]

Phrase: "intra-sample heterogeneity/population substructure"

Phrase: "and"

Phrase: "analysis of the marker variant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "instead of the disease variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "with varying degrees"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0449286:degrees [Quantitative Concept]
   861   C0542560:degrees [Intellectual Product]
   827 E C0441889:Degree [Qualitative Concept]
   827 E C1561545:degree [Quantitative Concept]
   827 E C2348088:Degree [Quantitative Concept]

Phrase: "of LD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]
Processing 00000000.tx.208: While we tried to minimize these factors by gathering large series, age matching the Mayo Clinic series and choosing a variant that is likely to be functional itself, it is still plausible that some of these problems may be contributing to inter-series variations observed for PLAU_1. 

Phrase: "While"

Phrase: "we"

Phrase: "tried"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "these factors by gathering large series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "matching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:MATCHING [Research Activity]
  1000   C1708943:Matching [Qualitative Concept]

Phrase: "the Mayo Clinic series"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C2985404:Clinical Series [Research Activity]
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "and"

Phrase: "choosing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:choosing [Activity]

Phrase: "a variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variant [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "itself,"

Phrase: "it"

Phrase: "is"

Phrase: "still plausible"

Phrase: "that"

Phrase: "some of these problems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C1546466:Problems [Idea or Concept]
   770   C3540770:Some [Intellectual Product]
   737 E C0033213:Problem [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "contributing to inter-series variations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205103:Inter- [Spatial Concept]
   760   C0205419:variations [Qualitative Concept]
   760   C0205549:Series [Quantitative Concept]
   760   C1548610:Inter [Temporal Concept]
   760   C1880177:Contributing [Activity]
   760   C2348044:Series [Intellectual Product]

Phrase: "observed for PLAU_1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1335224:PLAU [Gene or Genome]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.209: Indeed, the association for PLAU_1 is marginally significant with the confidence interval of 1.01.47 in the six series analyzed. 

Phrase: "Indeed,"

Phrase: "the association for PLAU_1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "marginally significant with the confidence interval of 1.01.47"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0237881:significant [Quantitative Concept]
   739   C0750502:Significant [Idea or Concept]
   739   C1546944:Significant [Qualitative Concept]

Phrase: "in the six series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.210: Nonetheless, this statistical result should be considered in the presence of evidence from the family and animal data on the effect of PLAU in A; 

Phrase: "Nonetheless,"

Phrase: "this statistical result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "should"

Phrase: "be"

Phrase: "considered in the presence of evidence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0332120:Evidence of [Functional Concept]
           Evidence
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0750591:considered [Idea or Concept]

Phrase: "from the family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "animal data on the effect of PLAU"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0597710:animal data [Intellectual Product]
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.211: and with the understanding that there likely exist other variants in PLAU that affect the risk of AD, as suggested by the compound genotype data in the casecontrol series. 

Phrase: "and with the understanding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0162340:Understanding [Mental Process]
   770   C1515981:And [Idea or Concept]

Phrase: "that there likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "other variants in PLAU"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205419:variants [Qualitative Concept]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the risk of AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "as"

Phrase: "suggested by the compound genotype data"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0017431:Genotype [Organism Attribute]
   753   C0205198:Compound [Qualitative Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1706082:Compound [Chemical]
   753   C3245479:data [Medical Device]
   719   C1705535:Suggest [Idea or Concept]

Phrase: "in the casecontrol series."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]
Processing 00000000.tx.212: Furthermore, given the likely presence of important variants in other genes, such as VR22 and IDE, the finding of highly significant P-values for variants of modest effect in complex diseases may need to await the identification of most, if not all, functional mutations in multiple genes and their analyses in multiple large series. 

Phrase: "Furthermore,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the likely presence of important variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in other genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "such as VR22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413797:VR22 [Gene or Genome]

Phrase: "and"

Phrase: "IDE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "the finding of highly significant P-values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "for variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "of modest effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "in complex diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "may"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "await"

Phrase: "the identification of most,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "if"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all,"

Phrase: "functional mutations in multiple genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "their analyses in multiple large series."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]
Processing 00000000.tx.213: We recently published our findings of significant association in two other genes on chromosome 10 (31,32), IDE and VR22. 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "our findings of significant association"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "in two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other genes on chromosome 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Genes [Gene or Genome]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "and"

Phrase: "VR22."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413797:VR22 [Gene or Genome]
Processing 00000000.tx.214: When we tested the key variants in all three genes, we did not find evidence of LD. 

Phrase: "When"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the key variants in all three genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "evidence of LD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.215: Joint analysis of the key variants demonstrates separate, independent effects. 

Phrase: "Joint analysis of the key variants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "demonstrates"

Phrase: "separate, independent effects."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0085862:Independent [Idea or Concept]
   827   C1280500:effects [Qualitative Concept]
   827   C1299583:Independent [Finding]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.216: Of all of the variants, only those in VR22 account for the linkage on chromosome 10. 

Phrase: "Of all"

Phrase: "of the variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "those in VR22 account"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1413797:VR22 [Gene or Genome]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "for the linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "on chromosome 10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.217: PLAU variants are different from the other two in their age-related effects that manifest themselves more strongly after age 50. 

Phrase: "PLAU variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "are"

Phrase: "different from the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "other two in their age-related effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205448:Two [Quantitative Concept]

Phrase: "that"

Phrase: "manifest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "themselves more strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "after"

Phrase: "age 50."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]
Processing 00000000.tx.218: Thus, each of these genes appears to act independently of one another via apparent separate mechanisms. 

Phrase: "Thus,"

Phrase: "each of these genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017337:Genes [Gene or Genome]
   770   C1457900:Each [Quantitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act independently of one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0205447:One [Quantitative Concept]

Phrase: "another via apparent separate mechanisms."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0441712:Mechanisms [Functional Concept]
   760   C0443299:Separate [Spatial Concept]
   760   C0750489:apparent [Idea or Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.219: While the unequivocal effects of these genes in the pathogenesis of AD await the identification of all of the functional variants and testing them in large series, these findings provide evidence for the existence of LOAD risk variants that affect A, within and/or in the vicinity of these genes.  

Phrase: "While"

Phrase: "the unequivocal effects of these genes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of AD"

Phrase: "await"

Phrase: "the identification of all of the functional variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "testing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]

Phrase: "them in large series,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205549:Series [Quantitative Concept]
   770   C0549177:Large [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for the existence of LOAD risk variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0393009:Levels of Evidence [Finding]
           evidence level
   749   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "A"

Phrase: ","

Phrase: "within"

Phrase: "and/or in the vicinity of these genes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1706528:And/Or [Conceptual Entity]
   744   C0017337:Genes [Gene or Genome]
   744   C1515981:And [Idea or Concept]
Processing 00000000.tx.220: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Subjects We initially collected 10 extended LOAD families. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "10 extended LOAD families."
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
   879   C0015341:Extended Family [Family Group]
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Families [Family Group]
   791   C0205087:Late [Temporal Concept]
   791   C0231448:Extended [Functional Concept]
   791   C0231449:Extended [Spatial Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0439792:extended [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C1704727:Family [Conceptual Entity]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   708 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.221: Four of these families were collected via an LOAD patient who had extremely high plasma A42 and/or A40 levels (extremes, top 10th percentile of the 545 AD patients in our series). 

Phrase: "Four of these families"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015576:Families [Family Group]
   770   C0205450:Four [Quantitative Concept]
   770   C1704727:Family [Conceptual Entity]

Phrase: "were"

Phrase: "collected via an LOAD patient"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   775   C0814122:late disease onset [Finding]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0277793:disease onset [Temporal Concept]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0030705:*^patient [Patient or Disabled Group]
   739   C0205087:Late [Temporal Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C1516695:Collected [Idea or Concept]
   739   C1516698:Collected [Functional Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "who"

Phrase: "had"

Phrase: "extremely high plasma A42"

Phrase: "and/or"

Phrase: "A40 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(extremes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205403:Extreme [Qualitative Concept]

Phrase: "top 10th percentile of the 545 AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1264641:Percentile [Quantitative Concept]

Phrase: "in our series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.222: The remaining six families were ascertained via a LOAD proband who had multiple relatives with LOAD, without prior A measurements (non-extremes). 

Phrase: "The remaining six families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "were"

Phrase: "ascertained via a LOAD proband"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   775   C0814122:late disease onset [Finding]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   757   C0277793:disease onset [Temporal Concept]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0205087:Late [Temporal Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C1948021:Proband [Family Group]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "who"

Phrase: "had"

Phrase: "multiple relatives with LOAD,"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   827   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset
   781   C0814122:late disease onset [Finding]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   762   C0277793:disease onset [Temporal Concept]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0080103:Relatives [Family Group]
   742   C0205087:Late [Temporal Concept]
   742   C0332162:Onset [Qualitative Concept]
   742   C0439064:Multiple [Quantitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0205345:Relative [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547039:*Relative [Quantitative Concept]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "without prior A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332152:Prior [Temporal Concept]
   827   C0332288:Without [Qualitative Concept]
   827   C2826257:PRIOR [Event]

Phrase: "measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "(non-extremes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205403:Extreme [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.223: One of the probands from the non-extreme families was determined to have extremely high-plasma A levels after the family collection; 

Phrase: "One of the probands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "from the non-extreme families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "extremely high-plasma A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0032105:Plasma [Body Substance]
   812   C0205250:High [Qualitative Concept]
   812   C1299351:High [Qualitative Concept]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C2700149:HIGH [Intellectual Product]

Phrase: "levels after the family collection"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.224: therefore, this family was grouped with the extreme families subsequently. 

Phrase: "therefore,"

Phrase: "this family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "was"

Phrase: "grouped with the extreme families subsequently."
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   767   C0015576:Family Group [Family Group]
           Families
   753   C0205403:Extreme [Qualitative Concept]
   753   C0439745:Grouped [Spatial Concept]
   753   C1704727:Family [Conceptual Entity]
   719 E C0441833:Group [Idea or Concept]
   719 E C0687744:group [Population Group]
   719 E C1257890:Group [Population Group]
   719 E C1552516:Group [Health Care Related Organization]
   719 E C1705428:Group [Conceptual Entity]
   719 E C1705429:Group [Population Group]
Processing 00000000.tx.225: The detailed collection strategies and family profiles for these families are provided elsewhere (1). 

Phrase: "The detailed collection strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]

Phrase: "and"

Phrase: "family profiles for these families"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "are"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "elsewhere"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.226: In addition to these 10 families, 14 independent extended LOAD pedigrees were subsequently collected. 

Phrase: "In addition to these 10 families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "14 independent extended LOAD pedigrees"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0030761:pedigrees [Intellectual Product]
   790   C0085862:Independent [Idea or Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0231448:Extended [Functional Concept]
   790   C0231449:Extended [Spatial Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0439792:extended [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C1299583:Independent [Finding]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "were"

Phrase: "subsequently"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.227: These additional pedigrees were collected via a proband who was a first-degree relative of a LOAD patient. 

Phrase: "These additional pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:pedigrees [Intellectual Product]

Phrase: "were"

Phrase: "collected via a proband"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1948021:Proband [Family Group]
   715 E C0702110:Propositus [Organism Attribute]

Phrase: "who"

Phrase: "was"

Phrase: "a first-degree relative"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C1517194:First Degree Relative [Family Group]
   901   C0444502:First degree [Qualitative Concept]
   827   C0080103:Relative [Family Group]
   827   C0205345:Relative [Qualitative Concept]
   827   C0205435:First [Quantitative Concept]
   827   C0441889:Degree [Qualitative Concept]
   827   C0449286:Degree [Quantitative Concept]
   827   C0542560:Degree [Intellectual Product]
   827   C1279901:First [Qualitative Concept]
   827   C1547039:*Relative [Quantitative Concept]
   827   C1561545:degree [Quantitative Concept]
   827   C2348088:Degree [Quantitative Concept]

Phrase: "of a LOAD patient."
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0030705:*^patient [Patient or Disabled Group]
   791   C0205087:Late [Temporal Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332285:Of [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.228: All except one of these probands for the 14 additional pedigrees had elevated plasma A levels. 

Phrase: "All except one of these probands"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205447:One [Quantitative Concept]
   753   C0444868:All [Quantitative Concept]
   753   C0702111:probands [Organism Attribute]
   753   C3539085:All [Idea or Concept]
   719 E C1948021:Proband [Family Group]

Phrase: "for the 14 additional pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030761:pedigrees [Intellectual Product]

Phrase: "had"

Phrase: "elevated plasma A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032105:Plasma [Body Substance]
   827   C0205250:Elevated [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C3163633:Elevated [Qualitative Concept]

Phrase: "levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.229: The LOAD families studied in this article lacked a clear autosomal dominant mode of segregation for AD. 

Phrase: "The LOAD families"
Meta Candidates (Total=17; Excluded=7; Pruned=0; Remaining=10)
   861   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C0344339:disease family [Finding]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0015576:Families [Family Group]
   793   C0205087:Late [Temporal Concept]
   793   C0332162:Onset [Qualitative Concept]
   793   C0441889:Levels [Qualitative Concept]
   793   C1704727:Family [Conceptual Entity]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
   710 E C0241888:Familial [Functional Concept]

Phrase: "studied in this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1706852:Article [Intellectual Product]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "lacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332268:lack [Qualitative Concept]

Phrase: "a clear autosomal dominant mode of segregation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1513371:Mode [Functional Concept]
   748   C1705738:Mode [Quantitative Concept]
   748   C2347637:Mode [Quantitative Concept]
   748   C2348146:Mode [Quantitative Concept]

Phrase: "for AD."
Processing 00000000.tx.230: In addition to the extended LOAD families, six different casecontrol series were analyzed in this study. 

Phrase: "In addition to the extended LOAD families,"
Meta Candidates (Total=24; Excluded=8; Pruned=0; Remaining=16)
   853   C0015341:Extended Family [Family Group]
   827   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   812   C0332287:In addition to [Qualitative Concept]
   799   C0002395:Alzheimer's Disease [Disease or Syndrome]
   799   C0344339:disease family [Finding]
   799   C1521724:Alzheimer's Disease [Pathologic Function]
   787   C0012634:Disease [Disease or Syndrome]
   787   C0015576:Families [Family Group]
   787   C0205087:Late [Temporal Concept]
   787   C0231448:Extended [Functional Concept]
   787   C0231449:Extended [Spatial Concept]
   787   C0332162:Onset [Qualitative Concept]
   787   C0439792:extended [Spatial Concept]
   787   C0441889:Levels [Qualitative Concept]
   787   C1704727:Family [Conceptual Entity]
   787   C1883712:Addition [Functional Concept]
   754 E C0456079:Level [Classification]
   754 E C1547707:Level [Geographic Area]
   754 E C2946261:Level [Pharmacologic Substance]
   732 E C1836721:MALS [Finding]
   732 E C3538764:MALS [Gene or Genome]
   732 E C3540595:MAL [Gene or Genome]
   716 E C1524062:Additional [Functional Concept]
   704 E C0241888:Familial [Functional Concept]

Phrase: "six different casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "analyzed in this study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C0936012:Analyzed [Research Activity]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.231: These series are named as follows: Mayo Clinic Rochester (MCR), Mayo Clinic Jacksonville (MCJ), University of Kentucky (UKy), Gothenburg, Gothenburg-Postmortem and Scottish. 

Phrase: "These series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "are"

Phrase: "named"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027365:named [Intellectual Product]
   966 E C1547383:Name [Intellectual Product]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Mayo Clinic Rochester"

Phrase: "(MCR"

Phrase: ")"

Phrase: ","

Phrase: "Mayo Clinic Jacksonville"

Phrase: "(MCJ"

Phrase: ")"

Phrase: ","

Phrase: "University of Kentucky"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "(UKy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022557:Kentucky [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ","

Phrase: "Gothenburg,"

Phrase: "Gothenburg-Postmortem"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]

Phrase: "and"

Phrase: "Scottish."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0240966:Scottish [Population Group]
Processing 00000000.tx.232: MCR samples were collected as part of the Mayo Clinic Alzheimer's disease patient registry, a community-based prospective registry and the Mayo Clinic Rochester memory disorders clinic casecontrol series. 

Phrase: "MCR samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected as part of the Mayo Clinic Alzheimer's disease patient registry,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   770   C0597185:patient/disease registry [Intellectual Product]
   756   C0002395:Alzheimer's Disease [Disease or Syndrome]
   756   C0920631:patient registry [Intellectual Product]
   756   C1292711:Part of [Spatial Concept]
   756   C1521724:Alzheimer's Disease [Pathologic Function]
   754   C0920465:disease registry [Intellectual Product]
   738   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   738   C0012634:Disease [Disease or Syndrome]
   738   C0030705:*^patient [Patient or Disabled Group]
   738   C0034975:Registry [Intellectual Product]
   738   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   738   C0449719:Part [Spatial Concept]
   738   C0454788:Mayo [Geographic Area]
   738   C1077578:mayo [Plant]
   738   C1516695:Collected [Idea or Concept]
   738   C1516698:Collected [Functional Concept]
   738   C1709471:Part [Quantitative Concept]

Phrase: "a community-based prospective registry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034975:Registry [Intellectual Product]

Phrase: "and"

Phrase: "the Mayo Clinic Rochester memory disorders clinic casecontrol series."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   842   C2985404:Clinical Series [Research Activity]
   793   C0205549:Series [Quantitative Concept]
   793   C2348044:Series [Intellectual Product]
Processing 00000000.tx.233: MCJ samples were collected at Mayo Clinic Jacksonville memory disorders clinic. 

Phrase: "MCJ samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected at Mayo Clinic Jacksonville memory disorders clinic."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0025261:Memory Disorders [Mental or Behavioral Dysfunction]
   744   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   744   C0012634:Disorders [Disease or Syndrome]
   744   C0025260:Memory [Mental Process]
   744   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   744   C0454788:Mayo [Geographic Area]
   744   C0700327:memory [Finding]
   744   C1077578:mayo [Plant]
   744   C1516695:Collected [Idea or Concept]
   744   C1516698:Collected [Functional Concept]
   744   C1706377:Memory [Manufactured Object]
Processing 00000000.tx.234: UKy series were collected as part of the University of Kentucky memory disorders clinic and BRAINS program. 

Phrase: "UKy series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "collected as part of the University of Kentucky memory disorders clinic"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0025261:Memory Disorders [Mental or Behavioral Dysfunction]
   756   C1292711:Part of [Spatial Concept]
   738   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   738   C0012634:Disorders [Disease or Syndrome]
   738   C0022557:Kentucky [Geographic Area]
   738   C0025260:Memory [Mental Process]
   738   C0041740:University [Manufactured Object,Organization]
   738   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   738   C0449719:Part [Spatial Concept]
   738   C0700327:memory [Finding]
   738   C1516695:Collected [Idea or Concept]
   738   C1516698:Collected [Functional Concept]
   738   C1706377:Memory [Manufactured Object]
   738   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "BRAINS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]
Processing 00000000.tx.235: MCR, MCJ and UKy series consisted of Caucasian subjects from the United States. 

Phrase: "MCR,"

Phrase: "MCJ"

Phrase: "and"

Phrase: "UKy series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "consisted of Caucasian subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0007457:Caucasian [Population Group]
   770   C0043157:Caucasian [Population Group]
   737   C0332529:CONSIST [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "from the United States."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0041703:United States [Geographic Area]
   861   C1301808:states [Geographic Area]
   827   C0166872:unite [Biomedical or Dental Material]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]
Processing 00000000.tx.236: The Gothenburg and Gothenburg-Postmortem series consisted of Swedish AD cases recruited from a prospective longitudinal study of patients with dementia (The Mlndal prospective dementia study). 

Phrase: "The Gothenburg"

Phrase: "and"

Phrase: "Gothenburg-Postmortem series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "consisted of Swedish AD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   760   C1710263:Swedish [Population Group]
   726   C0332529:CONSIST [Qualitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "recruited from a prospective longitudinal study of patients"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0033522:prospective longitudinal study [Research Activity]
           prospective study
   770   C0023981:Longitudinal Study [Research Activity]
           prospective
   767   C1709709:Prospective Study [Research Activity]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0205127:Longitudinal [Spatial Concept]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "("

Phrase: "The Mlndal prospective dementia study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0033522:prospective study [Research Activity]
   875   C1709709:Prospective Study [Research Activity]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.237: Swedish controls consisted of healthy volunteers (Gothenburg) and autopsy cases (Gothenburg-Postmortem). 

Phrase: "Swedish controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "consisted of healthy volunteers"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C1708335:Healthy Volunteers [Population Group]
   770   C0042960:Volunteers [Professional or Occupational Group]
   737   C0332529:CONSIST [Qualitative Concept]
   737 E C1549078:Volunteer [Idea or Concept]
   737 E C1997894:volunteer [Population Group]

Phrase: "(Gothenburg"

Phrase: ")"

Phrase: "and"

Phrase: "autopsy cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0004398:Autopsy [Diagnostic Procedure]
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(Gothenburg-Postmortem"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]

Phrase: ")."
Processing 00000000.tx.238: Finally, the Scottish samples were composed of EOAD patients from the Lothian Psychiatric case register, and Scottish controls consisting of local church congregation volunteers from the Lothian region. 

Phrase: "Finally,"

Phrase: "the Scottish samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "composed of EOAD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "from the Lothian Psychiatric case register,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0205487:Psychiatric [Functional Concept]
   812   C0868928:Case [Functional Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   741 E C0033872:Psychiatry [Professional or Occupational Group]
   741 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Scottish controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "consisting of local church congregation volunteers"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0042960:Volunteers [Professional or Occupational Group]
   753   C0205276:Local [Spatial Concept]
   753   C0562324:Church [Manufactured Object]
   719   C0332529:CONSIST [Qualitative Concept]
   719 E C1549078:Volunteer [Idea or Concept]
   719 E C1997894:volunteer [Population Group]

Phrase: "from the Lothian region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.239: The EOAD materials were selected from non-familial cases, and the most common presenilin-I mutations have been screened for. 

Phrase: "The EOAD materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "were"

Phrase: "selected from non-familial cases,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1518422:Non [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
   726   C1707391:Select [Activity]

Phrase: "and"

Phrase: "the most common presenilin-I mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "screened for."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0220908:screen [Health Care Activity]
   799   C1305399:screen [Functional Concept]
   799   C1705053:Screen [Medical Device]
Processing 00000000.tx.240: The few positives found were discarded from the test set. 

Phrase: "The few positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "were"

Phrase: "discarded from the test set."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0022885:Test [Laboratory Procedure]
   760   C0036849:Set [Mental Process]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.241: Clinical AD diagnoses in all series were made according to the NINCDS-ADRDA criteria (33). 

Phrase: "Clinical AD diagnoses in all series"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0332140:Diagnosis, clinical [Qualitative Concept]
   753   C0011900:Diagnoses [Finding]
   719 E C1704338:diagnosis [Qualitative Concept]
   719 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "were"

Phrase: "made according to the NINCDS-ADRDA criteria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243161:criteria [Intellectual Product]
   748   C0680240:according [Social Behavior]
   714   C1881534:Make [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.242: All neuropathologically diagnosed AD patients (Gothenburg-Postmortem) also fulfilled the clinical NINCDS criteria for probable AD and met the neuropathological CERAD criteria for definitive AD. 

Phrase: "All neuropathologically"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(Gothenburg-Postmortem"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]

Phrase: ")"

Phrase: "also"

Phrase: "fulfilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Fulfill [Idea or Concept]

Phrase: "the clinical NINCDS criteria for probable AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "the neuropathological CERAD criteria for definitive AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.243: The ADs in all series except the Scottish series had ages of onset 59 years. 

Phrase: "The ADs in all series"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0450984:ADS [Intellectual Product]

Phrase: "except the Scottish series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "had"

Phrase: "ages of onset 59 years."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   833   C3274945:Year of Onset [Temporal Concept]
   797   C1510829:Age-Years [Temporal Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]
   760   C0439234:years [Temporal Concept]
   726 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.244: This study was approved by the appropriate institutional review boards, and appropriate informed consent was obtained from all participants. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "approved by the appropriate institutional review boards,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0086911:Institutional Review Boards [Professional or Occupational Group]
   748   C0205540:Approved [Qualitative Concept]
   748   C0282443:Review [Intellectual Product]
   748   C0972401:board [Medical Device]
   748   C1548787:Appropriate [Qualitative Concept]
   748   C1552617:Review [Idea or Concept]
   748   C1948070:Board [Organization]
   738   C0003633:Appropriateness Review [Occupational Activity]

Phrase: "and"

Phrase: "appropriate informed consent"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0021430:Informed Consent [Regulation or Law]
   827   C1511481:Consent [Functional Concept]
   827   C1522154:Informed [Qualitative Concept]
   827   C1554192:consent [Idea or Concept]
   793 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   793 E C0700287:inform [Health Care Activity]
   793 E C1552002:inform [Idea or Concept]

Phrase: "was"

Phrase: "obtained from all participants."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0679646:participants [Population Group]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
   737 E C2698741:Participant [Classification]
Processing 00000000.tx.245: Identification and genotyping of PLAU SNPs Eleven members were selected from the 10 extended LOAD families that gave the linkage signal on chromosome 10 (1). 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "genotyping of PLAU SNPs Eleven members"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1285573:Genotyping [Laboratory Procedure]

Phrase: "were"

Phrase: "selected from the 10 extended LOAD families"
Meta Candidates (Total=25; Excluded=4; Pruned=0; Remaining=21)
   790   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   777   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   767   C1864828:ALZHEIMER DISEASE 10 [Disease or Syndrome]
           Alzheimer Disease, Familial, 10
   766   C0814122:late disease onset [Finding]
   753   C0002395:Alzheimer's Disease [Disease or Syndrome]
   753   C0344339:disease family [Finding]
   753   C1521724:Alzheimer's Disease [Pathologic Function]
   751   C0015341:Extended Family [Family Group]
   751   C0277793:disease onset [Temporal Concept]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0015576:Families [Family Group]
   736   C0205087:Late [Temporal Concept]
   736   C0231448:Extended [Functional Concept]
   736   C0231449:Extended [Spatial Concept]
   736   C0332162:Onset [Qualitative Concept]
   736   C0439792:extended [Spatial Concept]
   736   C0441889:Levels [Qualitative Concept]
   736   C1704727:Family [Conceptual Entity]
   726   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   709 E C0277558:Familial disease [Disease or Syndrome]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703   C1707391:Select [Activity]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "the linkage signal on chromosome 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.246: The genomic DNA from five family members and two probands with high-plasma A level and from two members and two married-in spouses with low levels were sequenced. 

Phrase: "The genomic DNA from five family members"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017428:Genomic [Gene or Genome]
   748   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "two probands with high-plasma A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0032105:Plasma [Body Substance]
   753   C0205250:High [Qualitative Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0702111:probands [Organism Attribute]
   753   C1299351:High [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C2700149:HIGH [Intellectual Product]
   719 E C1948021:Proband [Family Group]

Phrase: "level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "and from two members"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205448:Two [Quantitative Concept]
   770   C0680022:members [Population Group]
   770   C1515981:And [Idea or Concept]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "married"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024841:Married [Finding]
  1000   C0555047:Married [Finding]

Phrase: "-"

Phrase: "in spouses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162409:Spouses [Family Group]

Phrase: "with low levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.247: The samples came from four different families, three of which had probands with extreme high A levels. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "came from four different families,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015576:Families [Family Group]
   760   C0205450:Four [Quantitative Concept]
   760   C1704727:Family [Conceptual Entity]
   760   C1705242:Different [Qualitative Concept]

Phrase: "three of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205449:Three [Quantitative Concept]

Phrase: "had"

Phrase: "probands with extreme high A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0702111:probands [Organism Attribute]
   726 E C1948021:Proband [Family Group]

Phrase: "levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.248: Intronic primers flanking the PLAU exons were used for PCR amplification. 

Phrase: "Intronic primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the PLAU exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used for PCR amplification."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C1273517:used [Finding]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.249: All of the coding regions, 400bp of the 5' untranslated region (5' UTR) and 1000bp of the 3'-UTR of PLAU were sequenced. 

Phrase: "All of the coding regions,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   773   C0079941:Coding Region [Gene or Genome]
   760   C0009219:Coding [Occupational Activity]
   760   C0444868:All [Quantitative Concept]
   760   C3539085:All [Idea or Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]
   726 E C0805701:Code [Intellectual Product]

Phrase: "400bp of the 5' untranslated region"

Phrase: "(5' UTR)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1420099:UTR [Gene or Genome]
   861   C1540171:UTR [Gene or Genome]

Phrase: "and"

Phrase: "1000bp of the 3'-UTR of PLAU"

Phrase: "were"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.250: The sequencing was done via a semi-automated fluorescent method using an ABI377 sequencer and associated Factura software packages. 

Phrase: "The sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "done via a semi-automated fluorescent method"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0025663:Method [Intellectual Product]
   748   C0205554:Automated [Functional Concept]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1272695:Done [Qualitative Concept]
   748   C2746065:Done [Temporal Concept]
   714 E C1072074:Automate [Eukaryote]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ABI377 sequencer"

Phrase: "and"

Phrase: "associated Factura software packages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0013194:Package [Medical Device]
   779   C2700580:Package [Manufactured Object]
Processing 00000000.tx.251: The SNP databases at the National Center for Biotechnology Information (NCBI; 

Phrase: "The SNP databases at the National Center for Biotechnology Information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0242356:Databases [Intellectual Product]
   706 E C0993637:Database [Intellectual Product]

Phrase: "(NCBI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0995203:NCBI [Intellectual Product]
  1000   C1705803:NCBI [Organization]

Phrase: ";"
Processing 00000000.tx.252: URL: http://www.ncbi.nlm.nih.gov/SNP/) and University of Washington and the Fred Hutchinson Cancer Research Center (UW-FHCRC; 

Phrase: "URL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1710546:URL [Intellectual Product]
  1000   C3272380:URL [Intellectual Product]
  1000   C3541384:URL [Intellectual Product]

Phrase: ":"

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.ncbi.nlm.nih.gov/SNP/)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0752046:SNP [Nucleotide Sequence]
   799   C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "University of Washington"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043038:Washington [Geographic Area]

Phrase: "and"

Phrase: "the Fred Hutchinson Cancer Research Center"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1517309:Fred Hutchinson Cancer Research Center [Health Care Related Organization]
   853   C1513817:Cancer Center [Health Care Related Organization]
   840   C0683939:research center [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "(UW-FHCRC"

Phrase: ";"
Processing 00000000.tx.253: URL: http://pga.mbt.washington.edu) were also screened for SNP identification. 

Phrase: "URL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1710546:URL [Intellectual Product]
  1000   C3272380:URL [Intellectual Product]
  1000   C3541384:URL [Intellectual Product]

Phrase: ":"

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//pga.mbt.washington.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "screened for SNP identification."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]
   770   C0752046:SNP [Nucleotide Sequence]
   770   C1527094:SNP [Conceptual Entity]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]
Processing 00000000.tx.254: The SNPs identified via the sequencing effort were used in the analysis as well as a rare missense SNP in exon 2 identified in the bioinformatics screen. 

Phrase: "The SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "identified via the sequencing effort"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0015264:Effort [Organism Function]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1553778:Sequencing [Intellectual Product]
   760   C1561491:Sequencing [Functional Concept]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162326:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "used in the analysis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "as well as"

Phrase: "a rare missense SNP in exon 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0752046:SNP [Nucleotide Sequence]
   748   C1527094:SNP [Conceptual Entity]

Phrase: "identified in the bioinformatics screen."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205396:Identified [Qualitative Concept]
   760   C0220908:screen [Health Care Activity]
   760   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]
   760   C1305399:screen [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1705053:Screen [Medical Device]
Processing 00000000.tx.255: When the seven SNPs, thus identified, were analyzed in haplotype analysis, it was determined that two of them, the missense exon 2 SNP and exon 11 deletion SNP yielded redundant information. 

Phrase: "When"

Phrase: "the seven SNPs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "thus"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "were"

Phrase: "analyzed in haplotype analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0018591:Haplotype [Organism Attribute]
   770   C0936012:Analysis [Research Activity]
           Analyzed
   770   C1524024:analysis [Functional Concept]

Phrase: "it"

Phrase: "was"

Phrase: "determined"

Phrase: "that two of them,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205448:Two [Quantitative Concept]

Phrase: "the missense exon 2 SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0752046:SNP [Nucleotide Sequence]
   812   C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "exon 11 deletion SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0752046:SNP [Nucleotide Sequence]
   812   C1527094:SNP [Conceptual Entity]

Phrase: "yielded"

Phrase: "redundant information."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]
Processing 00000000.tx.256: Therefore, remainder of the analysis was carried out with five SNPs. 

Phrase: "Therefore,"

Phrase: "remainder of the analysis"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with five SNPs."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0205451:Five [Quantitative Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
   719 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.257: PLAU SNP frequencies estimated in MCJ, MCR, UKy series and 24 LOAD families are summarized in Table 2. 

Phrase: "PLAU SNP frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "estimated in MCJ,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1441517:Clinical.estimated [Laboratory Procedure]
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0454788:Mayo [Geographic Area]
   760   C0750572:Estimated [Quantitative Concept]
   760   C1077578:mayo [Plant]

Phrase: "MCR,"

Phrase: "UKy series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "and"

Phrase: "24 LOAD families"
Meta Candidates (Total=17; Excluded=7; Pruned=0; Remaining=10)
   861   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C0344339:disease family [Finding]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0015576:Families [Family Group]
   793   C0205087:Late [Temporal Concept]
   793   C0332162:Onset [Qualitative Concept]
   793   C0441889:Levels [Qualitative Concept]
   793   C1704727:Family [Conceptual Entity]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
   710 E C0241888:Familial [Functional Concept]

Phrase: "are"

Phrase: "summarized in Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.258: Of all the SNPs tested in all these groups, the rare Exon 2 SNP is in HardyWeinberg disequilibrium in the control groups in MCJ and MCR. 

Phrase: "Of all"

Phrase: "the SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "tested in all"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "these groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "the rare Exon 2 SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0752046:SNP [Nucleotide Sequence]
   812   C1527094:SNP [Conceptual Entity]

Phrase: "is in HardyWeinberg disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "in the control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "in MCJ"

Phrase: "and"

Phrase: "MCR."
Processing 00000000.tx.259: This SNP is not used in the compound genotype analysis. 

Phrase: "This SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "used in the compound genotype analysis."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0017431:Genotype [Organism Attribute]
   753   C0205198:Compound [Qualitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1273517:used [Finding]
   753   C1524024:analysis [Functional Concept]
   753   C1706082:Compound [Chemical]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.260: In addition, exon 6 SNP is in HardyWeinberg disequilibrium in the MCJ control series. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "exon 6 SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0752046:SNP [Nucleotide Sequence]
   827   C1527094:SNP [Conceptual Entity]

Phrase: "is in HardyWeinberg disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "in the MCJ control series."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C2985404:Clinical Series [Research Activity]
   804   C0205549:Series [Quantitative Concept]
   804   C2348044:Series [Intellectual Product]
Processing 00000000.tx.261: DNA was extracted from peripheral blood leukocytes using routine methods. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from peripheral blood leukocytes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0023516:blood leukocytes [Cell]
           Leukocytes
   806   C0229664:peripheral blood [Body Substance]
           Blood
   765 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0205100:Peripheral [Spatial Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "routine methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.262: The Gothenburg, Gothenburg-Postmortem and Scottish series were genotyped using dynamic allele specific hybridization (34,35). 

Phrase: "The Gothenburg,"

Phrase: "Gothenburg-Postmortem"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004398:postmortem [Diagnostic Procedure]
   861   C0580205:Postmortem [Temporal Concept]
   861   C0848632:post mortem [Finding]

Phrase: "and"

Phrase: "Scottish series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dynamic allele specific hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.263: The other series were genotyped on an ABI7900 instrument using TaqMan technology. 

Phrase: "The"

Phrase: "other series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "genotyped on an ABI7900 instrument"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0348000:Instrument [Medical Device]
   726   C0017431:Genotype [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TaqMan technology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:Technology [Occupation or Discipline]
Processing 00000000.tx.264: For the TaqMan assays, software for designing primers and probes implemented within the ABI PRISM 7900 HT sequence detection system was utilized. 

Phrase: "For the TaqMan assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "software for designing primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "implemented within the ABI PRISM 7900 HT sequence detection system"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0018510:HT [Geographic Area]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0449913:System [Functional Concept]
   739   C0677607:HT [Disease or Syndrome]
   739   C0814195:PRISM [Intellectual Product]
   739   C1328319:ABI [Clinical Attribute]
   739   C1511790:Detection [Therapeutic or Preventive Procedure]
   739   C1519249:Sequence [Functional Concept]
   739   C1553451:System [Manufactured Object]
   739   C1704459:System [Medical Device]

Phrase: "was"

Phrase: "utilized."
Processing 00000000.tx.265: The NCBI GenBank PLAU gene sequence AF377330 was used. 

Phrase: "The NCBI GenBank PLAU gene sequence AF377330"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.266: The pedigree structure, phenotypic and genotypic information, was maintained in PEDSYS (36) (http://www.sfbr.org/sfbr/public/software/pedsys/pedsys.html), which also produced output files for the analysis performed with SOLAR, as explained subsequently. 

Phrase: "The pedigree structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "phenotypic"

Phrase: "and"

Phrase: "genotypic information,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "was"

Phrase: "maintained in PEDSYS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "(36"

Phrase: ")"

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.sfbr.org/sfbr/public/software/pedsys/pedsys.html"

Phrase: ")"

Phrase: ","

Phrase: "which also produced output files for the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0016094:File [Occupational Activity]
   711   C0180853:File [Medical Device]
   711   C1522646:File [Functional Concept]

Phrase: "performed with SOLAR,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
   734   C0038817:Sun [Natural Phenomenon or Process]
   734   C0376223:Sun [Geographic Area]

Phrase: "as"

Phrase: "explained"

Phrase: "subsequently."
Processing 00000000.tx.267: Analysis of LD among the SNPs We measured LD between the SNPs within the 10 extended LOAD families by using the GOLD program (22). 

Phrase: "Analysis of LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0796345:analysis linkage [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "among the SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "LD between the SNPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0023746:Linkage Disequilibrium [Quantitative Concept]
   774   C1883037:Single Linkage [Research Activity]
   748   C0023745:linkage [Molecular Function]
   748   C0281825:Disequilibrium [Finding]
   748   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "within the 10 extended LOAD families"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
   860   C0015341:Extended Family [Family Group]
   832   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   801   C0002395:Alzheimer's Disease [Disease or Syndrome]
   801   C0344339:disease family [Finding]
   801   C1521724:Alzheimer's Disease [Pathologic Function]
   788   C0012634:Disease [Disease or Syndrome]
   788   C0015576:Families [Family Group]
   788   C0205087:Late [Temporal Concept]
   788   C0231448:Extended [Functional Concept]
   788   C0231449:Extended [Spatial Concept]
   788   C0332162:Onset [Qualitative Concept]
   788   C0332285:Within [Spatial Concept]
   788   C0439792:extended [Spatial Concept]
   788   C0441889:Levels [Qualitative Concept]
   788   C1704727:Family [Conceptual Entity]
   755 E C0456079:Level [Classification]
   755 E C1547707:Level [Geographic Area]
   755 E C2946261:Level [Pharmacologic Substance]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]
   705 E C0241888:Familial [Functional Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GOLD program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.268: This program determines various pairwise statistical parameters for LD, such as Lewontin's standardized disequilibrium coefficient (19) D' and d2. 

Phrase: "This program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "determines"

Phrase: "various pairwise statistical parameters for LD,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0449381:Parameters [Finding]
   714 E C0549193:Parameter [Spatial Concept]
   714 E C1704769:Parameter [Conceptual Entity]
   714 E C2350001:Parameter [Quantitative Concept]

Phrase: "such as Lewontin's standardized disequilibrium coefficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707429:*Coefficient [Quantitative Concept]

Phrase: "(19"

Phrase: ")"

Phrase: "D'"

Phrase: "and"

Phrase: "d2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414052:D2 [Gene or Genome]
  1000   C1415944:D2 [Gene or Genome]
Processing 00000000.tx.269: LD was detected from the founders and married-ins using the expectationmaximization algorithm of Slatkin and Excoffier (37). 

Phrase: "LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "detected from the founders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0263541:founders [Disease or Syndrome]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "married"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024841:Married [Finding]
  1000   C0555047:Married [Finding]

Phrase: "-"

Phrase: "ins"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the expectationmaximization algorithm of Slatkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002045:algorithm [Intellectual Product]
   760   C1553907:algorithm [Laboratory Procedure]

Phrase: "and"

Phrase: "Excoffier"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.270: We also detected LD within the ADs and controls from MCR, MCJ and UKy series using the same program. 

Phrase: "We also detected LD within the ADs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0023746:Linkage Disequilibrium [Quantitative Concept]
   744   C0023745:linkage [Molecular Function]
   744   C0281825:Disequilibrium [Finding]
   744   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "controls from MCR,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0243148:control [Qualitative Concept]
   760   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   760   C0454788:Mayo [Geographic Area]
   760   C1077578:mayo [Plant]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "MCJ"

Phrase: "and"

Phrase: "UKy series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]
Processing 00000000.tx.271: Tests of association between PLAU SNP haplotypes and plasma A levels in LOAD families We estimated the haplotypes for the five PLAU SNPs genotyped in the members of the ten LOAD families using GOLD (22) and Simwalk2 (17). 

Phrase: "Tests of association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0022885:Tests [Laboratory Procedure]
   790   C0392366:Tests [Intellectual Product]
   756 E C0039593:Test [Functional Concept]

Phrase: "between PLAU SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "levels in LOAD families"

Phrase: "We"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "the haplotypes for the five PLAU SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0018591:Haplotypes [Organism Attribute]

Phrase: "genotyped in the members of the ten LOAD families"
Meta Candidates (Total=26; Excluded=6; Pruned=0; Remaining=20)
   782   C0338448:Familial Alzheimer's disease of late onset [Disease or Syndrome]
           Late onset familial Alzheimer disease
   778   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   759   C0814122:late disease onset [Finding]
   748   C0002395:Alzheimer's Disease [Disease or Syndrome]
   748   C0344339:disease family [Finding]
   748   C1521724:Alzheimer's Disease [Pathologic Function]
   747   C0086282:Family Members [Family Group]
   747   C0277793:disease onset [Temporal Concept]
   734   C0012634:Disease [Disease or Syndrome]
   734   C0014518:TEN [Disease or Syndrome]
   734   C0015576:Families [Family Group]
   734   C0205087:Late [Temporal Concept]
   734   C0205456:Ten [Quantitative Concept]
   734   C0332162:Onset [Qualitative Concept]
   734   C0441889:Levels [Qualitative Concept]
   734   C0680022:members [Population Group]
   734   C1704727:Family [Conceptual Entity]
   730 E C1611821:Family Member [Intellectual Product]
   719   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   705 E C0277558:Familial disease [Disease or Syndrome]
   701   C0017431:Genotype [Organism Attribute]
   701 E C0456079:Level [Classification]
   701 E C1547707:Level [Geographic Area]
   701 E C2698041:Member [Professional or Occupational Group]
   701 E C2946261:Level [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GOLD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1304897:Gold [Functional Concept]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "Simwalk2"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.272: There was highly significant LD among all five PLAU SNPs, and no crossover events were observed. 

Phrase: "There"

Phrase: "was"

Phrase: "highly significant LD among all five PLAU SNPs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0023746:Linkage Disequilibrium [Quantitative Concept]
   754   C1883037:Single Linkage [Research Activity]
   738   C0023745:linkage [Molecular Function]
   738   C0281825:Disequilibrium [Finding]
   738   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "no crossover events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "were"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.273: In our 10 extended LOAD families, we tested for association between PLAU haplotypes and plasma A42 phenotype using the variance components method implemented in the computer program SOLAR (20). 

Phrase: "In our 10 extended LOAD families,"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   860   C0015341:Extended Family [Family Group]
   832   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   801   C0002395:Alzheimer's Disease [Disease or Syndrome]
   801   C0344339:disease family [Finding]
   801   C1521724:Alzheimer's Disease [Pathologic Function]
   788   C0012634:Disease [Disease or Syndrome]
   788   C0015576:Families [Family Group]
   788   C0150312:In [Quantitative Concept]
   788   C0205087:Late [Temporal Concept]
   788   C0231448:Extended [Functional Concept]
   788   C0231449:Extended [Spatial Concept]
   788   C0332162:Onset [Qualitative Concept]
   788   C0332285:In [Spatial Concept]
   788   C0439792:extended [Spatial Concept]
   788   C0441889:Levels [Qualitative Concept]
   788   C1704727:Family [Conceptual Entity]
   755 E C0456079:Level [Classification]
   755 E C1547707:Level [Geographic Area]
   755 E C2946261:Level [Pharmacologic Substance]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]
   705 E C0241888:Familial [Functional Concept]

Phrase: "we"

Phrase: "tested for association"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0392366:tested [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "between PLAU haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "plasma A42 phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the variance components method"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0025663:Method [Intellectual Product]
   827   C0449432:Components [Manufactured Object]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
   827   C1711260:Variance [Qualitative Concept]
   827   C2348152:Variance [Quantitative Concept]
   793 E C1705248:Component [Conceptual Entity]
   755 E C0205419:Variant [Qualitative Concept]

Phrase: "implemented in the computer program"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0037585:Computer Program [Intellectual Product,Manufactured Object]
   760   C0009622:Computer [Manufactured Object]
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]

Phrase: "SOLAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0038817:Sun [Natural Phenomenon or Process]
   944   C0376223:Sun [Geographic Area]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.274: This method, described in detail elsewhere (20), estimates the amount of variance in a quantitative trait owing to residual genetic factors (g2), shared-family environment (2h) and individual specific, random environmental factors (2e), based on the phenotype covariance between arbitrary relative pairs. 

Phrase: "This method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "described in detail elsewhere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the amount of variance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "in a quantitative trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599883:Trait [Organism Attribute]

Phrase: "owing to residual genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "(g2"

Phrase: ")"

Phrase: ","

Phrase: "shared-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: "family environment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680056:family environment [Social Behavior]
   861   C0014406:Environment [Spatial Concept]

Phrase: "(2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "individual specific, random environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C1516998:Environmental Factors [Functional Concept]
   823 E C0686732:Environmental Factor [Qualitative Concept]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "(2e"

Phrase: ")"

Phrase: ","

Phrase: "based on the phenotype covariance"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "between arbitrary relative pairs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.275: The covariance matrix takes the form where 2 is the matrix of kinship coefficients describing polygenic factors, I is the identity matrix describing sporadic environmental factors and H is the household matrix. 

Phrase: "The covariance matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "the form where 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "the matrix of kinship coefficients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "describing"

Phrase: "polygenic factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "the identity matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "describing"

Phrase: "sporadic environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1516998:Environmental Factors [Functional Concept]
   884 E C0686732:Environmental Factor [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "is"

Phrase: "the household matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.276: This is a matrix whose ijth element is equal to 1 if individuals i and j share a specified environment, and 0 otherwise. 

Phrase: "This"

Phrase: "is"

Phrase: "a matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]

Phrase: "whose ijth element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "is"

Phrase: "equal to 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0205163:Equal To [Qualitative Concept]
           Equal
   790   C1549782:Equal [Idea or Concept]

Phrase: "if"

Phrase: "individuals i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "j"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a specified environment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]

Phrase: "and"

Phrase: "0 otherwise."
Processing 00000000.tx.277: Our family collection is largely composed of extended pedigrees, where we have measured the plasma A of most members from each family in a single batch of ELISAs. 

Phrase: "Our family collection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2700055:Family Collection [Classification]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]

Phrase: "is"

Phrase: "largely"

Phrase: "composed of extended pedigrees,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030761:pedigrees [Intellectual Product]
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]

Phrase: "where"

Phrase: "we"

Phrase: "have"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "of most members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "from each family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "in a single batch"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1550176:Batch [Idea or Concept]
   861   C1948031:Batch [Quantitative Concept]

Phrase: "of ELISAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.278: To rigorously account for any possible assay batch to batch variations that may affect the variance in plasma A, we included a household matrix in the models. 

Phrase: "To rigorously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "account for any possible assay batch"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0332149:Possible [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1550176:Batch [Idea or Concept]
   753   C1551359:account [Idea or Concept]
   753   C1705910:Possible [Qualitative Concept]
   753   C1948031:Batch [Quantitative Concept]
   753   C2362652:Possible [Qualitative Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "to batch variations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variations [Qualitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the variance in plasma A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0032105:Plasma [Body Substance]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1711260:Variance [Qualitative Concept]
   760   C2348152:Variance [Quantitative Concept]

Phrase: ","

Phrase: "we"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a household matrix in the models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]
Processing 00000000.tx.279: As almost all individuals from each family were measured in one batch, the household matrix included an element equal to 1 for those individuals from the same extended family, and 0 otherwise. 

Phrase: "As"

Phrase: "almost"

Phrase: "all individuals from each family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "were"

Phrase: "measured in one batch,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205447:One [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1550176:Batch [Idea or Concept]
   770   C1948031:Batch [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "the household matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013879:Element [Element, Ion, or Isotope]
  1000   C1705248:Element [Conceptual Entity]

Phrase: "equal to 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0205163:Equal To [Qualitative Concept]
           Equal
   790   C1549782:Equal [Idea or Concept]

Phrase: "for those individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "from the same extended family,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0015341:Extended Family [Family Group]
   827   C0015576:Family [Family Group]
   827   C0231448:Extended [Functional Concept]
   827   C0231449:Extended [Spatial Concept]
   827   C0439792:extended [Spatial Concept]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "0 otherwise."
Processing 00000000.tx.280: We realize that by doing so, we may be overly conservative. 

Phrase: "We"

Phrase: "realize"

Phrase: "that by"

Phrase: "doing"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "we"

Phrase: "may"

Phrase: "be"

Phrase: "overly conservative."
Processing 00000000.tx.281: Our collection is largely weighted towards families with high-A segregating within the family. 

Phrase: "Our collection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516698:Collection [Functional Concept]
  1000   C1704814:Collection [Idea or Concept]
   928 E C1516695:Collected [Idea or Concept]

Phrase: "is"

Phrase: "largely"

Phrase: "weighted towards families"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0005910:weighted [Organism Attribute]
   790   C0015576:Families [Family Group]
   790   C0043100:weighted [Quantitative Concept]
   790   C1305866:weighted [Diagnostic Procedure]
   790   C1704727:Family [Conceptual Entity]
   756 E C1705104:Weight [Idea or Concept]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with high-A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205250:High [Qualitative Concept]
   827   C0332287:With [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C1705690:With [Intellectual Product]
   827   C2700149:HIGH [Intellectual Product]

Phrase: "segregating within the family."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.282: Given that the shared-family effect (household) overlaps with kinship, we may have over corrected and underestimated the shared-genetic effect by including the household term in the model. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "the shared-family effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "(household"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020052:Household [Family Group]

Phrase: ")"

Phrase: "overlaps with kinship,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0185027:overlap [Therapeutic or Preventive Procedure]
   756   C1948020:Overlap [Conceptual Entity]

Phrase: "we"

Phrase: "may"

Phrase: "have"

Phrase: "over"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205136:Over [Spatial Concept]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "and"

Phrase: "underestimated"

Phrase: "the shared-genetic effect by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the household term in the model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C2826302:TERM [Intellectual Product]
Processing 00000000.tx.283: The scalars g2, h2 and e2 are estimated using maximum likelihood. 

Phrase: "The scalars g2,"

Phrase: "h2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]

Phrase: "and"

Phrase: "e2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "are"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "maximum likelihood."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0033204:Likelihood [Quantitative Concept]
   861   C0806909:Maximum [Quantitative Concept]
   861   C1552615:maximum [Quantitative Concept]
   861   C2826546:MAXIMUM [Quantitative Concept]
   789 E C0205289:Maximal [Qualitative Concept]
   789 E C0332148:Likely [Qualitative Concept]
   789 E C0750492:Likely [Idea or Concept]
Processing 00000000.tx.284: To formulate an association model for PLAU SNP haplotypes, we used the within-pedigree association model of Hopper and Mathews (21). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "formulate"

Phrase: "an association model for PLAU SNP haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the within-pedigree association model of Hopper"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0004083:Association [Mental Process]
   748   C0030761:Pedigree [Intellectual Product]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "Mathews"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.285: Under this model, the matrix of allelic sharing within pedigrees, =(ij), is defined such that ij=1 if individuals i and j are from the same pedigree and share both alleles of a haplotype identical in state, ij=1/2 if individuals i and j are from the same pedigree and share one allele identical in state and ij=0 otherwise. 

Phrase: "Under this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "the matrix of allelic sharing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "within pedigrees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:pedigrees [Intellectual Product]

Phrase: "="

Phrase: "(ij"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "such"

Phrase: "that ij"

Phrase: "=1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "if"

Phrase: "individuals i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "j"

Phrase: "are from the same pedigree"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030761:Pedigree [Intellectual Product]
   760   C0445247:Same [Qualitative Concept]
   760   C1551058:Are [Quantitative Concept]

Phrase: "and"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "both alleles of a haplotype identical in state, ij"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Alleles [Gene or Genome]

Phrase: "=1/2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "if"

Phrase: "individuals i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "j"

Phrase: "are from the same pedigree"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030761:Pedigree [Intellectual Product]
   760   C0445247:Same [Qualitative Concept]
   760   C1551058:Are [Quantitative Concept]

Phrase: "and"

Phrase: "share one allele identical in state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C2361523:Allelic state [Finding]
   799   C1301808:State [Geographic Area]
   799   C1442792:State [Functional Concept]
   799   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "ij"

Phrase: "=0 otherwise."
Processing 00000000.tx.286: Under the association model, SOLAR estimates the variance in the quantitative trait owing to association (a2), residual genetic factors (g2), same-household effects (h2) and environmental effects (e2). 

Phrase: "Under the association model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "SOLAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0038817:Sun [Natural Phenomenon or Process]
   944   C0376223:Sun [Geographic Area]

Phrase: "estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the variance in the quantitative trait"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1711260:Variance [Qualitative Concept]
   753   C2348152:Variance [Quantitative Concept]

Phrase: "owing to association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "(a2"

Phrase: ")"

Phrase: ","

Phrase: "residual genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "(g2"

Phrase: ")"

Phrase: ","

Phrase: "same-household effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "(h2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919509:H2 [Gene or Genome]
  1000   C1419394:H2 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "environmental effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0871974:environmental effects [Natural Phenomenon or Process]
   861   C0014406:Environmental [Spatial Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "(e2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.287: Under the null-model of no association, a2 is fixed to zero. 

Phrase: "Under the null-model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of no association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "a2"

Phrase: "is"

Phrase: "fixed to zero."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C0919414:Zero [Quantitative Concept]
   790   C2827483:Fixed [Body Substance]
Processing 00000000.tx.288: The difference between the log10 likelihoods of these two models produces a test statistic with the same distribution as the LOD score of genetic linkage analysis. 

Phrase: "The difference between the log10 likelihoods of these two models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "produces"

Phrase: "a test statistic with the same distribution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C2348149:Statistic [Quantitative Concept]
   748   C2828391:Statistic [Quantitative Concept]
   738   C0038205:Statistical Distribution [Quantitative Concept]
   738   C0237913:Statistical Test [Intellectual Product]

Phrase: "as the LOD score"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023956:Lod Score [Quantitative Concept]
   861   C0449820:Score [Quantitative Concept]
   861   C2247199:Lod [Molecular Function]

Phrase: "of genetic linkage analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0796345:genetic linkage analysis [Laboratory Procedure]
           linkage analysis
   913   C0679560:genetic analysis [Laboratory Procedure]
   913   C0796344:Genetic Analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0023745:genetic linkage [Molecular Function]
Processing 00000000.tx.289: There is one degree of freedom between the two models (association fixed, association tested) and one-sided test is performed. 

Phrase: "There"

Phrase: "is"

Phrase: "one degree of freedom"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "between the two models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "(association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: ","

Phrase: "association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "one-sided test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   734   C0205092:One-sided [Spatial Concept]

Phrase: "is"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.290: Tests of association in the LOAD casecontrol series by CLUMP In our casecontrol series, we tested for association between the PLAU compound genotypes and LOAD using CLUMP. 

Phrase: "Tests of association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0022885:Tests [Laboratory Procedure]
   790   C0392366:Tests [Intellectual Product]
   756 E C0039593:Test [Functional Concept]

Phrase: "in the LOAD casecontrol series"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0205549:Series [Quantitative Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   790   C2348044:Series [Intellectual Product]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "by CLUMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205387:clump [Qualitative Concept]

Phrase: "In our casecontrol series,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "we"

Phrase: "tested for association"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0392366:tested [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "between the PLAU compound genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "LOAD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CLUMP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205387:clump [Qualitative Concept]
Processing 00000000.tx.291: The CLUMP program (23) measures the statistical significance of a variety of 2xm contingency tables by simulation. 

Phrase: "The CLUMP program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "the statistical significance of a variety of 2xm contingency tables"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   760   C1709380:Statistical Significance [Quantitative Concept]
   739   C0038215:Statistical [Occupation or Discipline]
   739   C0750502:Significance [Idea or Concept]

Phrase: "by simulation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679083:Simulation [Research Activity]
   928 E C0284447:simulated [Biomedical or Dental Material]
Processing 00000000.tx.292: We employed the T1 test within CLUMP, which analyzes the raw 2xm table where m is the total number of categories. 

Phrase: "We"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "the T1 test within CLUMP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]

Phrase: "which"

Phrase: "analyzes"

Phrase: "the raw 2xm table where m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "the total number of categories."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.293: In our application of CLUMP, the 2xm table consisted of two diagnostic categories and m genotypic categories, each corresponding to a unique combination of genotypes at the five PLAU SNPs. 

Phrase: "In our application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0185125:Application [Health Care Activity]
  1000   C1947919:Application [Intellectual Product]
  1000   C2347934:Application [Intellectual Product]
  1000   C3539080:APPLICATION [Quantitative Concept]

Phrase: "of CLUMP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205387:clump [Qualitative Concept]

Phrase: "the 2xm table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "consisted of two diagnostic categories"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0011900:Diagnostic [Finding]
   760   C0205448:Two [Quantitative Concept]
   760   C0348026:Diagnostic [Functional Concept]
   760   C0683312:Categories [Intellectual Product]
   726   C0332529:CONSIST [Qualitative Concept]
   726 E C1555713:category [Idea or Concept]

Phrase: "and"

Phrase: "m genotypic categories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   896   C0456533:M category [Intellectual Product]
   827   C0683312:Categories [Intellectual Product]
   793 E C1555713:category [Idea or Concept]

Phrase: "each"

Phrase: "corresponding to a unique combination of genotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0017431:Genotypes [Organism Attribute]
   748   C0205195:Combination [Qualitative Concept]
   748   C1710548:Unique [Qualitative Concept]
   748   C1947911:Combination [Physical Object]

Phrase: "at the five PLAU SNPs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:polymorphisms [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   771 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.294: A analysis Plasma A40 and A42 were measured as previously described (11). 

Phrase: "A"

Phrase: "analysis Plasma A40"

Phrase: "and"

Phrase: "A42"

Phrase: "were"

Phrase: "measured as previously"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.295: The relationship between plasma A42, age and PLAU_1 genotypes in LOAD family members was initially analyzed by fitting polynomial regression curves separately for all family members with rs2227564 CC, CT, TT or CT+TT genotypes, using 10log(A42) as the dependent variable and age and age(2) as the independent variables. 

Phrase: "The relationship between plasma A42,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "PLAU_1 genotypes in LOAD family members"
Meta Candidates (Total=28; Excluded=6; Pruned=0; Remaining=22)
   790   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   780   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   767   C2931257:Alzheimer disease 1 [Disease or Syndrome]
   766   C0814122:late disease onset [Finding]
   753   C0002395:Alzheimer's Disease [Disease or Syndrome]
   753   C0086282:Family Members [Family Group]
   753   C0344339:disease family [Finding]
   753   C1521724:Alzheimer's Disease [Pathologic Function]
   751   C0277793:disease onset [Temporal Concept]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0015576:Family [Family Group]
   736   C0017431:Genotypes [Organism Attribute]
   736   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   736   C0205087:Late [Temporal Concept]
   736   C0332162:Onset [Qualitative Concept]
   736   C0441889:Levels [Qualitative Concept]
   736   C0680022:members [Population Group]
   736   C1335224:PLAU [Gene or Genome]
   736   C1704727:Family [Conceptual Entity]
   734   C0456947:Level 1 [Intellectual Product]
   732   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   723   C1425075:MALS-1 [Gene or Genome]
   719 E C1611821:Family Member [Intellectual Product]
   715 E C0277558:Familial disease [Disease or Syndrome]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2698041:Member [Professional or Occupational Group]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "analyzed by fitting polynomial regression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0036572:Fitting [Sign or Symptom]
   760   C0441548:Fitting [Health Care Activity]
   760   C0684320:Regression [Pathologic Function]
   760   C0684321:Regression [Mental Process]
   760   C0936012:Analyzed [Research Activity]
   760   C2698848:Polynomial [Quantitative Concept]

Phrase: "curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curve [Spatial Concept]

Phrase: "separately for all family members"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0086282:Family Members [Family Group]
   773 E C1611821:Family Member [Intellectual Product]
   760   C0015576:Family [Family Group]
   760   C0680022:members [Population Group]
   760   C1704727:Family [Conceptual Entity]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "with rs2227564 CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "TT"

Phrase: "or"

Phrase: "CT+TT genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "10log"

Phrase: "(A42"

Phrase: ")"

Phrase: "as the dependent variable"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439828:Variable [Qualitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "age(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "as the independent variables."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]
Processing 00000000.tx.296: These analyses showed genotype-specific age-related effects on plasma A42 levels and indicated that plasma A42 increases with aging beginning at age 50 in those individuals with a CT or TT genotype. 

Phrase: "These analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "genotype-specific age-related effects on plasma A42 levels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that plasma A42"

Phrase: "increases with aging beginning"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0001811:Ageing [Organism Function]
   770   C0439659:Beginning [Temporal Concept]
   770   C0442805:Increase [Functional Concept]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "at age 50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "in those individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with a CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "or"

Phrase: "TT genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.297: We had used the 2065 year age group in our previous studies where we found linkage between plasma A levels and a locus on chromosome 10 (1). 

Phrase: "We"

Phrase: "had"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 2065 year age group in our previous studies where"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0027362:Age Group [Age Group]
   760   C2348001:Age Group [Population Group]
   739   C0001779:Age [Organism Attribute]
   739   C0441833:Group [Idea or Concept]
   739   C0687744:group [Population Group]
   739   C1257890:Group [Population Group]
   739   C1552516:Group [Health Care Related Organization]
   739   C1705428:Group [Conceptual Entity]
   739   C1705429:Group [Population Group]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "linkage between plasma A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "a locus on chromosome 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.298: As described previously, the 2065 year age group was initially chosen because of our observation that plasma A is elevated in individuals <25 and >65 years old. 

Phrase: "As"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously,"

Phrase: "the 2065 year age group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0027362:Age Group [Age Group]
   861   C2348001:Age Group [Population Group]
   812   C0001779:Age [Organism Attribute]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "chosen because of our observation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1707391:Chosen [Activity]
   760   C1964257:Observation [Diagnostic Procedure]

Phrase: "that plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "is"

Phrase: "elevated in individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "<25"

Phrase: "and >"

Phrase: "65 years old."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]
Processing 00000000.tx.299: In addition, plasma A appears to have complex likely deposition-related changes in individuals with AD, who are in the >65 age group. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "complex likely deposition-related changes in individuals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "with AD,"

Phrase: "who"

Phrase: "are in the >65 age group."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0027362:Age Group [Age Group]
   790   C2348001:Age Group [Population Group]
   753   C0001779:Age [Organism Attribute]
   753   C0441833:Group [Idea or Concept]
   753   C0450385:65 [Intellectual Product]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1551058:Are [Quantitative Concept]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
Processing 00000000.tx.300: In this study, we determined significant age-related effects of PLAU_1 genotypes on plasma A levels in those individuals >50 years, depicted subsequent. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "determined"

Phrase: "significant age-related effects of PLAU_1 genotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on plasma A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1720176:On [Functional Concept]
   827   C1720294:On [Intellectual Product]

Phrase: "levels in those individuals"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: ">50 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "depicted subsequent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332282:Subsequent [Temporal Concept]
Processing 00000000.tx.301: Thus, all analyses were performed in the all ages, 20- to 65-year-old and >50 years groups. 

Phrase: "Thus,"

Phrase: "all analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed in the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "all"

Phrase: "ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: ","

Phrase: "20-"

Phrase: "to 65-year-old"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "and >"

Phrase: "50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.302: Tests of association between the PLAU_1 (rs2227564) SNP and plasma A levels in LOAD families We applied variance components methodology implemented in the software package SOLAR (20) to estimate the effect of covariates on plasma A levels, while controlling for the pairwise genetic relationships and shared-family effects among family members in the extended LOAD pedigrees. 

Phrase: "Tests of association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0022885:Tests [Laboratory Procedure]
   790   C0392366:Tests [Intellectual Product]
   756 E C0039593:Test [Functional Concept]

Phrase: "between the PLAU_1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1335224:PLAU [Gene or Genome]

Phrase: "(rs2227564"

Phrase: ")"

Phrase: "SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "plasma A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "levels in LOAD families"

Phrase: "We"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "variance components methodology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0969625:methodology [Intellectual Product]
   827   C3266812:Methodology [Idea or Concept]

Phrase: "implemented in the software package"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0013194:Package [Medical Device]
   760   C0037585:Software [Intellectual Product,Manufactured Object]
   760   C2700580:Package [Manufactured Object]

Phrase: "SOLAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   944   C0038817:Sun [Natural Phenomenon or Process]
   944   C0376223:Sun [Geographic Area]

Phrase: "(20"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the effect of covariates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on plasma A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1720176:On [Functional Concept]
   827   C1720294:On [Intellectual Product]

Phrase: "levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "while"

Phrase: "controlling for the pairwise genetic relationships"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
   767   C0017263:genetic control [Genetic Function]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]
   753   C0332298:controlling [Functional Concept]
   753   C0439849:Relationships [Qualitative Concept]
   753   C2587213:Controlling [Functional Concept]
   739 E C0700589:Birth Control [Therapeutic or Preventive Procedure]
   719 E C0243148:control [Qualitative Concept]
   719 E C1550141:Control [Substance]
   719 E C1705630:Relationship [Idea or Concept]
   719 E C1706279:Relationship [Idea or Concept]
   719 E C1882979:Control [Conceptual Entity]
   719 E C3274648:Control [Qualitative Concept]
   719 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "shared-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: "family effects among family members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in the extended LOAD pedigrees."
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
   840   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   804   C0002395:Alzheimer's Disease [Disease or Syndrome]
   804   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C0012634:Disease [Disease or Syndrome]
   790   C0030761:pedigrees [Intellectual Product]
   790   C0150312:In [Quantitative Concept]
   790   C0205087:Late [Temporal Concept]
   790   C0231448:Extended [Functional Concept]
   790   C0231449:Extended [Spatial Concept]
   790   C0332162:Onset [Qualitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0439792:extended [Spatial Concept]
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.303: We tested for the association of PLAU_1 genotypes on plasma A by performing a multivariate regression analysis, while including the kinship, identity and household matrices, described earlier, in the model. 

Phrase: "We"

Phrase: "tested for the association of PLAU_1 genotypes"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   744   C0004083:Association [Mental Process]
   744   C0017431:Genotypes [Organism Attribute]
   744   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0392366:tested [Intellectual Product]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   744   C1335224:PLAU [Gene or Genome]
   711 E C0022885:Test [Laboratory Procedure]
   711 E C0039593:Test [Functional Concept]

Phrase: "on plasma A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1720176:On [Functional Concept]
   827   C1720294:On [Intellectual Product]

Phrase: "by performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0884358:Perform [Functional Concept]
   966   C2947996:Perform [Pharmacologic Substance]

Phrase: "a multivariate regression analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0026777:Multivariate Analysis [Quantitative Concept]
   901   C0034980:Regression Analysis [Intellectual Product]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "while"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the kinship,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870772:kinship [Idea or Concept]

Phrase: "identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424215:Identity [Mental Process]
  1000   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "household matrices,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1704639:Matrices [Manufactured Object]
   827 E C1704640:Matrix [Spatial Concept]
   827 E C1706515:Matrix [Body Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "in the model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]
Processing 00000000.tx.304: We tested two different models. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "two different models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Models [Intellectual Product]
Processing 00000000.tx.305: The significance and coefficients for all covariates were tested using the polygenic-screen-all option of SOLAR, which provides a p-value and coefficient by comparing a model that includes the covariate to a model that excludes it. 

Phrase: "The significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "and"

Phrase: "coefficients for all covariates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707429:*Coefficient [Quantitative Concept]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polygenic-screen-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220908:screen [Health Care Activity]
   861   C1305399:screen [Functional Concept]
   861   C1705053:Screen [Medical Device]

Phrase: "all option of SOLAR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1518601:Option [Functional Concept]
   770   C1550456:option [Idea or Concept]

Phrase: "which"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a p-value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "coefficient by comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707429:*Coefficient [Quantitative Concept]

Phrase: "a model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the covariate to a model"

Phrase: "that"

Phrase: "excludes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "it."
Processing 00000000.tx.306: This option causes all covariates to stay in the model regardless of their significance. 

Phrase: "This option"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1518601:Option [Functional Concept]
  1000   C1550456:option [Idea or Concept]
   928 E C1518600:Optional [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "all covariates to"

Phrase: "stay in the model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "regardless of their significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.307: In Model 1, the covariates tested were CT and TT genotypes, age, CT genotypexage and TT genotypexage. 

Phrase: "In Model 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "the covariates"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "CT genotypexage"

Phrase: "and"

Phrase: "TT genotypexage."
Processing 00000000.tx.308: For Model 2, the CT and TT genotypes were pooled into a single CT+TT variable encoded as one for subjects with a CT or TT genotype and zero for those with a CC genotype. 

Phrase: "For Model 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "the CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "pooled into a single CT+TT variable"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0439828:Variable [Qualitative Concept]
   748   C1709595:Pooled [Conceptual Entity]
   748   C2349200:Pooled [Functional Concept]
   748   C3540513:CT [Gene or Genome]
   714 E C0337051:Pool [Geographic Area]
   714 E C1509144:pool [Clinical Attribute]

Phrase: "encoded as one"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205447:One [Quantitative Concept]
   790   C0679058:encoded [Mental Process]
   790   C2700640:Encoded [Activity]

Phrase: "for subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with a CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "or"

Phrase: "TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "zero for those with a CC genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0919414:Zero [Quantitative Concept]
Processing 00000000.tx.309: All analyses were performed in family members who were 50 years of age. 

Phrase: "All analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed in family members"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0086282:Family Members [Family Group]
   799 E C1611821:Family Member [Intellectual Product]
   770   C0015576:Family [Family Group]
   770   C0680022:members [Population Group]
   770   C0884358:Performed [Functional Concept]
   770   C1704727:Family [Conceptual Entity]
   737 E C2698041:Member [Professional or Occupational Group]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "who"

Phrase: "were"

Phrase: "50 years of age."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1510829:Age-Years [Temporal Concept]
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.310: We selected this subset because we determined an age-related increase in plasma A42 levels after age 50 in those individuals with PLAU_1 genotypes CT or TT. 

Phrase: "We"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "this subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "because"

Phrase: "we"

Phrase: "determined"

Phrase: "an age-related increase in plasma A42 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "after age 50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "in those individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with PLAU_1 genotypes CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3540513:CT [Gene or Genome]

Phrase: "or"

Phrase: "TT."
Processing 00000000.tx.311: All analyses were performed both with all A values and a second time by excluding the two extreme outliers with plasma A levels 4 SD beyond the mean. 

Phrase: "All analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "both with all A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "a second time by excluding"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "the two extreme outliers with plasma A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032105:Plasma [Body Substance]
   748   C0205403:Extreme [Qualitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   714   C2698674:Outlier [Quantitative Concept]

Phrase: "levels 4 SD beyond the mean."
Processing 00000000.tx.312: The PLAU_1 CTxage and PLAU_1 CT+TTxage were still significant variables in Model 1 and 2, respectively, after excluding the outliers. 

Phrase: "The PLAU_1 CTxage"

Phrase: "and"

Phrase: "PLAU_1 CT+TTxage"

Phrase: "were"

Phrase: "still significant variables in Model 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439828:variables [Qualitative Concept]

Phrase: "and"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "respectively,"

Phrase: "after"

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the outliers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2698674:Outlier [Quantitative Concept]
Processing 00000000.tx.313: To determine the age-related effect of PLAU_1 genotypes and PLAU_1 genotypes on plasma A42 levels in LOAD family members of all ages, we fitted two non-linear regression models, while taking into account the same variance components as described earlier. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the age-related effect of PLAU_1 genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "PLAU_1 genotypes on plasma A42 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017431:Genotypes [Organism Attribute]

Phrase: "in LOAD family members"
Meta Candidates (Total=23; Excluded=9; Pruned=0; Remaining=14)
   849   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   807   C0002395:Alzheimer's Disease [Disease or Syndrome]
   807   C0086282:Family Members [Family Group]
   807   C0344339:disease family [Finding]
   807   C1521724:Alzheimer's Disease [Pathologic Function]
   791   C0012634:Disease [Disease or Syndrome]
   791   C0015576:Family [Family Group]
   791   C0150312:In [Quantitative Concept]
   791   C0205087:Late [Temporal Concept]
   791   C0332162:Onset [Qualitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0441889:Levels [Qualitative Concept]
   791   C0680022:members [Population Group]
   791   C1704727:Family [Conceptual Entity]
   774 E C1611821:Family Member [Intellectual Product]
   758 E C0456079:Level [Classification]
   758 E C1547707:Level [Geographic Area]
   758 E C2698041:Member [Professional or Occupational Group]
   758 E C2946261:Level [Pharmacologic Substance]
   735 E C1836721:MALS [Finding]
   735 E C3538764:MALS [Gene or Genome]
   735 E C3540595:MAL [Gene or Genome]
   720 E C0241888:Familial [Functional Concept]

Phrase: "of all ages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "we"

Phrase: "fitted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "two non-linear regression models,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   888   C0206165:Models, Nonlinear [Conceptual Entity]
   853   C0023732:Linear Models [Quantitative Concept]
   804   C3161035:Models [Intellectual Product]

Phrase: "while"

Phrase: "taking into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "the same variance components"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0449432:Components [Manufactured Object]
   827   C1711260:Variance [Qualitative Concept]
   827   C2348152:Variance [Quantitative Concept]
   793 E C1705248:Component [Conceptual Entity]
   755 E C0205419:Variant [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.314: In Model 1 for family members of all ages, age(2), PLAU_1 CTxage(2) and PLAU_1 TTxage(2) were tested as covariates in addition to age, PLAU_1 CT, PLAU_1 TT, PLAU_1 CTxage and PLAU_1 TTxage. 

Phrase: "In Model 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "for family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]

Phrase: "of all ages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "age(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "PLAU_1 CTxage"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "PLAU_1 TTxage"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "tested as covariates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "in addition to age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "PLAU_1 CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540513:CT [Gene or Genome]

Phrase: "PLAU_1 TT,"

Phrase: "PLAU_1 CTxage"

Phrase: "and"

Phrase: "PLAU_1 TTxage."
Processing 00000000.tx.315: In Model 2, age(2) and PLAU_1 CT+TTxage(2) were included as covariates besides age, PLAU_1 CT+TT and PLAU_1 CT+TTxage. 

Phrase: "In Model 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "age(2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "PLAU_1 CT+TTxage"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "included as covariates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332257:included [Functional Concept]
   790   C3538986:INCLUDED [Gene or Genome]
   756 E C1552866:include [Idea or Concept]
   756 E C2700399:Include [Activity]

Phrase: "besides age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "PLAU_1 CT+TT"

Phrase: "and"

Phrase: "PLAU_1 CT+TTxage."
Processing 00000000.tx.316: The rationale for testing these non-linear models is described in detail in the main text. 

Phrase: "The rationale for testing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392360:Rationale [Idea or Concept]
   770   C2699007:Rationale [Idea or Concept]

Phrase: "these non-linear models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206165:Models, Nonlinear [Conceptual Entity]
   901   C0023732:Linear Models [Quantitative Concept]
   827   C3161035:Models [Intellectual Product]

Phrase: "is"

Phrase: "described in detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522508:Detail [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "in the main text."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]
Processing 00000000.tx.317: Logistic regression analysis to test for association with the PLAU_1 (rs2227564) SNP in casecontrols Logistic regression analysis implemented in SAS version 8 was utilized to test for association between AD and PLAU_1 genotypes. 

Phrase: "Logistic regression analysis to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0681925:logistic regression analysis [Research Activity]
   861   C0034980:Regression Analysis [Intellectual Product]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "test for association"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0004083:Association [Mental Process]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:test [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "with the PLAU_1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1335224:PLAU [Gene or Genome]

Phrase: "(rs2227564"

Phrase: ")"

Phrase: "SNP in casecontrols Logistic regression analysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0752046:SNP [Nucleotide Sequence]
   753   C1527094:SNP [Conceptual Entity]

Phrase: "implemented in SAS version 8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0333052:Version [Functional Concept]
   760   C0605290:SAS [Organic Chemical]
   760   C1426104:SAS [Gene or Genome]
   760   C1823519:SAS [Gene or Genome]
   760   C2607870:Version [Spatial Concept]

Phrase: "was"

Phrase: "utilized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for association"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0004083:Association [Mental Process]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:test [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "between AD"

Phrase: "and"

Phrase: "PLAU_1 genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.318: Initially, a model that estimated and tested the effects of PLAU_1 CT and TT genotypes separately was utilized. 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "a model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "that estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effects of PLAU_1 CT"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "TT genotypes separately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotypes [Organism Attribute]

Phrase: "was"

Phrase: "utilized."
Processing 00000000.tx.319: The results of this analysis suggested similar risky estimates for these genotypes. 

Phrase: "The results of this analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "similar risky"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0035647:Risk [Qualitative Concept]

Phrase: "estimates for these genotypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017431:Genotypes [Organism Attribute]
   770   C0750572:Estimate [Quantitative Concept]
Processing 00000000.tx.320: Given this result and that the PLAU_1 TT genotype is relatively rare, a second model was fitted, where CT and TT genotypes were combined into one variable, CT+TT, coded as 1 for those with CT or TT genotype and 0 for those with CC genotype. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "this result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "and"

Phrase: "that"

Phrase: "the PLAU_1 TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017431:Genotype [Organism Attribute]

Phrase: "is"

Phrase: "relatively rare,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521114:Rare [Temporal Concept]
   861   C0522498:Rare [Qualitative Concept]
   861   C1514917:RARE [Gene or Genome]

Phrase: "a second model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "fitted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: ","

Phrase: "where CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "TT genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "combined into one variable,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205195:Combined [Qualitative Concept]
   770   C0205447:One [Quantitative Concept]
   770   C0439828:Variable [Qualitative Concept]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "CT+TT,"

Phrase: "coded as 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0009219:code [Occupational Activity]
   756   C0805701:Code [Intellectual Product]

Phrase: "for those with CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "or"

Phrase: "TT genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "0 for those with CC genotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017431:Genotype [Organism Attribute]
   753   C3538933:CC [Cell Component]
Processing 00000000.tx.321: Meta-analysis of PLAU_1 (rs2227564) SNP in 10 casecontrol series Using the genotype counts for PLAU_1 CT+TT versus CC genotypes in AD cases and controls from the six series described in this article, we performed meta-analysis implemented in the StatsDirect statistical package. 

Phrase: "Meta-analysis of PLAU_1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]

Phrase: "(rs2227564"

Phrase: ")"

Phrase: "SNP in 10 casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0752046:SNP [Nucleotide Sequence]
   760   C1527094:SNP [Conceptual Entity]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "counts for PLAU_1 CT+TT"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1332801:CT-1 [Gene or Genome]
   783   C1707158:CT-1 [Gene or Genome]
   753   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0439157:counts [Quantitative Concept]
   753   C0750480:Count [Activity]
   753   C1335224:PLAU [Gene or Genome]
   753   C1705566:Count [Quantitative Concept]
   753   C3540513:CT [Gene or Genome]

Phrase: "versus"

Phrase: "CC genotypes in AD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "controls from the six series"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205452:Six [Quantitative Concept]
   760   C0205549:Series [Quantitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2348044:Series [Intellectual Product]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "described in this article,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "implemented in the StatsDirect statistical package."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0013194:Package [Medical Device]
   753   C0038215:Statistical [Occupation or Discipline]
   753   C2700580:Package [Manufactured Object]
Processing 00000000.tx.322: BreslowDay test was performed to test for heterogeneity among the samples. 

Phrase: "BreslowDay test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for heterogeneity"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0019409:Heterogeneity [Qualitative Concept]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:test [Intellectual Product]
   706 E C1512426:Heterogenous [Idea or Concept]

Phrase: "among the samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.323: Pooled OR estimates were calculated using both fixed effects and random effects model as implemented in the MantelHaenszel, and DerSimonianLaird tests, respectively. 

Phrase: "Pooled OR estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0750572:estimates [Quantitative Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both fixed effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "random effects model"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0034656:RANDOM [Research Activity]
   827   C0439605:Random [Qualitative Concept]
   827   C1280500:effects [Qualitative Concept]
   827   C3161035:Model [Intellectual Product]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "implemented in the MantelHaenszel,"

Phrase: "and"

Phrase: "DerSimonianLaird tests,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "respectively."
Processing 00000000.tx.324: Analysis of plasma and brain A in PLAU KO mice Plasma A42 and A40 were analyzed by sandwich ELISA as previously described (11). 

Phrase: "Analysis of plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "brain A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in PLAU KO mice Plasma A42"

Phrase: "and"

Phrase: "A40"

Phrase: "were"

Phrase: "analyzed by sandwich ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014441:ELISA [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.325: Brain A42 and A40 were analyzed by ELISA following direct extraction into formic acid and neutralization as previously described (28). 

Phrase: "Brain A42"

Phrase: "and"

Phrase: "A40"

Phrase: "were"

Phrase: "analyzed by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "direct extraction into formic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "neutralization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1578828:Neutralization [Laboratory Procedure]
  1000   C2987668:Neutralization [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.326: All KO mice were homozygous for the null allele. 

Phrase: "All KO mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0560617:knock out [Injury or Poisoning]
   734   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "were"

Phrase: "homozygous for the null allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]
Processing 00000000.tx.327: All results were normalized to the A present in 3- to 6-month-old control (wild-type) mice. 

Phrase: "All results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "normalized to the A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882115:Normalized [Research Activity]

Phrase: "present in 3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "to 6-month-old control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "(wild-type) mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.328: Numbers analyzed were as follows: 3- to 6-month-old PLAU KO mice (16) (n=9), control mice (n=6); 

Phrase: "Numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 6-month-old PLAU KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0206745:Knock-out Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(16"

Phrase: ")"

Phrase: "(n=9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.329: 11-month-old PLAU KO mice (n=2), control (n=7) mice; 

Phrase: "11-month-old PLAU KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0206745:Knock-out Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(n=2),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(n=7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.330: 3- to 6-month-old neprilysin KO mice (24) (n=3), control mice (n=3). 

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 6-month-old neprilysin KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0206745:Knock-out Mice [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(24"

Phrase: ")"

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.331: The neprilysin KO mice were used for additional positive control (24). 

Phrase: "The neprilysin KO mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used for additional positive control"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1524062:Additional [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.332: To evaluate brain A42 and A40, we used the same methods that we previously employed to demonstrate that endogenous brain A42 increases in transgenic mice expressing presenilin 1 mutations linked to early-onset familial AD (9).  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "brain A42"

Phrase: "and"

Phrase: "A40,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "we previously"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that endogenous brain A42"

Phrase: "increases in transgenic mice"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0442805:Increase [Functional Concept]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "expressing"

Phrase: "presenilin 1 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "to early-onset familial AD (9"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C1833334:Early-onset [Finding]
   799   C0015576:familial [Family Group]
   799   C0241888:Familial [Functional Concept]
   799   C0332162:Onset [Qualitative Concept]
   799   C1279919:Early [Temporal Concept]
   799   C1883351:To [Qualitative Concept]
   727 E C1704727:Family [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.333: ACKNOWLEDGEMENTS  We acknowledge the Mayo Clinic and UKy ADRC members for their help in the collection of samples. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "acknowledge"

Phrase: "the Mayo Clinic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "UKy ADRC members for their"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "help in the collection of samples."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0200345:collection sample [Laboratory Procedure]
   753   C0018896:Help [Social Behavior]
   753   C1516698:Collection [Functional Concept]
   753   C1552861:help [Idea or Concept]
   753   C1704814:Collection [Idea or Concept]
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.334: We are grateful to all of the individuals who participated in this study, without whom this work would not be possible. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to all of the individuals"

Phrase: "who"

Phrase: "participated in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "without whom"

Phrase: "this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.335: This study was supported by the NIH grants AG18023 (S.G.Y.), AG06656 (S.G.Y.), AG20903 (N.E.T.), AG21545 (S.E.), 2P50AG05144 (W.M.), a grant from American Federation for Aging Research Grant PD01062 (N.E.T.) and a Robert and Clarice Smith Fellowship (N.E.T.).  

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by the NIH grants AG18023"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0018173:Grants [Quantitative Concept]
   753   C0027468:NIH [Health Care Related Organization]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]
   719 E C1548284:Grant [Idea or Concept]

Phrase: "(S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Y."

Phrase: ")"

Phrase: ","

Phrase: "AG06656"

Phrase: "(S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Y."

Phrase: ")"

Phrase: ","

Phrase: "AG20903"

Phrase: "(N.E."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "AG21545"

Phrase: "("

Phrase: "S."

Phrase: "E."

Phrase: ")"

Phrase: ","

Phrase: "2P50AG05144"

Phrase: "(W."

Phrase: "M."

Phrase: ")"

Phrase: ","

Phrase: "a grant from American Federation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018173:Grant [Quantitative Concept]
   760   C1548284:Grant [Idea or Concept]

Phrase: "for Aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Grant PD01062"

Phrase: "(N.E."

Phrase: "T.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "a Robert"

Phrase: "and"

Phrase: "Clarice Smith Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015770:Fellowship [Educational Activity]

Phrase: "(N.E."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.336: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Ertekin-Taner, N., Graff-Radford, N., Younkin, L.H., Eckman, C., Baker, M., Adamson, J., Ronald, J., Blangero, J., Hutton, M. and Younkin, S.G. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ertekin-Taner,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Graff-Radford,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Ronald,"

Phrase: "J.,"

Phrase: "Blangero,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.337: (2000) Linkage of plasma A42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Linkage of plasma A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "to a quantitative locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "in late-onset Alzheimer's disease pedigrees."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030761:pedigrees [Intellectual Product]
   771   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.338: Science, 290, 23032304.[Abstract/Free FullText] Myers, A., Holmans, P., Marshall, H., Kwon, J., Meyer, D., Ramic, D., Shears, S., Booth, J., DeVrieze, F.W., Crook, R. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "290,"

Phrase: "23032304."

Phrase: "[Abstract/Free FullText"

Phrase: "] Myers,"

Phrase: "A.,"

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kwon,"

Phrase: "J.,"

Phrase: "Meyer,"

Phrase: "D."

Phrase: ","

Phrase: "Ramic,"

Phrase: "D."

Phrase: ","

Phrase: "Shears,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175735:shears [Medical Device]
   966 E C0205013:shear [Therapeutic or Preventive Procedure]

Phrase: "S."

Phrase: ","

Phrase: "Booth,"

Phrase: "J.,"

Phrase: "DeVrieze,"

Phrase: "F.W., Crook,"

Phrase: "R. etal."
Processing 00000000.tx.339: (2000) Susceptibility locus for Alzheimer's disease on chromosome 10. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Susceptibility locus for Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.340: Science, 290, 23042305.[Abstract/Free FullText] Tucker, H.M., Kihiko, M., Caldwell, J.N., Wright, S., Kawarabayashi, T., Price, D., Walker, D., Scheff, S., McGillis, J.P., Rydel, R.E. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "290,"

Phrase: "23042305."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tucker,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Kihiko,"

Phrase: "M."

Phrase: ","

Phrase: "Caldwell,"

Phrase: "J.N., Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S."

Phrase: ","

Phrase: "Kawarabayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "D."

Phrase: ","

Phrase: "Scheff,"

Phrase: "S."

Phrase: ","

Phrase: "McGillis,"

Phrase: "J.P.,"

Phrase: "Rydel,"

Phrase: "R.E. etal."
Processing 00000000.tx.341: (2000) The plasmin system is induced by and degrades amyloid-beta aggregates. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The plasmin system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "induced by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205263:Induced [Functional Concept]

Phrase: "and"

Phrase: "degrades"

Phrase: "amyloid-beta aggregates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205418:aggregates [Qualitative Concept]
   734   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.342: J. 

Phrase: "J."
Processing 00000000.tx.343: Neurosci., 20, 39373946.[Abstract/Free FullText] Glenner, G.G. and Wong, C.W. 

Phrase: "Neurosci.,"

Phrase: "20,"

Phrase: "39373946."

Phrase: "[Abstract/Free FullText"

Phrase: "] Glenner,"

Phrase: "G.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1319635:g/g [Quantitative Concept]

Phrase: "and"

Phrase: "Wong,"

Phrase: "C.W."
Processing 00000000.tx.344: (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: ":"

Phrase: "sharing of a unique cerebrovascular amyloid fibril protein."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   789   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0225328:Fibril [Cell Component]
   744   C0237876:Sharing [Social Behavior]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1710548:Unique [Qualitative Concept]
   744   C1880018:Cerebrovascular [Qualitative Concept]
   744   C1948066:Fibril [Physical Object]
Processing 00000000.tx.345: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.346: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.347: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.348: Commun., 122, 11311135.[ISI][Medline] Gravina, S.A., Ho, L., Eckman, C.B., Long, K.E., Otvos, L., Younkin, L.H., Suzuki, N. and Younkin, S.G. 

Phrase: "Commun.,"

Phrase: "122,"

Phrase: "11311135."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gravina,"

Phrase: "S."

Phrase: "A.,"

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Long,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "K.E.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.349: (1995) Amyloid beta protein (A beta) in Alzheimer's disease brain. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Amyloid beta protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "(A"

Phrase: "beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0330390:Beta [Plant]
  1000   C0439096:Beta [Intellectual Product]
  1000   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "in Alzheimer's disease brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.350: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). 

Phrase: "Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "immunocytochemical analysis with antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "specific for forms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "ending at A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444930:ending [Spatial Concept]
   790   C2746065:Ending [Temporal Concept]

Phrase: "beta 40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C0439509:/40 [Temporal Concept]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "or"

Phrase: "A"

Phrase: "beta 42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.351: J. 

Phrase: "J."
Processing 00000000.tx.352: Biol. 

Phrase: "Biol."
Processing 00000000.tx.353: Chem., 270, 70137016.[Abstract/Free FullText] Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I. and Selkoe, D.J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "270,"

Phrase: "70137016."

Phrase: "[Abstract/Free FullText"

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A.Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.354: (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mutation of the beta-amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "beta-protein production."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033268:production [Occupational Activity]
   734   C1750295:beta protein [Genetic Function]
   734   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.355: Nature, 360, 672674.[CrossRef][ISI][Medline] Suzuki, N., Cheung, T.T., Cai, X.D., Odaka, A., Otvos, L., Jr, Eckman, C., Golde, T.E. and Younkin, S.G. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "360,"

Phrase: "672674."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.356: (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. 

Phrase: "(1994"

Phrase: ")"

Phrase: "An increased percentage of long amyloid beta protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439165:Percentage [Quantitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]

Phrase: "secreted by familial amyloid beta protein precursor"
Meta Candidates (Total=24; Excluded=3; Pruned=0; Remaining=21)
   853   C0085151:Amyloid beta-Protein Precursor [Amino Acid, Peptide, or Protein]
           Amyloid Protein Precursor
   831 E C3538722:Amyloid Beta Precursor Protein [Laboratory Procedure]
           Amyloid Beta Precursor
       E   Amyloid Precursor Protein
   814   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   778   C1750295:beta protein [Genetic Function]
   778   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   778   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   774   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774 E C2825879:Amyloid, Beta [Laboratory Procedure]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0015576:familial [Family Group]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0241888:Familial [Functional Concept]
   748   C0330390:Beta [Plant]
   748   C0439096:Beta [Intellectual Product]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1327616:Secreted [Cell Function]
   748   C1709634:Precursor [Idea or Concept]
   748   C2004068:Beta [Qualitative Concept]
   738   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(beta APP717"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0299605:APP717 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.357: Science, 264, 13361340.[ISI][Medline] Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., Prada, C.M., Kim, G., Seekins, S., Yager, D. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "264,"

Phrase: "13361340."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Prada,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seekins,"

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D. etal."
Processing 00000000.tx.358: (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta142/140 ratio in vitro and in vivo. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Familial Alzheimer's disease-linked presenilin 1 variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0205419:variants [Qualitative Concept]
   701   C2931257:Alzheimer disease 1 [Disease or Syndrome]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "Abeta142/140 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.359: Neuron, 17, 10051013.[ISI][Medline] Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D. etal. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "17,"

Phrase: "10051013."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zehr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Prada,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Perez-tur,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Buee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Harigaya,"

Phrase: "Y.,"

Phrase: "Yager,"

Phrase: "D. etal."
Processing 00000000.tx.360: (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin1. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Increased amyloid-beta42"

Phrase: "(43"

Phrase: ")"

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "mutant presenilin1."
Processing 00000000.tx.361: Nature, 383, 710713.[CrossRef][ISI][Medline] Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "383,"

Phrase: "710713."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hsiao,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chapman,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nilsen,"

Phrase: "S."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Harigaya,"

Phrase: "Y.,"

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.362: (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Correlative memory deficits,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0233794:Memory Deficits [Mental or Behavioral Dysfunction]
   827   C2987487:deficits [Qualitative Concept]
   793 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "Abeta elevation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "and"

Phrase: "amyloid plaques in transgenic mice."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   806   C2936349:Plaques, Amyloid [Acquired Abnormality]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
Processing 00000000.tx.363: Science, 274, 99102.[Abstract/Free FullText] Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "274,"

Phrase: "99102."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W. etal."
Processing 00000000.tx.364: (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Secreted amyloid beta-protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1750295:beta protein [Genetic Function]
   861   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in the senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in vivo by the presenilin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "APP mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "linked to familial Alzheimer's disease."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.365: Nat. 

Phrase: "Nat."
Processing 00000000.tx.366: Med., 2, 864870.[ISI][Medline] Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A. etal. 

Phrase: "Med.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864870."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Carlson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "A. etal."
Processing 00000000.tx.367: (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutant presenilins of Alzheimer's disease increase production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "of 42-residue amyloid beta-protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C1750295:beta protein [Genetic Function]
   840   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   840   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C2004068:Beta [Qualitative Concept]

Phrase: "in both transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.368: Nat. 

Phrase: "Nat."
Processing 00000000.tx.369: Med., 3, 6772.[ISI][Medline] Li, X., Bokman, A.M., Llinas, M., Smith, R.A. and Dobson, C.M. 

Phrase: "Med.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6772."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "Bokman,"

Phrase: "A."

Phrase: "M."

Phrase: ","

Phrase: "Llinas,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R.A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Dobson,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: (1994) Solution structure of the kringle domain from urokinase-type plasminogen activator. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Solution structure of the kringle domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "from urokinase-type plasminogen activator."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0042071:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Plasminogen Activator, Urokinase
           Urokinase
  1000   C1522670:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Urokinase Plasminogen Activator
           Urokinase
   923   C1335224:plasminogen activator, urokinase [Gene or Genome]
           UROKINASE
   861   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C1367553:PLASMINOGEN [Gene or Genome]
   812   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.371: J. 

Phrase: "J."
Processing 00000000.tx.372: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.373: Biol., 235, 15481559.[CrossRef][ISI][Medline] Yoshimoto, M., Ushiyama, Y., Sakai, M., Tamaki, S., Hara, H., Takahashi, K., Sawasaki, Y. and Hanada, K. 

Phrase: "Biol.,"

Phrase: "235,"

Phrase: "15481559."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Ushiyama,"

Phrase: "Y.,"

Phrase: "Sakai,"

Phrase: "M."

Phrase: ","

Phrase: "Tamaki,"

Phrase: "S."

Phrase: ","

Phrase: "Hara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2758676:Hara [Fish]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sawasaki,"

Phrase: "Y."

Phrase: "and"

Phrase: "Hanada,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.374: (1996) Characterization of single chain urokinase-type plasminogen activator with a novel amino-acid substitution in the kringle structure. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Characterization of single chain urokinase-type plasminogen activator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1880022:Characterization [Activity]
   743   C0086987:Single-Chain Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "with a novel amino-acid substitution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0525038:Amino Acid Substitution [Genetic Function,Molecular Biology Research Technique]
   812   C1555721:Substitution [Idea or Concept]
   812   C1706204:Substitution [Activity]

Phrase: "in the kringle structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.375: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.376: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.377: Acta, 1293, 8389.[ISI][Medline] Finckh, U., van Hadeln, K., Muller-Thomsen, T., Alberici, A., Binetti, G., Hock, C., Nitsch, R.M., Stoppe, G., Reiss, J. and Gal, A. 

Phrase: "Acta,"

Phrase: "1293,"

Phrase: "8389."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Finckh,"

Phrase: "U.,"

Phrase: "van Hadeln,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Muller-Thomsen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Alberici,"

Phrase: "A.,"

Phrase: "Binetti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003086:Hock [Body Location or Region]
  1000   C1522382:Hock [Body Location or Region]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Stoppe,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Reiss,"

Phrase: "J."

Phrase: "and"

Phrase: "Gal,"

Phrase: "A."
Processing 00000000.tx.378: (2003) Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Association of late-onset Alzheimer disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1511978:Disease Association [Temporal Concept]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]
   716   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]

Phrase: "with a genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "of PLAU,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042071:PLAU [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1335224:PLAU [Gene or Genome]

Phrase: "the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   797   C0042071:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Plasminogen Activator, Urokinase
           Urokinase
   797   C1522670:Urokinase-Type Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
           Urokinase Plasminogen Activator
           Urokinase
   788   C1335224:Plasminogen Activator, Urokinase Gene [Gene or Genome]
           plasminogen activator, urokinase
           UROKINASE
   756   C0032144:Plasminogen Activator [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   754   C0314611:Gene type [Genetic Function]
   754   C0441730:Type 2 [Classification]
   754   C0678927:chromosome type [Cell Component]
   754   C1367553:Plasminogen Gene [Gene or Genome]
           PLASMINOGEN
   738   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0332307:Type [Qualitative Concept]
   738   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.379: Neurogenetics, 4, 213217.[CrossRef][ISI][Medline] Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J.J., Collen, D. and Mulligan, R.C. 

Phrase: "Neurogenetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597047:Neurogenetics [Biomedical Occupation or Discipline]

Phrase: "4,"

Phrase: "213217."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carmeliet,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schoonjans,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kieckens,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ream,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Degen,"

Phrase: "J.,"

Phrase: "Bronson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "De Vos,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "van den Oord,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "J.J.,"

Phrase: "Collen,"

Phrase: "D."

Phrase: "and"

Phrase: "Mulligan,"

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.380: (1994) Physiological consequences of loss of plasminogen activator gene function in mice. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Physiological consequences of loss of plasminogen activator gene function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.381: Nature, 368, 419424.[CrossRef][ISI][Medline] Weeks D.E., Sobel E., O'Connell J.R. and Lange K. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "368,"

Phrase: "419424."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439230:weeks [Temporal Concept]
   966 E C0332174:/week [Temporal Concept]

Phrase: "D."

Phrase: "E.,"

Phrase: "Sobel E.,"

Phrase: "O'Connell J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Lange K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.382: (1995) Computer programs for multilocus haplotyping of general pedigrees. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Computer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009622:Computer [Manufactured Object]

Phrase: "programs for multilocus haplotyping of general pedigrees."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0030761:pedigrees [Intellectual Product]
   748   C0205246:General [Spatial Concept]
   748   C0376691:Programs [Intellectual Product]
   748   C1553889:General [Idea or Concept]
   748   C1709697:Program [Conceptual Entity]
   748   C2728259:Program [Pharmacologic Substance]
   748   C3484370:Program [Functional Concept]
   714   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.383: Am. 

Phrase: "Am."
Processing 00000000.tx.384: J. 

Phrase: "J."
Processing 00000000.tx.385: Hum. 

Phrase: "Hum."
Processing 00000000.tx.386: Genet., 56, 15061507.[ISI][Medline] Sobel, E. and Lange, K. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "56,"

Phrase: "15061507."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sobel,"

Phrase: "E."

Phrase: "and"

Phrase: "Lange,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.387: (1996) Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Descent graphs in pedigree analysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681493:graphs [Intellectual Product]
   726 E C2698021:Graph [Conceptual Entity]

Phrase: ":"

Phrase: "applications to haplotyping,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0185125:applications [Health Care Activity]
   756 E C1947919:Application [Intellectual Product]
   756 E C2347934:Application [Intellectual Product]
   756 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "location scores,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Scores [Quantitative Concept]

Phrase: "and"

Phrase: "marker-sharing statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0038215:Statistics [Occupation or Discipline]
   827   C0600673:Statistics [Intellectual Product]
   793 E C2348149:Statistic [Quantitative Concept]
   793 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.388: Am. 

Phrase: "Am."
Processing 00000000.tx.389: J. 

Phrase: "J."
Processing 00000000.tx.390: Hum. 

Phrase: "Hum."
Processing 00000000.tx.391: Genet., 58, 13231337.[ISI][Medline] Lewontin, R.C. and Kojima, K. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "58,"

Phrase: "13231337."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lewontin,"

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Kojima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.392: (1960) The evolutionary dynamics of complex polymorphisms. 

Phrase: "(1960"

Phrase: ")"

Phrase: "The evolutionary dynamics of complex polymorphisms."
Processing 00000000.tx.393: Evolution, 14, 450472. 

Phrase: "Evolution,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015219:Evolution [Genetic Function]

Phrase: "14,"

Phrase: "450472."
Processing 00000000.tx.394: Almasy, L. and Blangero, J. 

Phrase: "Almasy,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Blangero,"

Phrase: "J."
Processing 00000000.tx.395: (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Multipoint quantitative-trait linkage analysis in general pedigrees."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0796345:linkage analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0023745:linkage [Molecular Function]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
Processing 00000000.tx.396: Am. 

Phrase: "Am."
Processing 00000000.tx.397: J. 

Phrase: "J."
Processing 00000000.tx.398: Hum. 

Phrase: "Hum."
Processing 00000000.tx.399: Genet., 62, 11981211.[CrossRef][ISI][Medline] Hopper, J.L. and Mathews, J.D. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "62,"

Phrase: "11981211."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hopper,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Mathews,"

Phrase: "J.D."
Processing 00000000.tx.400: (1982) Extensions to multivariate normal models for pedigree analysis. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Extensions to multivariate normal models"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1290989:Normal extension [Finding]
   760   C0231448:extensions [Functional Concept]
   726 E C1880641:Extension [Conceptual Entity]

Phrase: "for pedigree analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.401: Ann. 

Phrase: "Ann."
Processing 00000000.tx.402: Hum. 

Phrase: "Hum."
Processing 00000000.tx.403: Genet., 46, 373383.[ISI] Abecasis, G.R. and Cookson, W.O. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "46,"

Phrase: "373383."

Phrase: "[ISI] Abecasis,"

Phrase: "G.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Cookson,"

Phrase: "W.O."
Processing 00000000.tx.404: (2000) GOLDgraphical overview of linkage disequilibrium. 

Phrase: "(2000"

Phrase: ")"

Phrase: "GOLDgraphical overview of linkage disequilibrium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814812:overview [Intellectual Product]
Processing 00000000.tx.405: Bioinformatics, 16, 182183.[Abstract] Sham, P.C. and Curtis, D. 

Phrase: "Bioinformatics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "16,"

Phrase: "182183."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sham,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0068899:S-HAM [Therapeutic or Preventive Procedure]
  1000   C0073980:SHAM [Organic Chemical,Pharmacologic Substance]

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Curtis,"

Phrase: "D."
Processing 00000000.tx.406: (1995) Monte, Carlo tests for associations between disease and alleles at highly polymorphic loci. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Monte,"

Phrase: "Carlo tests for associations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0022885:Tests [Laboratory Procedure]
   770   C0392366:Tests [Intellectual Product]
   737 E C0039593:Test [Functional Concept]

Phrase: "between disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "alleles at highly polymorphic loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.407: Ann. 

Phrase: "Ann."
Processing 00000000.tx.408: Hum. 

Phrase: "Hum."
Processing 00000000.tx.409: Genet., 59, 97105.[ISI][Medline] Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N.P., Gerard, C., Hama, E., Lee, H.J. and Saido, T.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "59,"

Phrase: "97105."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N.P.,"

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Lee,"

Phrase: "H.J."

Phrase: "and"

Phrase: "Saido,"

Phrase: "T.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.410: (2001) Metabolic regulation of brain Abeta by neprilysin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Metabolic regulation of brain Abeta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by neprilysin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]
Processing 00000000.tx.411: Science, 292, 15501552.[Abstract/Free FullText] Patil, N., Berno, A.J., Hinds, D.A., Barrett, W.A., Doshi, J.M., Hacker, C.R., Kautzer, C.R., Lee, D.H., Marjoribanks, C., McDonough, D.P. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "292,"

Phrase: "15501552."

Phrase: "[Abstract/Free FullText"

Phrase: "] Patil,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Berno,"

Phrase: "A.J.,"

Phrase: "Hinds,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2983612:Hind [Spatial Concept]

Phrase: "D."

Phrase: "A.,"

Phrase: "Barrett,"

Phrase: "W.A.,"

Phrase: "Doshi,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Hacker,"

Phrase: "C.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0722969:c r [Organic Chemical,Pharmacologic Substance]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kautzer,"

Phrase: "C.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0722969:c r [Organic Chemical,Pharmacologic Substance]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Marjoribanks,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McDonough,"

Phrase: "D.P. etal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512024:D.P. [Intellectual Product]
Processing 00000000.tx.412: (2001) Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Blocks of limited haplotype diversity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0018591:Haplotype [Organism Attribute]
   760   C0028778:Block [Pathologic Function]
   760   C0332206:Block [Functional Concept]
   760   C0439801:Limited [Functional Concept]
   760   C1533157:Block [Substance]
   760   C1706084:Block [Geographic Area]
   760   C1880371:Diversity [Qualitative Concept]
   760   C2828370:Block [Quantitative Concept]
   760   C3542948:Limited [Intellectual Product]

Phrase: "revealed by high-resolution scanning of human chromosome 21."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0008643:Human Chromosome [Cell Component]
   764   C0008664:Chromosome 21 [Cell Component]
   764   C1719039:High resolution [Laboratory Procedure]
   742   C0008633:Chromosome [Cell Component]
   742   C0034606:Scanning [Diagnostic Procedure]
   742   C0086418:Human [Human]
   742   C0205250:High [Qualitative Concept]
   742   C0441633:Scanning [Diagnostic Procedure]
   742   C0443289:Revealed [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C1514893:Resolution [Idea or Concept]
   742   C1706463:Resolution [Quantitative Concept]
   742   C2699488:Resolution [Conceptual Entity]
   742   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.413: Science, 294, 17191723.[Abstract/Free FullText] Daly, M.J., Rioux, J.D., Schaffner, S.F., Hudson, T.J. and Lander, E.S. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "294,"

Phrase: "17191723."

Phrase: "[Abstract/Free FullText"

Phrase: "] Daly,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Rioux,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Schaffner,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Hudson,"

Phrase: "T.J."

Phrase: "and"

Phrase: "Lander,"

Phrase: "E.S."
Processing 00000000.tx.414: (2001) High-resolution haplotype structure in the human genome. 

Phrase: "(2001"

Phrase: ")"

Phrase: "High-resolution haplotype structure in the human genome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.415: Nat. 

Phrase: "Nat."
Processing 00000000.tx.416: Genet., 29, 229232.[CrossRef][ISI][Medline] Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "29,"

Phrase: "229232."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gabriel,"

Phrase: "S."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Schaffner,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Nguyen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Roy,"

Phrase: "J.,"

Phrase: "Blumenstiel,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Higgins,"

Phrase: "J.,"

Phrase: "DeFelice,"

Phrase: "M."

Phrase: ","

Phrase: "Lochner,"

Phrase: "A.,"

Phrase: "Faggart,"

Phrase: "M. etal."
Processing 00000000.tx.417: (2002) The structure of haplotype blocks in the human genome. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The structure of haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:Structure [Spatial Concept]

Phrase: "blocks in the human genome."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0017429:Genome, Human [Gene or Genome]
   760   C0017428:Genome [Gene or Genome]
   760   C0028778:Block [Pathologic Function]
   760   C0086418:Human [Human]
   760   C0332206:Block [Functional Concept]
   760   C1533157:Block [Substance]
   760   C1706084:Block [Geographic Area]
   760   C2338314:Genome [Conceptual Entity]
   760   C2828370:Block [Quantitative Concept]
Processing 00000000.tx.418: Science, 296, 22252229.[Abstract/Free FullText] Kawarabayashi, T., Younkin, L.H., Saido, T.C., Shoji, M., Hsiao, Ashe, K. and Younkin, S.G. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "296,"

Phrase: "22252229."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kawarabayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Hsiao,"

Phrase: "Ashe,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.419: (2001) Age-dependent changes in brain, CSF, and plasma amyloid  protein in the Tg2576 transgenic mouse model of Alzheimer's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Age-dependent changes in brain,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "CSF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "plasma amyloid  protein in the Tg2576 transgenic mouse model of Alzheimer's disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1168405:protein plasma [Laboratory Procedure]
   751   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1451673:Mal protein, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.420: J. 

Phrase: "J."
Processing 00000000.tx.421: Neurosci., 21, 372381.[Abstract/Free FullText] Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S. and Hirschhorn, J.N. 

Phrase: "Neurosci.,"

Phrase: "21,"

Phrase: "372381."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lohmueller,"

Phrase: "K.E.,"

Phrase: "Pearce,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "M."

Phrase: ","

Phrase: "Lander,"

Phrase: "E.S."

Phrase: "and"

Phrase: "Hirschhorn,"

Phrase: "J.N."
Processing 00000000.tx.422: (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Meta-analysis of genetic association studies"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   783   C0679560:genetic analysis [Laboratory Procedure]
   783   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a contribution of common variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to common disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.423: Nat. 

Phrase: "Nat."
Processing 00000000.tx.424: Genet., 33, 177182.[CrossRef][ISI][Medline] Myers, A.J., Marshall, H., Holmans, P., Compton, D., Crook, R.J., Mander, A.P., Nowotny, P., Smemo, S., Dunstan, M., Jehu, L. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "33,"

Phrase: "177182."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Myers,"

Phrase: "A.J.,"

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Compton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1467391:compton [Eukaryote]

Phrase: "D."

Phrase: ","

Phrase: "Crook,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mander,"

Phrase: "A.P.,"

Phrase: "Nowotny,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Smemo,"

Phrase: "S."

Phrase: ","

Phrase: "Dunstan,"

Phrase: "M."

Phrase: ","

Phrase: "Jehu,"

Phrase: "L. etal."
Processing 00000000.tx.425: (2004) Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Variation in the urokinase-plasminogen activator gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variation [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "the chromosome 10 linkage signal for late onset AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.426: Am. 

Phrase: "Am."
Processing 00000000.tx.427: J. 

Phrase: "J."
Processing 00000000.tx.428: Med. 

Phrase: "Med."
Processing 00000000.tx.429: Genet., 124B, 2937.[CrossRef] Ertekin-Taner, N., Ronald, J., Asahara, H., Younkin, L., Hella, M., Jain, S., Gnida, E., Younkin, S., Fadale, D., Ohyagi, Y. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "124B,"

Phrase: "2937."

Phrase: "[CrossRef"

Phrase: "] Ertekin-Taner,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ronald,"

Phrase: "J.,"

Phrase: "Asahara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hella,"

Phrase: "M."

Phrase: ","

Phrase: "Jain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337694:Jain [Idea or Concept]
  1000   C1998092:Jain [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "Gnida,"

Phrase: "E.,"

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Fadale,"

Phrase: "D."

Phrase: ","

Phrase: "Ohyagi,"

Phrase: "Y. etal."
Processing 00000000.tx.430: (2003) Fine mapping of the {alpha}-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Fine mapping of the {alpha}-T catenin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0008630:Gene Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   744   C1283195:Mapping [Activity]

Phrase: "to a quantitative trait locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597336:quantitative trait locus [Gene or Genome]
   827   C0392762:Quantitative [Quantitative Concept]
   827   C0599883:Trait [Organism Attribute]
   827   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008652:Chromosome 10 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "in late-onset Alzheimer's disease pedigrees."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030761:pedigrees [Intellectual Product]
   771   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
Processing 00000000.tx.431: Hum. 

Phrase: "Hum."
Processing 00000000.tx.432: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.433: Genet., 12, 31333143.[Abstract/Free FullText] Ertekin-Taner, N., Allen, M., Fadale, D., Scanlin, L., Younkin, L., Petersen, R.C., Graff-Radford, N. and Younkin, S.G. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "31333143."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ertekin-Taner,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Allen,"

Phrase: "M."

Phrase: ","

Phrase: "Fadale,"

Phrase: "D."

Phrase: ","

Phrase: "Scanlin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Petersen,"

Phrase: "R.C., Graff-Radford,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.434: (2004) Genetic variants in a haplotype block spanning IDE are significantly associated with plasma A42 levels and risk for Alzheimer's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Genetic variants in a haplotype block spanning IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:variants [Qualitative Concept]

Phrase: "are"

Phrase: "significantly"

Phrase: "associated with plasma A42 levels"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0032105:Plasma [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "risk for Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.435: Hum. 

Phrase: "Hum."
Processing 00000000.tx.436: Mutat., 23, 334342.[CrossRef][ISI][Medline] McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. 

Phrase: "Mutat.,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "334342."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.437: (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of Department of Health and Human Services Task Force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer's Disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.438: Neurology, 34, 939944.[Abstract] Howell, W.M., Jobs, M., Gyllensten, U. and Brookes, A.J. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939944."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Howell,"

Phrase: "W."

Phrase: "M."

Phrase: ","

Phrase: "Jobs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028811:jobs [Occupation or Discipline]
   966 E C2826594:Job [Machine Activity]

Phrase: "M."

Phrase: ","

Phrase: "Gyllensten,"

Phrase: "U."

Phrase: "and"

Phrase: "Brookes,"

Phrase: "A.J."
Processing 00000000.tx.439: (1999) Dynamic allele-specific hybridization. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Dynamic allele-specific hybridization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.440: A new method for scoring single nucleotide polymorphisms. 

Phrase: "A"

Phrase: "new method for scoring single nucleotide polymorphisms."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0036449:Scoring Method [Research Activity]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.441: Nat. 

Phrase: "Nat."
Processing 00000000.tx.442: Biotechnol., 17, 8788.[CrossRef][ISI][Medline] Prince, J.A., Feuk, L., Howell, W.M., Jobs, M., Emahazion, T., Blennow, K. and Brookes, A.J. 

Phrase: "Biotechnol.,"

Phrase: "17,"

Phrase: "8788."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Prince,"

Phrase: "J.A.,"

Phrase: "Feuk,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Howell,"

Phrase: "W."

Phrase: "M."

Phrase: ","

Phrase: "Jobs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0028811:jobs [Occupation or Discipline]
   966 E C2826594:Job [Machine Activity]

Phrase: "M."

Phrase: ","

Phrase: "Emahazion,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Blennow,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Brookes,"

Phrase: "A.J."
Processing 00000000.tx.443: (2001) Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Robust"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986815:Robust [Qualitative Concept]

Phrase: "and"

Phrase: "accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1285573:Genotyping [Laboratory Procedure]

Phrase: ":"

Phrase: "design criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "assay validation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519941:Validation [Research Activity]
Processing 00000000.tx.444: Genome Res., 11, 152162.[Abstract/Free FullText] Dyke, B. and Mamelka, P. 

Phrase: "Genome Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "11,"

Phrase: "152162."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dyke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337122:Dike [Manufactured Object]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Mamelka,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.445: (1996) PEDSYS, A Pedigree Data Management System, version 2.0. 

Phrase: "(1996"

Phrase: ")"

Phrase: "PEDSYS,"

Phrase: "A"

Phrase: "Pedigree Data Management System,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   875   C1622900:System, Data [Intellectual Product,Manufactured Object]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "version 2.0."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]
Processing 00000000.tx.446: Population Genetics Laboratory Department of Genetics Southwest Foundation for Biomedical Research, San Antonio, TX. 

Phrase: "Population Genetics Laboratory Department of Genetics Southwest Foundation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0587466:Genetics department [Health Care Related Organization]
   744   C1704729:Department [Organization]

Phrase: "for Biomedical Research,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005540:Biomedical Research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1879848:Biomedical [Biomedical Occupation or Discipline]

Phrase: "San Antonio,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "TX."
Processing 00000000.tx.447: Excoffier, L. and Slatkin, M. 

Phrase: "Excoffier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Slatkin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.448: (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Maximum-likelihood estimation of molecular haplotype frequencies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C1708949:Maximum Likelihood Estimation [Research Activity]
   748   C0680844:estimation [Mental Process]
   748   C0681916:Estimation [Quantitative Concept]
   748   C0750572:Estimation [Quantitative Concept]

Phrase: "in a diploid population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.449: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.450: Biol. 

Phrase: "Biol."
Processing 00000000.tx.451: Evol., 12, 921927.[Abstract]

Phrase: "Evol.,"

Phrase: "12,"

Phrase: "921927."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

